{"title": "Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda de Atenci\u00f3n Primaria", "author": null, "url": "https://www.aepap.org/grupos/grupo-de-patologia-infecciosa/actualidad-bibliografica/bibliografia-de-2020", "hostname": "aepap.org", "description": "Actualidad bibliogr\u00e1fica diciembre 2020TOP TENHelicobacter pylori infection in children. BMJ Paediatr Open. 2020; 4(1): e000679. doi: 10.1136/bmjpo-2020-000679. PMID: 32818155", "sitename": "aepap.org", "date": "2015-07-01", "cleaned_text": "Esta revisi\u00f3n de la infecci\u00f3n por H pylori se centra en algunas consideraciones actuales sobre epidemiolog\u00eda, diagn\u00f3stico y tratamiento de la infecci\u00f3n infantil. Las diferencias entre la infecci\u00f3n en adultos y poblaci\u00f3n pedi\u00e1trica es considerable y conlleva una serie de premisas, intervenciones y decisiones de tratamiento tambi\u00e9n muy diferentes. Aunque la prevalencia de la infecci\u00f3n es alta en ni\u00f1os, hay que considerar que la mayor\u00eda son asintom\u00e1ticos. En la revisi\u00f3n se expone claramente que la enfermedad, y no la infecci\u00f3n, est\u00e1 relacionada con la virulencia de la cepa, la predisposici\u00f3n gen\u00e9tica, la respuesta inmune del hu\u00e9sped, el tiempo de exposici\u00f3n y factores ambientales. La decisi\u00f3n de investigar y tratar la infecci\u00f3n por H. pylori en ni\u00f1os debe basarse en conseguir verdaderos beneficios, teniendo en cuenta la baja frecuencia de complicaciones en esta etapa, la recurrencia de la infecci\u00f3n, las probables relaciones inversas con enfermedades al\u00e9rgicas e inmunol\u00f3gicas (enfermedades inflamatorias intestinales), la resistencia a los antimicrobianos, as\u00ed como las pocas alternativas de tratamiento disponibles para tratar la infecci\u00f3n en ni\u00f1os. Tularemia colloquially also clinical the mode of acquisition and the responsible subspecies constitutes a major challenge for clinicians. This review aims to provide a summary and adolescents. Comentario: Revisi\u00f3n de una patolog\u00eda no frecuente pero con brotes recurrentes en nuestro pa\u00eds (Especialmente dedicado a los pediatras de Castilla y Le\u00f3n.) Dacryocystitis is considered benign, yet represent a of The presentation, management, and rates of serious bacterial infection in infants with dacryocystitis have not been described. of infants to single urban tertiary care pediatric emergency department between January 1995 and text software, followed by manual chart review. Results: We identified 333 subjects, and median Fifty-three were female. Most were afebrile (81%, T < 38\u00b0C) at triage while 6% had fever of 39\u00b0C. Two of 135 blood cultures (CSF) cultures were positive. Eye cultures were positive in 47% (N = 58) of infants cultured (N = 123); the most common pathogens were Haemophilus species (N = 17), Staphylococcus aureus (N 13), Gram-negative rods (N = 7), and Moraxella species (N = 4). Imaging was obtained in 11 with and 1 a was consulted an intervention/probe 6%. Topical antibiotics were used in 147 subjects (44%), oral antibiotics in 100 (33%), and parenteral antibiotics in 87 (26%). Conclusion: Infants with dacryocystitis have a variable presentation and management ranges from observation to aggressive management. The rates of serious bacterial infection were low in this sample and not associated with any presenting risk factors. Comentario: Estudio retrospectivo de 333 casos de dacriocistitis en menores de 12 meses recogiendo la etiolog\u00eda, las complicaciones y el tratamiento realizado. Background: There is limited information on severe acute respiratory 2 (SARS-CoV-2) infection database on SARS-CoV-2 infections. We studied in-family transmission. The level of viral load was categorized as high, moderate, or low based infection. Among the children (45.3%) (COVID-19), 24 (26.1%) were hospitalized. Infants <1 year were more likely to develop COVID-19 (19.5% of all COVID-19 cases) (P-value = 0.001). There was no significant difference between viral load and age, sex, underlying condition, fever and hospitalization, as well as between type of SARS-CoV-2 infection and age, sex, underlying condition and viral load. Transmission from a household member accounted for 132 of 178 (74.2%) children for whom the source of infection was identified. An adult member with COVID-19 was the first case in 125 (66.8%) family clusters. Child-to-adult transmission was found in one role in spread of the virus in families. Most children have moderate or high viral loads in the ongoing pandemic and particularly in light of schools reopening and the need to prioritize groups for vaccination, when COVID-19 vaccines will be available. Comentario: A partir de 203 casos de infecci\u00f3n COVID en ni\u00f1os, los autores concluyen que la mayor\u00eda de los ni\u00f1os tienen cargas virales moderadas o elevadas independientemente de la edad, los s\u00edntomas o la severidad de la infecci\u00f3n. No hubo diferencia significativa entre la carga viral, evaluada seg\u00fan los valores del umbral de ciclo, y la edad, sexo, afecci\u00f3n subyacente, fiebre y hospitalizaci\u00f3n, as\u00ed como entre el tipo de infecci\u00f3n por SARS-CoV-2 y la edad, sexo, afecci\u00f3n subyacente y carga viral. La transmisi\u00f3n ocurri\u00f3 a partir de un miembro de la familia en el 74% de los casos en los que se identific\u00f3 la fuente del contacto. En el 66,8% de los grupos familiares el primer caso fue un adulto de la familia con COVID19. La transmisi\u00f3n ni\u00f1o-adulto fue excepcional, solo en un caso. Background: Our aim was to describe the clinical features of mothers with coronavirus disease 2019 (COVID-19) infection during gestation or delivery, and the potential vertical transmission. We also wish to evaluate the possible horizontal transmission after hospital discharge, by means of a follow-up of all the newborns included at 1 month of age. Methods: This multicenter descriptive study involved 16 Spanish hospitals. We reviewed the medical records of 242 pregnant women diagnosed with COVID-19 from March 13 to May 31, 2020, when they were in their third trimester of pregnancy. They and their 248 newborn infants were Caesarean symptoms were coughing (33%) and fever (29.7%). Mothers hospitalized due to COVID-19 pathology had a higher risk of their pregnancy via (P = 0.027). Newborns whose mothers had been admitted due to their COVID-19 infection had a higher risk of premature delivery (P = 0.006). We admitted 115 (46.3%) newborn infants to the neonatal unit, of those, 87 (75.6%) were only admitted due to organizational circumstances. No infants died and no vertical or horizontal transmission was detected. Regarding type of feeding, 41.7% did not detect COVID-19 transmission during delivery or throughout the first month of life in the newborns included in our study. Exclusive breast-feeding rates at discharge and at 1 month of age were lower than expected. Comentario: Estudio espa\u00f1ol que recoge 242 casos de madres diagnosticadas de COVID-19 en su tercer trimester de embarazo. Nacen 248 ni\u00f1os. No detecta transmision en los RN y observa una menor tasa de lactancia maternal al alta de la maternidad y un mes despu\u00e9s. Se realiz\u00f3 ces\u00e1rea en 26%. Riesgo m\u00e1s elevado de prematuridad. Acute encephalitis in childhood referral centers often are reported. The aim of this study was to prospectively study the clinical picture and etiology of All children with acute encephalitis were prospectively included from 2011 to 2016. Laboratory tests, investigations and were performed according to (46 female and 43 male) with a median age of preventable by vaccination. Immune-mediated encephalitis was seen in 7 children. abnormal picture was seen in 77/86, pathologic were reported by 49%. A high prevalence of previous contact with child and adolescent psychiatry was seen and, although not statistically significant, the need for extra support at school before encephalitis and the presence of central nervous system disease in the family seemed to predispose for a longer hospital stay. Conclusion: Encephalitis is a condition with long-term consequences. Most children need admission to hospital, and many need surveillance in the intensive care unit. The etiology can be determined in a majority of cases, and 1/3 could have been prevented by vaccination. This study corroborates electroencephalography as a cornerstone in diagnosis. Comentario: estudio sueco que recoge 89 casos de encefalitis registrados durante 5 a\u00f1os. Se logra filiar su etiolog\u00eda en 61 casos (69%). El 34% hubieran children. and Europe. Methods: Multicenter retrospective cohort study. Children 0 to 18 years age with fever, positive urinalysis and positive urine culture for hospital from January treatment. Results: We included 142 children from 14 hospitals in 8 countries. Sixty-one children had IET and 77 IIT. There was no statistical difference in time to defervescence for effective/ineffective groups ( P 0.722) and single/combination groups or UTI occurred 15.5 days (interquartile range, 9.0-19.0) after the end of treatment. Conclusions: Time to defervescence and clinical failure did not IET/IIT beta-lactam de ITU febriles producidas por bacterias con BLEE, no hubo diferencias significativas en cuanto a los signos/s\u00edntomas de ITU recurrente entre los que recibieron tratamiento microbiol\u00f3gicamente efectivo inicial o los que lo recibieron microbiol\u00f3gicamente inefectivo inicial. Tampoco hubo diferencia en el tiempo de defervescencia. Por ello concluyen que se pueden usar antibi\u00f3ticos beta lact\u00e1micos no carbapen\u00e9micos para el tratamiento emp\u00edrico de ITUs febriles por BLEE hasta el resultado del antibiograma. Intussusception is the leading cause of acute been associated with intussusception. Methods: We searched the literature published between January 1, 1990, and March 16, 2020, to describe the association between intussusception among infants and young children and various reporting We identified 3793 records intussusception evaluations from 15 countries that evaluated 52 pathogens were included in the analysis. All 14 evaluations of adenovirus reported a statistically significant positive association with from 9 evaluations was 3.7 (interquartile range, 3.3, 8.2). Nine of 12 evaluations assessing rotavirus found no statistically significant association, 1 association and 2 reported a protective effect; the median OR from 12 range, 0.2, 1.8). No consistent observed between other pathogens and intussusception. Conclusions: We documented a consistent association of intussusception with adenovirus, but no relationship between wild-type rotavirus and intussusception. Future research should 3793 registros de invaginaci\u00f3n recogidos de la literature se documenta una asociaci\u00f3n entre invaginaci\u00f3n y adenovirus. No se observa con cualquier otro pat\u00f3geno. Coronavirus disease 2019 lead to wide-spread quarantines and cancelations. The noncoronavirus disease 2019, infectious diseases was analyzed within respiratory route effect from those transmitted through sexual activity. Comentario: Art\u00edculo de inter\u00e9s porque analiza la evoluci\u00f3n en frecuencia de distintas enfermedades infecciosas en relaci\u00f3n con la pandemia COVID. Considera datos de edad. Social distancing measures are used to reduce the spreading of infection. Our aim was to assess the immediate effects of national lockdown orders due to disease (COVID-19) on pediatric room (ER) visits (Kuopio Central Hospital) covering 1/5th of the Finnish children population, 4 weeks before and 4 weeks after the start of the nationwide lockdown on March 16, 2020. Nationwide weekly numbers of influenza (A + B) and respiratory syncytial virus (RSV) in children were assessed from the infectious disease register from 2015 to 2020. Results: A major in the rate of daily median pediatric ER visits was detected study during the nationwide lockdown compared with the study period before the lockdown (Mikkeli, 19 vs. 7, P < 0.001; Kuopio, 9 vs. 2,5, P < 0.001). The influenza season was shorter (8 weeks from peak to no cases), and the weekly rate of new cases decreased faster compared with the previous 4 influenza seasons (previously 15-20 weeks from peak to no cases). A similar decrease was also seen in RSV cases. No pediatric cases of COVID-19 were found in participating hospitals during the study period. Conclusion: distancing and strategies effective to slow down the spreading of common respiratory viral diseases and decreasing the need for hospitalization among children. Comentario: Estudio finland\u00e9s que muestra disminuci\u00f3n de casos de infecciones respiratorias durante la \u00e9poca de confinamiento por COVID. Se buscaron los estudios que evaluaron la precisi\u00f3n de las im\u00e1genes de t\u00f3rax (obtenidas mediante TC, radiograf\u00eda o ecograf\u00eda tor\u00e1cica) para diagnosticar covid-19 en personas con sospecha de presentar esta enfermedad. Los estudios pod\u00edan tener cualquier dise\u00f1o y haberse realizado en cualquier lugar. Los resultados agrupados mostraron que la TC de t\u00f3rax diagnostic\u00f3 correctamente la covid-19 en el 89,9% de las personas que presentaban covid-19. Sin embargo, identific\u00f3 incorrectamente la covid-19 en el 38% de las personas que no la ten\u00edan. El diagn\u00f3stico correcto de covid-19 con radiograf\u00edas de t\u00f3rax vari\u00f3 entre el 57% y el 89%. Sin embargo, el diagn\u00f3stico incorrecto de covid-19 en personas que no presentaban covid-19 vari\u00f3 entre el 11% y el 89%. La ecograf\u00eda de pulm\u00f3n diagnostic\u00f3 correctamente la covid-19 en el 96% de las personas con la enfermedad. Sin embargo, diagnostic\u00f3 incorrectamente la covid-19 en el 38% de las personas que no presentaban covid-19. Conclusiones de los autores: Los hallazgos indican que la TC de t\u00f3rax es sensible y moderadamente espec\u00edfica para el diagn\u00f3stico de covid-19 en pacientes con sospecha de la enfermedad, lo que significa que la TC puede tener una capacidad limitada para diferenciar la infecci\u00f3n por SARS-CoV-2 de otras causas de enfermedades respiratorias. Sin embargo, la confianza en estos resultados es limitada debido a la calidad deficiente de los estudios y a la heterogeneidad de los estudios incluidos. Debido a la limitaci\u00f3n de los datos, las estimaciones de la exactitud de la radiograf\u00eda de t\u00f3rax y la ecograf\u00eda de pulm\u00f3n para el diagn\u00f3stico de covid-19 se deben interpretar con cuidado. Se investig\u00f3 el efecto de la prescripci\u00f3n diferida de antibi\u00f3ticos en comparaci\u00f3n con la prescripci\u00f3n inmediata o el tratamiento sin antibi\u00f3ticos en pacientes con infecciones respiratorias que incluyen el dolor de garganta, la infecci\u00f3n del o\u00eddo medio, la tos (bronquitis) y el resfriado com\u00fan. Se incluyeron todas las IRA independientemente de si se indicaron o no antibi\u00f3ticos. Tambi\u00e9n se evalu\u00f3 el uso de los antibi\u00f3ticos, la satisfacci\u00f3n de los pacientes, la resistencia a los antibi\u00f3ticos, las tasas de nueva consulta y el uso de terapias suplementarias. \u00c9sta es una actualizaci\u00f3n de una revisi\u00f3n publicada en 2007, 2010 y 2013. La administraci\u00f3n diferida de antibi\u00f3ticos redujo el uso de antibi\u00f3ticos en comparaci\u00f3n con la administraci\u00f3n inmediata de antibi\u00f3ticos, pero no mostraron ser diferentes al tratamiento sin antibi\u00f3ticos en cuanto al control de los s\u00edntomas ni las complicaciones de la enfermedad. No hubo diferencias significativas en las tasas de complicaciones. Diferir la prescripci\u00f3n no dio lugar a niveles significativamente diferentes de satisfacci\u00f3n de los pacientes en comparaci\u00f3n con la administraci\u00f3n inmediata de los antibi\u00f3ticos Es una 'version history' o historial de versiones donde explica lo nuevo de cada actualizaci\u00f3n. En esta, se a\u00f1ade un nuevo estudio de 405 pacientes. El tratamiento de la OMSC con antibi\u00f3ticos t\u00f3picos (quinolonas) probablemente resulte en una mejor resoluci\u00f3n de la secreci\u00f3n del o\u00eddo en comparaci\u00f3n con el \u00e1cido b\u00f3rico a las dos semanas. Hubo evidencia limitada de la eficacia de otros antibi\u00f3ticos t\u00f3picos o antis\u00e9pticos t\u00f3picos, por lo que no es posible establecer conclusiones. Los eventos adversos no se informaron de manera adecuada. As schools plan for re-opening, understanding the potential role children play in the coronavirus infectious disease 2019 (COVID-19) pandemic and the factors that drive severe illness in children is critical. Study Massachusetts General Hospital were offered enrollment in the Massachusetts General for were quantified. Results A total of 192 children (mean age, 10.2 \u00b1 7.0 years) were enrolled. Forty-nine children (26%) were diagnosed with acute SARS-CoV-2 infection; an additional 18 children (9%) met the criteria for MIS-C. Only 25 nonspecific. Nasopharyngeal viral load was highest in children in the 2 days higher than hospitalized adults Age did not impact viral load, but younger children had lower angiotensin-converting enzyme 2 expression (P = .004). Immunoglobulin M (IgM) and Immunoglobulin G (IgG) to the receptor binding domain of the SARS-CoV-2 spike protein were increased observed. This study reveals that children the SARS-CoV-2 severe postinfectious MIS-C. Comentario: otro art\u00edculo que refiere m\u00e1s alta carga viral en ni\u00f1os que en adultos. Tiene inter\u00e9s un cuadro con la presencia/frecuencia de s\u00edntomas en distintas situaciones cl\u00ednicas. La incidencia de la enfermedad meningoc\u00f3cica invasiva (EMI) por serogrupo C ha disminuido desde la introducci\u00f3n de la vacunaci\u00f3n sistem\u00e1tica el a\u00f1o 2000. El objetivo de este estudio es determinar los casos de EMI diagnosticados desde entonces y los fallos vacunales en los casos por serogrupo C. Pacientes y m\u00e9todos, An\u00e1lisis retrospectivo de pacientes diagnosticados de EMI confirmada por cultivo o reacci\u00f3n en cadena de la polimerasa, en un hospital infantil de tercer nivel de Barcelona, entre 2001 y 2018. Se analiz\u00f3 el n\u00famero de dosis de vacuna recibidas y la edad, recogidos de la historia cl\u00ednica y del carnet de vacunaciones. Resultados, Se confirmaron 128 casos de EMI (7,1 casos/a\u00f1o; 70,3% en <5 a\u00f1os). Se estudi\u00f3 el serogrupo en 125 casos (97,6%): 103 fueron B (82,4%), 10 fueron C (8%), uno fue 29E (0,8%) y uno fue Y (0,8%); solo 10 (8%) no fueron serogrupables. De los 10 pacientes con serogrupo C, 4 no estaban vacunados y en 3 la pauta fue incompleta en cuanto a n\u00famero de dosis; 3 de ellos recibieron la pauta completa seg\u00fan la edad y el calendario vacunal vigente, por lo que se consideran fallos vacunales. Fallecieron 6 pacientes (tasa de letalidad: 4,7%): 5 por serogrupo B (letalidad: 4,8%) y uno por serogrupo C (letalidad: 10%). Conclusiones, El serogrupo C represent\u00f3 solo el 8% de los casos de EMI en el periodo de estudio y los fallos vacunales de este serogrupo unas enfermedades raras, frecuentemente infradiagnosticadas y potencialmente fatales. Las manifestaciones cl\u00ednicas de las IDP pueden ser muy graves y ocasionar secuelas que empeoran la calidad de vida de los pacientes. Tradicionalmente, el tratamiento de las IDP ha sido fundamentalmente de soporte, con excepci\u00f3n del trasplante de progenitores hematopoy\u00e9ticos y, m\u00e1s recientemente, la terapia g\u00e9nica. El descubrimiento de nuevos mecanismos patog\u00e9nicos, el desarrollo de nuevas mol\u00e9culas y f\u00e1rmacos biol\u00f3gicos y los avances en el conocimiento de las bases moleculares de estas enfermedades han abierto oportunidades para el tratamiento de esta afecci\u00f3n. El objetivo de este documento es revisar el conocimiento actual y aportar recomendaciones para el diagn\u00f3stico y el tratamiento cl\u00ednico de los pacientes adultos y pedi\u00e1tricos con IDP basado en la evidencia cient\u00edfica disponible y teniendo en cuenta la actual pr\u00e1ctica y los retos futuros. Se realiz\u00f3 una revisi\u00f3n sistem\u00e1tica, que justifica los niveles de evidencia para cada recomendaci\u00f3n. En el documento se responden a las siguientes cuestiones: 1-\u00bfcu\u00e1ndo deber\u00eda sospecharse una IDP en un ni\u00f1o o adultos ( habiendo descartado causas adquiridas de inmunodeficiencia? 2- \u00bf Qu\u00e9 pruebas diagn\u00f3sticas deber\u00edan realizarse si se sospecha una IDP? 3-\u00bf Qu\u00e9 otros estudios deber\u00edan realizarse en ni\u00f1os/adultos con IDP al diagn\u00f3stico y durante el seguimiento? 4- \u00bfC\u00f3mo deber\u00eda hacerse el screening en neonatos? 5- \u00bf Cu\u00e1ndo y qu\u00e9 tipo de profilaxis antibi\u00f3tica debe ofrecerse 6- \u00bfQu\u00e9 tipos de vacunas deben ofrecerse? 7- \u00bfCu\u00e1ndo se recomienda el tto sustitutivo con inmunoglobulinas (Igs)? \u00bfQu\u00e9 v\u00eda se recomienda? \u00bfC\u00f3mo se debe llevar a cabo la monitorizaci\u00f3n durante el seguimiento? 8- \u00bf cu\u00e1ndo considerar un trasplante de progenitores hematopoy\u00e9ticos en un ni\u00f1o con IDP? 9- \u00bf cu\u00e1ndo considerar un trasplante de progenitores hematopoy\u00e9ticos en un ADULTO con IDP? 10- \u00bf Qu\u00e9 otro tto inmunomodiladores y curativos pueden emplearse? To develop a more comprehensive description of multisystem inflammatory studies of MIS-C cases published from April 25, 2020, through June 29, 2020. MIS-C study metadata were assessed and information age of patients by study ranged from 7.3 to 10 years, and 59% of patients were male. Across all from 13% to 69% and for serology, from 75% to 100%. Patients with MIS-C had high prevalence of gastrointestinal (87%), case definition of MIS-C. Recently, severe coronavirus inflammatory syndrome in children (MIS-C) have been recognized. Analysis of studies for this novel syndrome is needed for a better understanding of effective articles to July 31, 2020. Observational cross-sectional, cohort, case series, and case reports were included. A total of 328 articles were identified. Sixteen studies with 655 participants (3 months-20 years of age) were included in the final analysis. Most of the children in reported studies presented with fever, gastrointestinal the clinical manifestations and outcomes of critically ill children with coronavirus disease-19 (COVID-19) in New York City. Retrospective observational study of children 1 month to 21 years admitted March 14 to May 2, 2020, to 9 New York City pediatric intensive care 20 extubated by day of 218 (IQR 79, 310.4) hours. Presence of ARDS was significantly associated with duration of PICU and hospital stay, and lower probability of PICU and hospital discharge at hospital day 14 (P < .05 for all). Critically ill children with COVID-19 predominantly are adolescents, have comorbidities, and require some form of respiratory support. The presence of ARDS is significantly associated with prolonged PICU and hospital stay. An otherwise healthy 11-year-old Japanese boy presented with a 3-week history of a right neck mass. Except for mild fatigue, he did not display any associated general symptoms, fever, night sweats, or lymphadenopathy posterior in adults and are associated with worse outcomes. We describe 2 adolescents with index of suspicion for testing and protective equipment use. Evaluaci\u00f3n del impacto del Documento de Consenso espa\u00f1ol sobre el abordaje de las infecciones osteoarticulares en nuestro medio a trav\u00e9s de la Red de Osteoarticulares Pedi\u00e1tricas (RIOPed) An Pediatr (Barc). 2020;93:289-96. DOI: 10.1016/j.anpedi.2019.11.008 Introducci\u00f3n En 2014 se public\u00f3 el Documento de Consenso desarrollado por SEIP-SERPE-SEOP para el diagn\u00f3stico y el tratamiento de las infecciones osteoarticulares (IOA). En 2015 se constituy\u00f3 RIOPed como red nacional multidisciplinar para la investigaci\u00f3n en IOA. El objetivo del estudio ha sido valorar el grado de adecuaci\u00f3n a las recomendaciones establecidas en el consenso durante un a\u00f1o de seguimiento. Material y m\u00e9todosEstudio prospectivo multic\u00e9ntrico nacional realizado entre septiembre de 2015 y septiembre de 2016 en 37 hospitales con inclusi\u00f3n de pacientes menores de16a\u00f1os diagnosticados de IOA, confirmada mediante aislamiento microbiol\u00f3gico, o probable: artritis s\u00e9ptica (AS) con >40.000 leucocitos en l\u00edquido sinovial u osteomielitis (OM)/osteoartritis (OA)/espondilodiscitis (ED) con prueba de imagen compatible. Los resultados se compararon con los obtenidos en el estudio retrospectivo realizado entre 2008 y 2012. Resultados Se incluyeron 255 casos: 131 OM, 79 AS, 30 OA y 15 ED. Respecto a las pruebas complementarias que el consenso consider\u00f3 de obligada realizaci\u00f3n, la radiograf\u00eda se llev\u00f3 a cabo en el 87,8% de los casos, el hemocultivo en el 91,6% y el cultivo de l\u00edquido sinovial en el 99% de AS. Se realiz\u00f3 RM en el 71% de las OM. La elecci\u00f3n del tratamiento antibi\u00f3tico intravenoso emp\u00edrico se adecu\u00f3 a las recomendaciones en el 65,1% de los casos, y en el 62,3% para el tratamiento oral. Se llev\u00f3 a cabo cirug\u00eda en el 36,8% de las AS (85,7% artrotom\u00eda), con un descenso significativo respecto al estudio retrospectivo (p=0,014). Solo el 58,5% de casos se ajustaron a las recomendaciones de duraci\u00f3n del tratamiento; sin embargo, se comprob\u00f3 una menor duraci\u00f3n del tratamiento intravenoso. Conclusiones En general, el grado de adecuaci\u00f3n a las recomendaciones que marcaron el grupo de expertos es bueno para las pruebas complementarias y aceptable respecto a la elecci\u00f3n del tratamiento antibi\u00f3tico, aun detect\u00e1ndose casi un 40% de inadecuaci\u00f3n. Se ha conseguido un descenso de la estancia hospitalaria In the midst of lockdown, just as patient acuity to intensive care unit (PICU) at Evelina London Children's Hospital for inotropic support in the raised concerns, which were discussed with Public Health England with pathogen pan-London tertiary paediatric services who had also seen a consensus was reached that a new clinical phenomenon was being seen across London. It was sufficiently concerning to send out an NHSE alert at April triggered international other countries have reported similar cases (figure 1). Introducci\u00f3n En este momento existen todav\u00eda grandes interrogantes acerca de las caracter\u00edsticas de enfermedad causada por el nuevo coronavirus (COVID-19) en los ni\u00f1os, as\u00ed como acerca de los factores asociados al desarrollo de formas graves de la enfermedad. M\u00e9todos Estudio retrospectivo que incluye pacientes menores de 18 a\u00f1os ingresados debido a infecci\u00f3n por SARS-CoV-2. La infecci\u00f3n fue confirmada por la reacci\u00f3n en cadena de la transcriptasa inversa-polimerasa (RT-PCR) en tiempo real o por serolog\u00eda. Describimos los datos epidemiol\u00f3gicos y cl\u00ednicos, los hallazgos de laboratorio y de im\u00e1genes, as\u00ed como el tratamiento y la evoluci\u00f3n de estos pacientes. Los pacientes se clasificaron en dos grupos de gravedad y luego se compararon. Resultados Se incluyeron 39 ni\u00f1os, con una mediana de edad de nueve a\u00f1os (rango 12 d\u00edas-16 a\u00f1os); 23 eran varones. Los casos con evoluci\u00f3n no complicada (24) se presentaron en su mayor\u00eda con fiebre y/o s\u00edntomas respiratorios sin alteraciones significativas en los hallazgos de laboratorio. De los 15 ni\u00f1os con enfermedad complicada, 12 desarrollaron shock. Adem\u00e1s de la fiebre, frecuentemente presentaban alteraciones de la apariencia, taquicardia extrema, dolor abdominal, v\u00f3mitos, diarrea, erupci\u00f3n cut\u00e1nea y/o hiperemia conjuntival. Tambi\u00e9n mostraron mayor linfopenia (p = 0,001), elevaci\u00f3n de la proporci\u00f3n neutr\u00f3filos/linfocitos (p = 0,001), prote\u00edna C reactiva (p < 0,001), procalcitonina (p = 0,001), d\u00edmero D (p < 0,001) y ferritina (p < 0,001). Conclusiones La infecci\u00f3n por SARS-CoV-2 en ni\u00f1os ingresados se presenta con una gran variabilidad cl\u00ednica. Cuando se les proporciona tratamiento de soporte, los pacientes con s\u00edntomas respiratorios que no tienen alteraci\u00f3n de las pruebas de laboratorio, generalmente tienen una enfermedad no complicada. Los pacientes con enfermedad complicada se presentan principalmente con fiebre y s\u00edntomas abdominales y/o mucocut\u00e1neos, la mayor\u00eda desarrollan un shock. La elevaci\u00f3n de los... Introducci\u00f3n SARS-CoV-2, responsable de la enfermedad por coronavirus 2019 (COVID-19), fue detectado por primera vez en Espa\u00f1a el 31 de enero de 2020. El 14 de marzo fue declarado el estado de alarma con el objetivo de controlar la pandemia. El objetivo de este estudio es analizar las consecuencias de esta crisis sanitaria sobre el patr\u00f3n de demanda asistencial, as\u00ed como el manejo y las caracter\u00edsticas de los pacientes con sospecha de COVID-19 en el Servicio de Urgencias Pedi\u00e1tricas. Pacientes y m\u00e9todos Estudio retrospectivo observacional en ni\u00f1os y adolescentes menores de 18 a\u00f1os, atendidos en nuestro Servicio de Urgencias Pe di\u00e1tricas durante el periodo comprendido desde el 14 de marzo hasta el 17 de abril de 2020. Resultados Durante el periodo de estudio se atendieron 1.666 pacientes, un 65,4% menos que en el mismo periodo de 2019. La edad media fue de 5,4 a\u00f1os y el 51,2% eran varones. El 39,9% fueron clasificados con niveles de alta prioridad, un 6,5% m\u00e1s que en 2019. Los principales motivos de consulta fueron fiebre (26,5%), s\u00edntomas respiratorios (16,1%) y traumatismos (15,2%). Un total de 218 pacientes (13%) fueron diagnosticados de posible COVID-19, confirm\u00e1ndose la infecci\u00f3n en el 18,4%. El 44% (96/218) fueron diagnosticados de infecci\u00f3n respiratoria inferior y el 33,9% (74/218), superior. El 23,8% (52/218) fueron hospitalizados. Conclusiones Durante el brote epid\u00e9mico SARS-CoV-2 disminuy\u00f3 la demanda de asistencia pedi\u00e1trica urgente, aumentando la proporci\u00f3n de casos con niveles de triaje de alta prioridad. La mayor\u00eda de los pacientes con sospecha o confirmaci\u00f3n microbiol\u00f3gica de COVID-19 cursaron con cl\u00ednica respiratoria leve To assess the impact with PCR-and their infants at 3 NYU Langone Health hospitals was conducted between March 25, 2020, and May 30, 2020. Mothers were surveyed by telephone regarding predelivery feeding plans, in-hospital change prompted an additional question to determine whether this change was due to coronavirus disease-2019 (COVID-19). Of the 160 mother-newborn dyads, 103 mothers were reached by telephone, and 85 consented to participate. There was no significant difference in feeding plan between with the separated dyads both in the hospital (P < .001) and at home (P = .012). Only 2 mothers in each group reported expressed breast milk as the (5.6% vs 4.1% of separated). COVID-19 was more commonly cited as the reason for change in the separated group (49.0% vs 16.7%; P < .001). When the dyads were compared with unseparated mothers and infants. No evidence of vertical transmission was observed; 1 case of postnatal transmission occurred from an unmasked symptomatic mother birth. Objective To compare cause-specific UK mapped using the Global Burden of Disease mortality hierarchy to 22 cause groups. We compared UK mortality by cause, age group and sex with EU15+ countries in 2015 (or latest available) using Poisson regression We then ranked compared with the EU15+ for in injuries (boys aged 15-19). The UK had the worst to third worst mortality rank for common infections in both sexes and all age groups, and in five out of eight non-communicable disease (NCD) causes in both sexes in at least one age group. UK mortality rank for injuries in 2015 was in the top half of countries for most causes. Conclusions UK CYP mortality is a NCD causes. Excess strengthening. Protracted (PBB) is the leading cause cough young children from developed countries. Despite its high prevalence there is a paucity of evidence to inform the optimal duration of treatment leading to variation in practice. Relapse chronic cough is common and recurrent PBB (>3 episodes in months) is associated future diagnosis of bronchiectasis. We investigated the factors associated with any relapse (1 episode in 12 months) and recurrent PBB in 66 children. No factor was significantly associated with any relapse. Duration of initial antibiotic treatment was the only factor significantly associated with recurrent PBB. Those who received antibiotics PBB than those who received for 2 weeks (p=0.046). This is the first study to show an association between duration of initial antibiotics are long the origins of these doses are often unclear. In 2011, we noted that dosing of the penicillins in paediatrics had remained unchanged for over 50 years and was no longer optimal due to changes in children's weights.1 The aim of this paper is to explore further the very early origins of the dosing of oral phenoxymethylpenicillin (penicillin V), as the first oral penicillin used in children. History of oral penicillin V use in children Being able to administer penicillin orally was always a clear goal for children where the original doses given as high-volume intramuscular injections were particularly painful. As far as we have been able to determine, the first reported use of oral penicillin in a child was from 1940 in a 6-month-old boy with a Staphylococcus aureus (penicillin G) demonstrated good oral absorption, but that children age of 6-12 degraded the penicillin V in 1948, capable of withstanding gastric acid, was a clear step forward for paediatric use. The first large series of penicillin V being administered to children, that we can identify, was from Germany in 1953 in 106 children. The dose was based on the weight of of the first recorded uses of oral penicillin V in children from the UK was reported ... Introducci\u00f3n.Se describe la distribuci\u00f3n de serotipos de Streptococcus neumoniae aislados en l\u00edquido cefalorraqu\u00eddeo (LCR) entre los a\u00f1os 2007-2018 en la Comunidad de Madrid (CM) identificando aquellos con mayor tropismo men\u00edngeo. M\u00e9todos. Se estudiaron las cepas de episodios de enfermedad neumoc\u00f3cica invasora enviadas al Laboratorio Regional de Salud P\u00fablica por los servicios de microbiolog\u00eda de hospitales p\u00fablicos y privados de la CM. La frecuencia de serotipos procedentes de LCR se compar\u00f3 con la observada en otras muestras. Resultados. Se procesaron 6.115 cepas. El 5% (n=304) se aislaron en LCR. Siete serotipos (11A, 19F, 23B, 10A, 24F, 23A y 35F) mostraron una frecuencia en LCR significativamente mayor que en otras muestras habitualmente est\u00e9riles. Los serotipos 24F, 11A y 23B mostraron alta resistencia a la penicilina. Conclusi\u00f3n. La frecuencia y la resistencia de determinados serotipos de neumococo con elevado tropismo men\u00edngeo podr\u00eda comprometer el tratamiento de las infecciones del sistema nervioso central. Aim: This study was designed to assess the efficacy and safety of diarrhea in children. Methods: A total of 100 infants children 3-36 months of age with acute diarrhea received medical care according to the World Health Organization guidelines on the management of acute diarrhea in children and were randomly ( S. of 5 billion CFU twice daily) or to the placebo group. Infants and children were treated for 5 days and an extended follow-up was planned 1 and 2 months after the end of the treatment period. Primary endpoint was the time of recovery from diarrhea defined as the duration of diarrhea. Other parameters, such frequency on duration severity of diarrhea. The time recovery from diarrhea was significantly shorter in the probiotic group compared with the placebo group (65.8 \u00b1 12 hours vs. 95.3 \u00b1 17.6 hours, P = 0.0001). Faster remission in the probiotic group was also demonstrated by a shorter time before the first of diarrhea in infants and children. Antecedentes Para estudiar el perfil neurocognitivo de j\u00f3venes infectados perinatalmente por VIH (PVIH+) es importante valorar tanto los factores asociados al virus como los no relacionados. El objetivo de nuestro estudio fue evaluar la cognici\u00f3n y la calidad de vida de una cohorte de j\u00f3venes PVIH+ y compararlas con las de un grupo control. M\u00e9todos Treinta j\u00f3venes PVIH+ y 30 sujetos sanos VIH pareados por edad, sexo y nivel socioecon\u00f3mico completaron un protocolo que inclu\u00eda pruebas neurocognitivas, entrevista psicosocial semiestructurada y cuestionario de calidad de vida PedsQL. Se calcul\u00f3 el Z-score global (NPZ-5) y espec\u00edfico para cada dominio neurocognitivo. Adicionalmente, se consider\u00f3 la categor\u00eda SIDA (PVIH+/C, PVIH+/noC). Se realiz\u00f3 an\u00e1lisis univariante y multivariante. Resultados De los 60 pacientes incluidos, el 67% eran mujeres; edad media (IQR) 19a\u00f1os (18-21). Respecto al grupo PVIH+, el 27% ten\u00edan categor\u00eda CDCC (ninguna encefalopat\u00eda), el 93% tomaban antirretrovirales y el 77% ten\u00edan carga viral indetectable. No hubo diferencias en cuanto a ocupaci\u00f3n, aunque el grupo VIH repiti\u00f3 menos cursos acad\u00e9micos (p=0,028) y tuvo mayor nivel educativo (p=0,021). No hubo diferencias entre los grupos PVIH+/noC y VIH. El grupo PVIH+/C tuvo un rendimiento inferior al de PVIH+/noC (NPZ-5, p=0,037) y VIH (inteligencia cristalizada, p=0,025; cociente de inteligencia, p=0,016). Mayor nadir de c\u00e9lulasT CD4+ se relacion\u00f3 con mejor Z-score en Memoria (p=0,007) y NPZ-5 (p=0,025). La exposici\u00f3n temprana y prolongada a la terapia antirretroviral favoreci\u00f3 un mejor rendimiento en Memoria (p=0,004) y en Funciones Ejecutivas (p=0,015), respectivamente. Conclusiones No hubo diferencias significativas en el perfil neurocognitivo ni en calidad de vida entre los adolescentes PVIH+/noC y VIH; sin embargo, los participantes PVIH+/C obtuvieron puntuaciones m\u00e1s bajas. La exposici\u00f3n temprana y prolongada a la terapia antirretroviral parece tener un efecto beneficioso. supportive evidence from convalescent sera or supplemental testing, raising a concern for the overdiagnosis of CSD. chart immunocompetent patients at the Hospital for Sick Children, Toronto, spanning an 11-year period. A total of 154 cases were included with serologic titers 1:128. These were divided into 3 groups: group 1 = 1:128, group 2 = 1:256, and group 3 1:512. Cases within groups were evaluated with respect to cat contact, clinical presentation, further testing, and final diagnosis. Results:One-third of a titer of 1:128 had an alternative diagnosis. Most cases with a titer of 1:128 or 1:256 did not have convalescent serologic testing performed. Within these 2 groups, only 1 case had a 4-fold rise in the convalescent titer. A trend of decreasing number of cases with alternative diagnoses ( P = 0.03) and increasing number of cases presenting with regional lymphadenopathy ( P = 0.07) was associated with higher titers in group 3 compared with group about the serologic diagnosis and a clinical indigenous Mori in Bay of Plenty region, more so male Mori students, especially when We Overall, to 59/100,000/year, 0.22-0.73) 0.52(CI 0.044. cases may be preventable. Methods: This was a nationwide study of children <18 years with TB from 2009 to 2014 in Denmark. Demographic, clinical, microbiologic and treatment outcome data and medical records. Results: We identified 145 cases; 99 were immigrants (68%) (73%) were the second-generation immigrants (52%), in contrast to Danish children who were by finding (70%). Symptoms were often nonspecific, and one-third of the children had normal blood tests at time of diagnosis. First-generation immigrants of the children represented cases of TB disease that could possibly have been prevented by screening or rigorous contact tracing. The overall treatment success rate was 97%, and cases of unsuccessful treatment contact investigation among children, tailored screening and vaccination of immigrant awareness living conducted prospective cohort study (January per 100,000 inhabitants <18 years of age in 2009 to 1.84 cases (95% CI: 1.15-2.79) in 2018 ( P < 0.05) and linearly correlated with the rate of migrants (R 2 = P < 0.0001). odds CI: 0.23-0.89; P = 0.02). They accounted for and loss to follow-up. Conclusion: Pediatric TB rate in Campania increased in the last 10 years in association with the increase in migration. Emphasizing Foreign children may need tailored programs. Background: Children with fever and respiratory symptoms represent a large patient group at decision rule-based treatment strategy improved antibiotics in a clinical trial. This study aims to evaluate decision and costs, to children with suspected lower respiratory tract infections (RTIs) in the ED in general. Methods: In a stepped-wedge, cluster randomized trial, we collected cost data of children 1 month to 5 years of age with fever and cough/dyspnea in 8 EDs in The Netherlands (2016-2018). We calculated medical costs and societal costs per patient, usual (n = 597), when antibiotic prescription was guided by the decision rule (n = We calculated cost-of-illness of this patient group and estimated their annual costs at national level. Results: The cost-of-illness of children under 5 years with suspected lower RTIs in the ED was on average \u20ac2130 per patient. At population level this is \u20ac15 million per year in The Netherlands (\u20ac1.7 million/100,000 children under 5). Mean costs per patient in \u20ac1870 in the intervention phase ( P = 0.01). Main cost drivers were hospitalization and lost parental workdays. Conclusions: Implementation of a decision rule-based treatment strategy in children with suspected lower RTI was cost-saving, due to a reduction in hospitalization and parental absenteeism. Given the high frequency of this disease in children, the decision rule has the potential to result in problems throughout Europe. The aim of this survey was to describe the current pediatric antibiotic stewardship (PAS) landscape countries. National guidelines on the management of children with common infections treated in hospital settings exist in 15 of 23 (70%); only 8 of 15 (53%) had been updated within the previous 4 years. Most provide guidance on antibiotic initiation and duration (14 of 15, 93%), but few on when to transition from intravenous to oral antibiotics (7 of 15, 47%). National PAS competencies have only been developed in 4 countries; only 1 addressed both community and hospital prescribing. Organized national PAS networks are only established in the United Kingdom and Germany; 21 of 23, 91% countries had no agreed metric antibiotic prescribing in children; 2 of based on daily defined doses. Conclusions: Fragmented implementation of no agreed competencies PAS networks along with inexistent funding is in view resistance in Europe. is leading congenital investigate of congenital A prospective screening for cCMV by viral load in saliva was performed. Saliva samples were obtained within the first 72 hours of life in a maternity ward in Madrid (Spain), during a 1-year period. All positive screening tests were confirmed with viral load in urine. Clinical, laboratory, auditory, visual and cerebral imaging assessments were all with cCMV. Results: 4097 neonates born during the study period, 3190 (78%) were included. CMV viral load in saliva was detectable in 24/3190 (0.75%) children, and and P = 0.04). Conclusions: One in 200 neonates born in our hospital presented a cCMV infection. CMV viral load in saliva has been shown to be a simple and highly accepted screening spite the fact that infected children had abnormalities in cerebral imaging, diagnosis during the neonatal period would have been impossible without a screening program in most cases. The clinical course of SARS-CoV-2 infection in In prospective cohort study, and duration of symptoms in febrile infants 60 days with (n = 7) and without (n = 16) SARS-CoV-2 infection. Overall, we observed overlapping symptoms and duration generally consistent chief complaints with the prior 3 years (2017 through 2019). Ingestions became a significantly more common chief complaint in 2020. As the world waits patiently for the development of the COVID-19 vaccine, it seems to be a fertile environment for those members of society who are the anti vaccine naysayers, breeding suspicion and indeed violence and using propagate their ill informed and dangerous opinions. There is growing evidence of vaccine delays or refusals due to a lack of trust in the importance, safety, or effectiveness of vaccines, alongside confidence 2019. Their Vaccine Confidence Project (VCP) was established in 2010 ... \u00b7Macrolide and Nonmacrolide Resistance twice yearly for 2 years has been shown to reduce childhood mortality in sub-Saharan Africa but at the cost of amplifying macrolide resistance. The effects on the gut resistome, a reservoir of antimicrobial resistance genes in the body, of twice-yearly administration of azithromycin for a longer period are unclear. METHODS: We investigated the gut resistome of children after they received twice-yearly distributions of azithromycin for 4 years. In the Niger site of the MORDOR trial, we enrolled 30 villages in a concurrent trial in which they were randomly assigned to receive mass distribution of either azithromycin or placebo, offered to all children 1 to 59 months of age every 6 months for 4 years. Rectal swabs were collected at baseline, 36 months, and 48 analysis of the participants' gut resistome. The primary outcome was the ratio of macrolide-resistance determinants in the azithromycin group to those in the placebo group at 48 months. RESULTS: Over the entire 48-month period, the 86.6+12% in the villages that received placebo and 83.2+16.4% in the villages that received azithromycin. total samples visit, 546 samples from 15 villages that received placebo and 504 from 14 villages that received azithromycin were analyzed. Determinants azithromycin group than in the placebo group: 7.4 times as high (95% confidence interval [CI], 4.0 to 16.7) at 36 months and 7.5 times as high (95% CI, 3.8 to 23.1) at 48 months. villages receive mass distributions twice yearly for 4 years, antibiotic resistance was more common in the villages that received azithromycin than in those that received placebo. azithromycin distributions may propagate antibiotic resistance. (Funded Gates Foundation and others; ClinicalTrials.gov number, NCT02047981.) La Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda de Atenci\u00f3n Primaria (AEPap) ha elaborado un documento con propuestas para la organizaci\u00f3n de las consultas de Atenci\u00f3n Primaria en la pr\u00f3xima temporada invernal, y as\u00ed poder garantizar la atenci\u00f3n a los pacientes pedi\u00e1tricos, con y sin sospecha de infecci\u00f3n por SARS-CoV-2. En dicho documento se insiste en la importancia de que la primera valoraci\u00f3n del paciente sea telef\u00f3nica para orientar a las familias sobre la idoneidad de una visita telem\u00e1tica o de una visita presencial y, en caso de ser as\u00ed, recibir indicaciones sobre la zona del centro de salud y horario de atenci\u00f3n en funci\u00f3n de los s\u00edntomas, para mantener las medidas de protecci\u00f3n y seguridad, tanto del paciente como del personal sanitario. AEPap y SEPEAP proponen que en los centros de salud se organicen dos circuitos, uno para atender pacientes con sospecha de infecci\u00f3n por SARS-CoV-2 y otro circuito para valorar el resto de las patolog\u00edas y llevar a cabo el Programa de Salud Infantil (PSI). Para ello, tambi\u00e9n insta a las Administraciones p\u00fablicas a mejorar las herramientas de la telemedicina para garantizar el intercambio seguro de informaci\u00f3n y as\u00ed poder realizar consultas no presenciales para evitar contagios en el centro sanitario, dotar a los centros de salud de personal sanitario, administrativo y de limpieza suficiente. Tambi\u00e9n es muy importante que los profesionales sanitarios dispongan de t\u00e9cnicas diagn\u00f3sticas para descartar las infecciones pedi\u00e1tricas m\u00e1s frecuente en \u00e9poca invernal (rinovirus, virus respiratorio sincitial, gripe, rotavirus) y agilizar el resultado de la reacci\u00f3n en cadena de la polimerasa (PCR) para COVID-19 y as\u00ed evitar aislamientos innecesarios. Covid-19: UK studies find gastrointestinal symptoms are common in childrenBMJ 2020;370:m3484 Los s\u00edntomas gastrointestinales son comunes en los ni\u00f1os infectados con SARS-CoV-2 y deber\u00edan desencadenar la petici\u00f3n de pruebas para detecci\u00f3n del virus. Un estudio prospectivo de 992 ni\u00f1os sanos (edad media de 10,1 a\u00f1os), hijos de trabajadores de la salud de todo el Reino Unido encontr\u00f3 que 68 (6,9%) dieron positivo en anticuerpos contra el SARS-CoV-2. La mitad de los ni\u00f1os que dieron positivo no hab\u00edan informado s\u00edntomas, pero entre los que s\u00ed lo hicieron, los m\u00e1s comunes fueron fiebre (21 de 68, 31%); s\u00edntomas gastrointestinales, que incluyen diarrea, v\u00f3mitos y calambres abdominales (13 de 68, 19%); y dolor de cabeza (12 de 68,18%). Los \u00faltimos hallazgos de la aplicaci\u00f3n Covid-19 Symptom Study,que se lanz\u00f3 a fines de marzo para rastrear los s\u00edntomas de las personas, tambi\u00e9n muestran que los s\u00edntomas gastrointestinales ocurren con frecuencia en ni\u00f1os con pruebas de frotis positivas. Los hallazgos del estudio respaldan que los s\u00edntomas gastrointestinales (diarrea y v\u00f3mitos) deben agregarse a la lista actual (temperatura alta, tos y p\u00e9rdida o cambio en el sentido del olfato o el gusto) que desencadenan pruebas de coronavirus. Tim Spector, l\u00edder del estudio y profesor de epidemiolog\u00eda gen\u00e9tica en el King's College de Londres, concluye que con los datos de 250 000 ni\u00f1os, aquellos con una prueba de frotis positiva tienen una gama de s\u00edntomas diferente a la de los adultos. La tos y la dificultad para respirar son mucho menos frecuentes y los problemas gastrointestinales, especialmente la p\u00e9rdida de apetito, m\u00e1s frecuentes. La fiebre sigue siendo una caracter\u00edstica, como en los adultos. El estudio confirm\u00f3 la necesidad de agregar una gama m\u00e1s amplia de s\u00edntomas a los enumerados para el covid-19, ya que alrededor del 50% de los ni\u00f1os no presentaban los tres principales s\u00edntomas del adulto (temperatura alta, tos y p\u00e9rdida o cambio del sentido del olfato o del gusto) y pueden presentar una amplia gama de s\u00edntomas no espec\u00edficos, como malestar, p\u00e9rdida de apetito, y erupci\u00f3n cut\u00e1nea que afect\u00f3 a uno de cada seis\". \"La clave es que los padres mantengan a los ni\u00f1os en casa con estos signos inespec\u00edficos hasta que se sientan mejor, hasta que las pruebas sean m\u00e1s r\u00e1pidas y accesibles\". Public health measures during the COVID-19 pandemic have potential to impact transmission reductions in RSV and influenza detections Western Australian children through winter 2020; despite reopening of schools. Border closures have likely been in limiting introductions from abroad. based on the results of an RT-PCR or other test. Studies could be of any design and take place anywhere. We found 84 studies with 8279 people. Studies included involving studies took place in Asia. Accuracy of for studies, 682 people). Lung ultrasound correctly identified infection in 100% of people with studies, 32 people). Accuracy of chest imaging diagnosing COVID-19 chest CT in people (13 studies, 2346 people). However, it incorrectly identified infection in 82% of people who were not infected with COVID-19. We did not find any studies that reported data on lung ultrasound. The uncertainty resulting from the poor study quality and heterogeneity studies limit is sensitive but diagnosis of COVID-19 in suspected patients, could also be the result of the poor sensitivity of the reference standard (RT-PCR), as CT could potentially be more sensitive than RT-PCR in some Because limited data, of chest X-ray and of the accuracy pathways. Evidence is current to 25th May 2017. We included 11 trials with a total 3555 evaluating prescribing strategies antibiotics. the 11 studies, five included only children (1173 participants), two included only adults (594 participants), and four included children and adults (1761 participants). The studies investigated a variety of respiratory tract infections. One study involving 405 participants was new for this update For many clinical outcomes, there were no differences shown to be different to no antibiotics in terms of symptom control and disease complications. Where feel it is safe not to antibiotics immediately for people with respiratory infections, no antibiotics with advice to return if symptoms do not resolve is likely to result in the least antibiotic use high case fatality rate. While most patients suffer from one single episode in life, there is anecdotal evidence for recurrent infection. Aim, The Haemophilus influenzae (NRZMHi) IMD cases from 2002 the risk of recurrent a sample of the same patient more than 30 days after the first episode Results Among 5,854 patients with a median 9.4 years, 14 suffered a second IMD episode and one patient a third one. The risk of a recurrent IMD was 29.4 per 100,000 person-years for survivors of the first episode. Rare serogroups (Y, W, E and Z) were more common in patients with recurrent IMD of another IMD episode compared with the general population. The study most likely underestimated the risk of recurrent infection. Increased risk may be due to undiagnosed high risk of the leading non-genetic cause of (SNLH) and in mothers with older gestational age at infection, while the risk significantly increases and morbidity among the neonatal population, not test the diagnosis and of recommend using a PCR assay saliva in neonates with suspected cCMV infection. At present, there is no evidence of the benefit of antiviral therapy in asymptomatic infants. In the case of symptomatic cCMV, actually recommend treatment with oral valganciclovir duration of months. The for neonates under 32 weeks of gestational age, or for infants more than 30 days old because of insufficient infants the burden of CMV-related pandemic significantly impacted the well-being of children as a result of the widespread closure of schools. Throughout the summer, began the fall semester in a partially or completely virtual fashion. A growing body of evidence suggests a return to in-person learning can be accomplished high prevalence areas.2 In other countries where school has been in session, reports of cases of SARS-CoV-2 infection in schools generally show little to no secondary spread.3 Initial evidence suggests that the school environment does not contribute to community transmission of the novel coronavirus in the same way that it does for other respiratory viruses such as influenza.4 When recommended mitigation have issued guidance on how to safely return to school in the fall of 2020. Key recommended elements include daily symptom screening, physical when an infectious case is identified. The ability of individual schools to implement these strategies is likely to vary based on school size, age of students, financial resources, community support, and access to consultation with health experts. To provide support to our local school community, a group of COVID-19 and schools (Figure and http://wupaarc.wustl.edu/COVID-19-and-Children/Algorithms-for-Clinicians-and-Schools). Included in the algorithms are a tree symptoms exposure. The goal of is to provide practical guidance for children experiencing school environment and the educational disruption experienced by students who are kept out of the classroom. We found 22 studies; 17 assessed people (modelling studies). Studies took place in USA, Europe, and Asia The evidence base for the effectiveness of screening comes from two mathematical modelling studies and is limited by their assumptions. Low-certainty evidence suggests that screening at travel hubs may slightly slow the importation of infected cases. This review highlights the uncertainty and variation in of screening high proportion of infected individuals may be missed and go on to infect others, and some may individuals. Further studies need to evaluate utility of rapid laboratory tests, combined screening, and repeated screening. More research is also reference poor sensitivity of existing approaches, our findings point to the need for greater emphasis on other ways that may prevent transmission such as face coverings, physical distancing, quarantine, personal protective equipment for workers. We examined We found 34 relevant studies of which 24 provided data for our primary outcome. Twelve studies (1000 children) provided data for the procalcitonin test; 16 studies (1895 children) provided data for the C-reactive protein test, and 8 studies (1910 children) provided data for the erythrocyte sedimentation rate test. We found all three tests to be sensitive (summary sensitivity values ranged from values ranged from to 76%). were accurate enough to allow to confidently differentiate upper from urinary tract ESR test does not appear to be sufficiently accurate to be helpful in differentiating children with cystitis from children with pyelonephritis. A low CRP value (< 20 mg/L) appears to somewhat out pyelonephritis < 20%), but heterogeneity in the data prevents us from making recommendations at this time. The procalcitonin test seems better suited for ruling in pyelonephritis, not find any compelling evidence to recommend the routine use of any of these tests in clinical practice. Introducci\u00f3n: el estudio de la relaci\u00f3n entre las parasitosis intestinales y las enfermedades at\u00f3picas, como el asma o la rinoconjuntivitis, ha arrojado resultados contradictorios. El objetivo de este estudio fue evaluar la relaci\u00f3n existente entre la parasitosis intestinal y la prevalencia de las enfermedades at\u00f3picas. Material y m\u00e9todos: se realiz\u00f3 un estudio observacional, transversal de campo, en ni\u00f1os mayores de 2 a\u00f1os, cuyos padres contestaron los cuestionarios para investigaci\u00f3n de prevalencia de enfermedades at\u00f3picas. A todos los ni\u00f1os seleccionados les fueron realizados ex\u00e1menes seriados de heces y pruebas al\u00e9rgicas cut\u00e1neas. El an\u00e1lisis estad\u00edstico se realiz\u00f3 por medio de la prueba de 2, asimismo se calcularon las razones de riesgo (odds ratio [OR]) y los intervalos de confianza del 95% (IC 95). Se consider\u00f3 de significancia estad\u00edstica cuando p <0,05. Resultados: fueron evaluados 185 ni\u00f1os, la edad fue 6,82 \u00b1 2,69 a\u00f1os, el 52% fueron masculinos, el 94% se ubicaron entre los estratos sociales III/IV. La prevalencia de cualquier enfermedad at\u00f3pica fue del 41% y la reactividad en piel del 43%, la detecci\u00f3n de cualquier par\u00e1sito se hizo en el 47% de todos los ni\u00f1os. Se encontr\u00f3 relaci\u00f3n con significaci\u00f3n entre el cuestionario ISAAC y la prueba cut\u00e1nea (p = 0,000). No se encontr\u00f3 asociaci\u00f3n entre prueba cut\u00e1nea y parasitosis intestinal (p = 1,29), as\u00ed como tampoco entre los resultados de ISAAC y parasitosis (p = 0,447). Conclusi\u00f3n: el estudio permiti\u00f3 considerar que la condici\u00f3n al\u00e9rgica no guarda relaci\u00f3n con el diagn\u00f3stico de la parasitosis. La fascitis necrotizante (FN) es un cuadro muy grave, causado por una infecci\u00f3n bacteriana de la piel y tejidos blandos subcut\u00e1neos, cuya evoluci\u00f3n es hacia la destrucci\u00f3n y necrosis de los tejidos en un corto espacio de tiempo. Hasta en un tercio de los casos llega a ocasionar un shock s\u00e9ptico con fallo multiorg\u00e1nico, que eleva la mortalidad de este cuadro hasta el 25%. Dependiendo del agente causante la FN se clasifica en polimicrobiana (tipo I) y estreptoc\u00f3cica (tipo II). Los principales microorganismos implicados son Streptococcus beta-hemol\u00edtico del grupo A, y con menor frecuencia Staphylococcus aureus [1]. Presentamos el caso de un paciente de 12 a\u00f1os de edad... Enteroviruses are one of the leading causes of central nervous system infections, but their causative peripheral facial nerve palsy large screening tool to 'exclude malignancy' (Grade B). Children with palpable cervical lymph nodes greater than 2 cm persisting investigation and management (Grade B). scenario You are the speciality registrar seeing a 6-year-old girl in clinic who was referred by her general practitioner (GP) with a 4-week history of 'persistent lymphadenopathy'. She is otherwise well with no fever, recent history of illness or infection. There is no medical history of note. There are palpable cervical lymph nodes on examination. There is no hepatosplenomegaly. The referred the patient for an a persistent facial rash. The rash spontaneously erupted above her upper lip as a cluster of papules and pustules that spread to the nasolabial folds and bilateral lower eyelids over the course of 3 weeks. She was systemically well and presumed to have impetigo. However, she did not improve with oral cephalexin or clindamycin. When seen by us, the clinical characteristics of the rash led us to a diagnosis of periorificial dermatitis. This acneiform eruption is more often seen in adults but is not uncommon in young children, with a mean age of presentation of 6.6 years.1 The sometimes pustules around the mouth, nose and eyes. In general, the vermillion border of the lips is spared,1-3 but it may angiofibromas.3 Use prior to onset, whether topical, 5 Resolution may take 4-8 weeks.5 El virus del herpes simple (VHS) produce una encefalitis necrotizante aguda, afectando t\u00edpicamente al l\u00f3bulo temporal. La existencia de un f\u00e1rmaco antiviral espec\u00edfico, as\u00ed como el uso de medicaci\u00f3n adyuvante como la corticoterapia, han mejorado el pron\u00f3stico de las infecciones graves. El retraso en el inicio del tratamiento con aciclovir es un factor claramente relacionado con mala evoluci\u00f3n, as\u00ed como las pautas cortas de tratamiento que se han asociado con mayor riesgo de recidivas. Se presenta el caso de una lactante de 13 meses, diagnosticada de encefalitis herp\u00e9tica tras un cuadro de fiebre prolongada. We report a 20-year-old female with SARS-CoV-2 encephalitis who presented and sudden acute altered mental status. An extensive work up led to the most likely cause for the neurologic decompensation to be manifestations of COVID-19 in children. We report the case of a 4-year-old child with a post-infectious multisystem inflammatory syndrome associated were well documented. We report dengue (DENV) infection in two Dutch tourists who visited D\u00e9partement Var, southern France, in July and August 2020. As some autochthonous dengue cases have occurred in Europe in recent years, awareness among physicians and public health experts about possible intermittent presence of DENV in southern Europe is important to minimise delay in diagnosis and treatment. Quick contain the and minimise transmission. El episodio hipoton\u00eda-hiporrespuesta (EHH) es un tipo muy inusual de efecto adverso despu\u00e9s de la vacunaci\u00f3n. Se ha observado con mayor frecuencia tras las vacunas de c\u00e9lulas enteras contra la tosferina. El EHH se caracteriza por el inicio repentino de hipoton\u00eda, hiporrespuesta y el cambio de color de la piel (palidez o cianosis) en las primeras 48 horas despu\u00e9s de la administraci\u00f3n de una vacuna en ni\u00f1os. Se ha descrito que los episodios pueden durar entre 6 y 30 minutos. Se desconoce la patog\u00e9nesis. Aunque se ha clasificado dentro de las reacciones adversas graves, no se han demostrado efectos a largo plazo y no se contraindica la administraci\u00f3n de una nueva dosis de la vacuna, si as\u00ed est\u00e1 indicado para completar el calendario de vacunaci\u00f3n del ni\u00f1o. Presentamos el caso de una lactante de 5 meses de edad que present\u00f3 un EHH tres horas despu\u00e9s de la administraci\u00f3n de una segunda dosis de la vacuna antimeningoc\u00f3cica B 4CMenB (Bexsero). La hematuria es un motivo de consulta frecuente. Una adecuada historia cl\u00ednica y exploraci\u00f3n f\u00edsica permiten una aproximaci\u00f3n diagn\u00f3stica inicial en la mayor\u00eda de los casos. Lo primero es reconocer y confirmar la hematuria, descartando otras circunstancias que pueden te\u00f1ir falsamente la orina. El an\u00e1lisis del aspecto macrosc\u00f3pico de la orina es clave para determinar el origen glomerular o extraglomerular de la hematuria. Presentamos el caso de una ni\u00f1a con falsa hematuria por agente externo (lej\u00eda), efectu\u00e1ndose el diagn\u00f3stico a trav\u00e9s de una exhaustiva historia cl\u00ednica. Un nuevo coronavirus llamado coronavirus 2 del s\u00edndrome respiratorio agudo severo (SARS-CoV-2), causante de una pandemia global, afecta a la poblaci\u00f3n pedi\u00e1trica con unas caracter\u00edsticas cl\u00ednicas diferentes a las de los adultos. Las lesiones dermatol\u00f3gicas acroisqu\u00e9micas que se pueden asociar, se manifiestan m\u00e1s en pacientes j\u00f3venes sin cuadro respiratorio. Se presentan tres casos cl\u00ednicos con estudios anal\u00edticos, que incluyen determinaci\u00f3n de anticuerpos neutralizantes por inmunocromatograf\u00eda. En ninguno de los casos se ha podido demostrar la participaci\u00f3n del SARS-CoV-2 como agente implicado. El t\u00e9rmino de \"acroisquemia aguda en el ni\u00f1o en tiempos de COVID-19\" parece ser el t\u00e9rmino m\u00e1s adecuado hasta tener un mayor conocimiento del cuadro. El fallo hep\u00e1tico agudo es un cuadro grave y poco frecuente en Pediatr\u00eda. Precisa un manejo multidisplinar. Aunque en la mitad de los casos no se llega a un diagn\u00f3stico etiol\u00f3gico definitivo, conviene conocer sus causas seg\u00fan los grupos de edad, debido a su implicaci\u00f3n pronostica y terap\u00e9utica. Se reconocen principalmente causas infecciosas, t\u00f3xicas, metab\u00f3licas y autoinmunes. Dentro de las causas infecciosas, destacan los virus de la familia herpes y los virus hepatotropos; sin embargo, tambi\u00e9n se ha relacionado con virus respiratorios y en concreto con el virus de la gripe, en cuyo caso, el pron\u00f3stico es bueno. Presentamos el caso de una ni\u00f1a de cuatro a\u00f1os que debut\u00f3 con cuadro de fallo hep\u00e1tico agudo secundario a infecci\u00f3n por virus influenza A con una evoluci\u00f3n muy favorable. La artritis s\u00e9ptica presenta una incidencia anual de 4 casos/100 000 ni\u00f1os. Es m\u00e1s frecuente en los miembros inferiores y suele estar provocada por Staphylococcus aureus v\u00eda hem\u00e1tica, por lo que la cobertura antibi\u00f3tica inicial est\u00e1 dirigida a cubrir al menos este pat\u00f3geno. Sin embargo, en algunas situaciones, como tras la manipulaci\u00f3n periodontal o enfermedad dentaria, debemos pensar en microorganimos procedentes de la flora microbiana orofar\u00edngea, como es Fusobacterium nucleatum, ya que el 50% de las cepas es resistente a penicilina y a algunas cefalosporinas, f\u00e1rmacos que forman parte del tratamiento antibi\u00f3tico emp\u00edrico de las infecciones osteoarticulares en la poblaci\u00f3n pedi\u00e1trica. OBJETIVO Revisar la evidencia disponible acerca de los riesgos infecciosos relacionados con los farmacos biologicos utilizados en las enfermedades inflamatorias de origen inmune. MATERIAL Y METODOS Se seleccionaron los farmacos biologicos con indicacion en enfermedades inflamatorias de origen inmune, que se dispensen desde las Unidades de Farmacia de Pacientes Externos del Servicio Navarro de Salud-Osasunbidea. Se consultaron las fichas tecnicas de los medicamentos y se realizo una busqueda en Pubmed revisando los articulos y guias mas relevantes. RESULTADOS Y CONCLUSIONES El riesgo asociado a las terapias inmunosupresoras se deduce en muchas ocasiones de su mecanismo de accion y establecer una relacion causal a veces es complicado. Realizar el cribado de tuberculosis se ha asociado a la reduccion del riesgo de reactivacion de la tuberculosis latente de hasta 7 veces y, por el momento, se recomienda mantener las recomendaciones basadas para las terapias anti-TNF-a para el resto de terapias biologicas. Aunque el herpes zoster es uno de los efectos adversos mas frecuentes con las terapias anti-TNF-a, existe controversia respecto a la causalidad debido a que los pacientes con enfermedades inflamatorias autoinmunes presentan un mayor riesgo del mismo. Se recomienda realizar cribado de VHB y VHC. En pacientes con HBsAg negativo es recomendable administrar la vacuna previamente al inicio de la terapia biologica y los pacientes con HBsAg positivo deben recibir profilaxis. Las vacunas con microorganismos atenuados estan contraindicadas durante el tratamiento biologico y se recomienda vacunar frente a la gripe y el neumococo a todos los pacientes que reciban estas terapias. Antes del inicio de la terapia se recomienda realizar cribado de VIH, descartar embarazo, y valorar otras patologias como insuficiencia cardiaca, citopenias, enfermedad pulmonar intersticial, enfermedad desmielinizante o enfermedad tumoral. PALABRAS CLAVE Farmacos biologicos, enfermedades inflamatorias, tuberculosis, riesgos infecciosos, vacunacion. Infant virus (RSV) bronchiolitis in the 6 months life was associated with increased odds of pneumonia, otitis media, and antibiotic prescription fills the second months of life. suggest a little We tried to the Turkey, wherein outpatient neonates with COVID-19 database. Full-term and premature neonates diagnosed with COVID-19 were included Down syndrome and congenital cardiovascular disorders died in the study period. C-reactive protein (CRP) and prothrombin time (PT) levels were higher in who needed vs. [11.7-18.0] 0.01, who were severe/critical (1.0 [0.01-8.6] vs. 4.5 [0.1-69.2] p = respiratory support requirements. High CRP levels or a greater PT should alert the physician to more severe disease. RESULTADOS: Hubo un total de 149 madres con infecci\u00f3n por SARS-CoV-2 y 149 reci\u00e9n nacidos analizados (3 pares de gemelos; 3 mortinatos). El cuarenta por ciento de estas madres estaban asintom\u00e1ticas. Aproximadamente el 15% de las madres sintom\u00e1ticas requiri\u00f3 alg\u00fan tipo de soporte respiratorio y el 8% requiri\u00f3 intubaci\u00f3n. Se ingresaron en la UCI 18 reci\u00e9n nacidos (12%). Quince (10%) nacieron prematuros y 5 (3%) requirieron ventilaci\u00f3n mec\u00e1nica. Las madres sintom\u00e1ticas tuvieron m\u00e1s partos prematuros (16% vs 3%, p = 0,02) y sus reci\u00e9n nacidos ten\u00edan m\u00e1s probabilidades de requerir cuidados intensivos (19% vs 2%, p = 0,001) que las madres asintom\u00e1ticas. Un reci\u00e9n nacido dio positivo por SARS-CoV-2, que se consider\u00f3 un caso de transmisi\u00f3n posnatal horizontal CONCLUSIONES: Aunque no hubo evidencia clara de transmisi\u00f3n vertical de madres con SARS-CoV-2 a sus reci\u00e9n nacidos, s\u00ed observamos morbilidades perinatales tanto en madres como en reci\u00e9n nacidos. Las madres sintom\u00e1ticas eran m\u00e1s propensas a experimentar un parto prematuro y sus reci\u00e9n nacidos a requerir cuidados intensivos. The long-term prognosis of hospitalized with first-time diagnosis of brain abscess in to 2016. A comparison cohort individually matched for age, sex and residence was identified, as were siblings of all study most common predisposing conditions for brain abscess. Overall mortality was 21/155 brain abscess 20/1,550 (1%) in were 150 abscess is associated with increased risk mortality for up to 5 years. New-onset epilepsy occurred in 28% of survivors and for several years after infection. The purpose of this study was to report the epidemiology, etiology, microbiologic profile and management of 3 tertiary centers across Sydney, Wales, This is a retrospective cohort study of patients 18 years of age with a clinical diagnosis of microbial keratitis presenting between 1 January 2010 December 2016 from hospital coding and pathology databases. from 80 pediatric patients with microbial keratitis were included in the study (10% had bilateral disease). The mean age was 11 \u00b1 5.3 years (range 0-18 years), and 44 were male (55%). patients had ocular and 13.5% systemic comorbidities. The most common risk factor overall was contact lens wear in 26%, trauma (24%), and external lid and eye disease (20%). Overall, 74 organisms were identified, and of those, the most common isolates were Gram-positive organism. Antimicrobial resistance were in 16 poor visual acuity. The majority of patients have a good visual outcome although serious complications are uncommon and poorly characterized the child population is, the objective was to describe the clinical behavior of this disease in children younger than 16 years of age. Methods: This was a descriptive study with prospective follow-up of all children younger than 16 years with clinical and serologic diagnoses between 2013 and 2018. Results: There the most frequent, followed by inguinal adenopathy. There were no differences between the type of manifestation and laboratory values our knowledge, the largest series of cat-scratch disease published. We demonstrate that in our environment, the inguinal location is suggestive of this disease, the disseminated other the in England were linked to immunisation records to investigate the risk after pneumococcal (PCV) vaccines. Both their be separately linked were validated as KD. The relative incidence (RI) within 28 days of PCV doses 1 or 2 measured by the self-controlled case-series method 3 (RI 0.30 (95% CI 0.11-0.77)). For MenB vaccine, the RI after doses 1 or 2 was 1.03 (95% CI 0.51-2.05) and 0.64 (95% CI 0.08-5.26) after dose 3. This study shows no evidence of an increased risk of KD is poorly described and often poses a diagnostic challenge. Cape Town, from January 1, 2014, through December 31, 2018, of all children (<13 years) diagnosed with confirmed clinical data were through folder review, laboratory records and reports. 966 with from further analysis because of lack of clinical data. The median age of the remaining 95 children was 43 months (interquartile range 20-94); 26 (27%) were organ on ultrasonography common in HIV-positive children < 0.001 and P = Liver were associated with age less than 5 years ( P = 0.03), while abdominal lymphadenopathy on ultrasonography was more common in children older than 5 years ( P = 0.038). collected in an attempt to identify Mycobacterium tuberculosis in 15 of 95 (15.8%) patients and were positive in 13 of 15 (86.7%). Conclusions: Over 10% of children with confirmed TB had Abdominal TB should should be the radiologic study of choice. RESULTADOS: Se identificaron un total de 3371 ni\u00f1os menores de 5 a\u00f1os; la mayor\u00eda naci\u00f3 en pa\u00edses con alta incidencia de TB (> 150 casos por 100 000). La mitad recibi\u00f3 IGRA (n = 1878; 56%), una cuarta parte recibi\u00f3 TST (n = 811; 24%); El 1,4% de los ni\u00f1os fueron positivos para IGRA (n = 26) y el 13% fueron positivos para TST (n = 106). Veintid\u00f3s resultados de IGRA fueron indeterminados (1,2%). Diecis\u00e9is ni\u00f1os tuvieron ambas pruebas; 9 fueron discrepantes (PT positiva con IGRA negativa). No se identificaron casos de tuberculosis durante 10 797 a\u00f1os-persona de seguimiento. CONCLUSIONES: La positividad de IGRA fue menor que la de TST en ni\u00f1os menores de 5 a\u00f1os de alto riesgo. A pesar de menos diagn\u00f3sticos de ITBL en la poblaci\u00f3n sometida a prueba IGRA, no se identificaron casos de enfermedad de TB entre los ni\u00f1os que dieron negativo en la prueba, lo que sugiere que IGRA es una herramienta valiosa para identificar ITBL en esta poblaci\u00f3n. \u00b7Ebola Leggiadro, cephalosporins in outpatients has conducted consecutive annual cross-sectional analyses and included all children aged 0-14 years (n = 9,389,183 in 2018) covered by statutory health insurance in Germany. Annual antibiotic prescription rates from 2010 to 2018 were calculated for the age groups 0-1, 2-5, 6-9 and 10-14 years. Poisson regression was used to from 746 prescriptions per 1,000 persons in 2010 to 428 per 1,000 in 2018 (p < 0.001). Reductions were most pronounced in the age groups 0-1 year (50%) and 2-5 years (44%). The age group 2-5 years exhibited the highest prescription rate with years: use substances for common and are responsible for the increase in healthcare expenditure and impact unclear. Methods: from April 2015 to December 2016 in Japan, targeting 1.4 million children under 2 years of age. We investigated the effects of primary care on confounders. mediation analyses that pathway was controlled by direct effects of 53.2 DOTs person-months (95% CI: 29.1-77.2), indicating that the effect further of paying incentives for not prescribing antibiotics healthcare and antibiotic use. Pregunta cl\u00ednica: \u00bfCu\u00e1l es el papel de las intervenciones farmacol\u00f3gicas en el tratamiento y la prevenci\u00f3n del covid-19?: Esta gu\u00eda fue desarrollada por la OMS y la Fundaci\u00f3n de Ecosistemas de Evidencia MAGIC (MAGIC), con el apoyo de The BMJ . Est\u00e1 impulsado por una necesidad urgente de colaboraci\u00f3n global para brindar una gu\u00eda confiable y viva, informando r\u00e1pidamente de las pol\u00edticas y pr\u00e1cticas en todo el mundo durante un brote de una enfermedad infecciosa emergente, como esta pandemia de covid-19. La OMS se ha asociado con MAGIC por su apoyo metodol\u00f3gico en el desarrollo y difusi\u00f3n de gu\u00edas de vida para los tratamientos farmacol\u00f3gicos del covid-19, en forma de recomendaciones r\u00e1pidas para proporcionar a los pacientes, m\u00e9dicos y responsables de la formulaci\u00f3n de pol\u00edticas informaci\u00f3n actualizada, basada en evidencia y orientaci\u00f3n f\u00e1cil de usar. Esta es una pauta viva, por lo que las recomendaciones incluidas aqu\u00ed se actualizar\u00e1n y se agregar\u00e1n nuevas recomendaciones sobre otras terapias para covid-19. La infograf\u00eda proporciona un resumen de las recomendaciones y la evidencia de apoyo e incluye enlaces a MAGIC app para obtener m\u00e1s detalles sobre la evidencia y el fundamento de la recomendaci\u00f3n, as\u00ed como ayudas para la toma de decisiones del paciente. El panel hizo una recomendaci\u00f3n fuerte para el uso de corticosteroides en covid-19 grave y cr\u00edtico porque existe un menor riesgo de muerte entre las personas tratadas con corticosteroides sist\u00e9micos (evidencia de certeza moderada), y creen que todos o casi todos los pacientes con covid-19 grave y cr\u00edtico plenamente informados elegir\u00edan este tratamiento. Por el contrario, el panel concluy\u00f3 que los pacientes con covid-19 no grave rechazar\u00edan este tratamiento porque es poco probable que se beneficien y puedan resultar perjudicados. Adem\u00e1s, teniendo en cuenta tanto la salud p\u00fablica como la perspectiva del paciente, el panel advirti\u00f3 que el uso indiscriminado de cualquier terapia para el covid-19 podr\u00eda agotar r\u00e1pidamente los recursos globales y privar a los pacientes que podr\u00edan beneficiarse m\u00e1s de ella como una terapia que podr\u00eda salvar vidas. Hand, foot, and mouth disease (HFMD) has posed We analyzed the citywide surveillance 2016 in Chengdu. Time series susceptible-infected-recovered model was developed to a major of severe gastroenteritis in children worldwide. The disease burden has in France among the 2018 population of children under the age of 5 years. Methods: To incorporate indirect protection effects accounted for 27% of the prevented rotavirus gastroenteritis cases. The balance remained in favour of the vaccine even in a scenario with a high assumption for intussusception case fatality. Conclusions: findings better assessment of the rotavirus vaccine benefit-risk balance Human cases of West Nile virus (WNV) infection are recorded and inform implementation of appropriate measures (mosquito control, health education, blood safety). Aim, We describe the epidemiology of WNV human infections in Greece focusing on the season. Methods, The National Public Organization advised physicians to test all suspect WNV infection samples to reference blood donors were diagnosis and the probable infection infection cases were diagnosed in neuroinvasive representing a increase the previous season. There were 51 deaths. Cases started occurring from week 22, earlier than usual. Both rural and urban areas were affected, with 86 (26% of the total) municipalities belonging to seven (54% of the total) regions recording cases. Two major epicentres were identified in Attica and Central Macedonia regions. distribution, suggesting intense virus circulation. Enhanced surveillance is vital for the early detection of human cases and the prompt implementation of response measures. Introducci\u00f3n: durante la pandemia de COVID-19, el uso de equipos y dispositivos de protecci\u00f3n por parte de los profesionales es fundamental para evitar la transmisi\u00f3n de la infecci\u00f3n en el colectivo de sanitarios. Material y m\u00e9todos: el Grupo Laboral-Profesional de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda de Atenci\u00f3n Primaria (AEPap) ha realizado una encuesta a los vocales auton\u00f3micos de la AEPap para conocer la disponibilidad que han tenido los pediatras de Atenci\u00f3n Primaria (PAP) de sistemas de protecci\u00f3n frente a la enfermedad, y las pruebas diagn\u00f3sticas realizadas para el diagn\u00f3stico de los contagios de los PAP. Resultados: en marzo de 2020, solo en el 32% de las comunidades aut\u00f3nomas (CC. AA.), los pediatras ten\u00edan sistemas de protecci\u00f3n adecuados. En abril ascendi\u00f3 al 70%. En todas las CC. AA. se han registrado casos de PAP enfermos, aunque es dif\u00edcil cuantificar el n\u00famero de afectados. De las que tenemos datos, sumando el n\u00famero de pediatras enfermos conocido, m\u00e1s test de reacci\u00f3n en cadena de la polimerasa (PCR) positivo, los que han estado en aislamiento y los ingresados, la cifra asciende al 7,65% de la cifra total de PAP. Los test r\u00e1pidos serol\u00f3gicos o PCR o ambos se han realizado en seis comunidades los \u00faltimos d\u00edas de abril y en otras seis los primeros d\u00edas de mayo. Entre las CC. AA. de las que hay informaci\u00f3n, Arag\u00f3n es la \u00fanica comunidad en la que no se ha realizado test. Se ha correlacionado la disponibilidad de los sistemas de protecci\u00f3n y el gasto sanitario. Conclusiones: los sistemas de protecci\u00f3n han sido insuficientes. Las CC. AA. con mayor gasto sanitario han contado m\u00e1s precozmente con sistemas de protecci\u00f3n adecuados. Han resultado infectados PAP en todas las comunidades aut\u00f3nomas, especialmente en Madrid, Castilla y Le\u00f3n y Comunidad Valenciana. La detecci\u00f3n de profesionales afectos por la infecci\u00f3n ha sido tard\u00eda. CONCLUSIONES: Entre los ni\u00f1os que est\u00e1n hospitalizados por COVID-19, la mayor\u00eda son menores de 60 d\u00edas o mayores de 12 a\u00f1os. Los ni\u00f1os pueden tener una infecci\u00f3n grave que requiera cuidados intensivos. El curso cl\u00ednico de los pacientes inmunodeprimidos no fue m\u00e1s grave que el de otros ni\u00f1os. El recuento elevado de gl\u00f3bulos blancos y el nivel de prote\u00edna C reactiva se asocian con una mayor gravedad de la enfermedad. Resumen: Esta declaraci\u00f3n actualiza las recomendaciones de la Academia Estadounidense de Pediatr\u00eda para el uso rutinario de la vacuna contra la influenza y los medicamentos antivirales en la prevenci\u00f3n y el tratamiento de la influenza en ni\u00f1os durante la temporada 2020-2021. La Academia Estadounidense de Pediatr\u00eda (AAP) recomienda la vacunaci\u00f3n rutinaria contra la influenza de todos los ni\u00f1os sin contraindicaciones m\u00e9dicas, a partir de los 6 meses de edad. La vacunaci\u00f3n contra la influenza es una intervenci\u00f3n importante para proteger a las poblaciones vulnerables y reducir la carga de enfermedades respiratorias durante la pandemia del s\u00edndrome respiratorio agudo severo-coronavirus 2 (SARS-CoV-2). Se puede administrar cualquier vacuna autorizada, recomendada y apropiada para la edad, sin preferencia por un producto o formulaci\u00f3n sobre otro. Se recomienda el tratamiento antiviral de la influenza con cualquier medicamento antiviral contra la influenza autorizado, recomendado y apropiado para la edad para los ni\u00f1os con influenza presunta o confirmada que est\u00e1n hospitalizados, tienen una enfermedad grave o progresiva o padecen afecciones subyacentes que aumentan el riesgo de complicaciones de la influenza. Se puede considerar el tratamiento antiviral para cualquier paciente ambulatorio sintom\u00e1tico previamente sano que no tenga un alto riesgo de complicaciones de la influenza en el que se confirme o sospeche un diagn\u00f3stico de influenza, si el tratamiento puede iniciarse dentro de las 48 horas posteriores al inicio de la enfermedad, y para los ni\u00f1os cuyos hermanos o contactos familiares son menores de 6 meses o tienen una condici\u00f3n de alto riesgo que los predispone a las complicaciones de la influenza. Objective To characterise the clinical features of children and young hospital confirmed severe acute respiratory explore factors associated with admission to critical care, mortality, and multisystem inflammatory in children observational cohort study with rapid data gathering and near real time analysis. Setting 260 hospitals in England, Wales, and Scotland between 17 January and 3 July 2020, with a minimum follow-up time of two weeks (to 17 July 2020). Participants 651 children and young people aged less than 19 years admitted to laboratory confirmed SARS-CoV-2. Main outcome measures Admission to critical intensive care), in-hospital mortality, or (367/650) male. 57% (330/576) were white, 12% (67/576) South and black. 42% for the WHO MIS-C criteria. 18% (116/632) of children were admitted to critical care. On multivariable analysis, this was associated with age under 1 month ratio 3.21, 95% of hospital, all of whom had profound comorbidity. 11% (52/456) met likely of non-white (64% (29/45) v 42% (148/355); P=0.004). Children with MIS-C were five times more likely to be admitted to critical care (73% (38/52) v 15% (62/404); P<0.001). In addition to the WHO criteria, children with MIS-C were more likely to v 3% (10/318); of not MIS-C. No deaths occurred in the MIS-C group. Conclusions shares features with MIS-C. This study provides additional evidence for refining the WHO MIS-C preliminary case definition. Children associated with coronavirus 2 positive children that the presence of gastrointestinal symptoms was more frequently associated with severe and of a quality improvement initiative that was begun 5 years earlier at the Lucile Packard Children's Hospital at Stanford. The initiative replaces the approach of screening laboratory tests and empiric antibiotic treatment for infants at perceived risk in 1, was sustained in phase 2, and the approach was safe. With the current extremely low incidence of EOS of 0.34 cases per 1000 live births at >35 weeks' gestation (7 cases in the 5-year study period) it would be difficult parents' in an antibiotic their child. Study design This pre-post test study enrolled English and Spanish speaking parents (n = 1051) of children ages 1-5 with acute respiratory 6 antibiotic analogue scale ranging from 0 to 100, with 0 being \"I definitely do not want an antibiotic,\" 50 \"Neutral,\" and 100 \"I absolutely want Parents were 84% female, with a mean age of 32 \u00b1 6.0, 26.0% had a high school education or less, 15% were black, and 19% were Hispanic. After watching the video, parents' average antibiotic interest ratings decreased by 10 points (mean, 57.0 \u00b1 to M \u00b1 21; parents with \u00b1 12.0 to 63.4 \u00b1 with more than one-half (52%) rating their interest in the low or neutral ranges after watching the video. Conclusions could be used in settings receiving antibiotics. of a postprescription review feedback-based antimicrobial performed intervention (2017-2018) expressed in the intervention period ( P = .002 and P = .001 respectively), and total antifungal use remained stable. A parenteral antimicrobial use was antimicrobial inpatients was An increasing trend in the of optimal prescriptions was observed ( .0898). Nonoptimal prescriptions were quality of prescription was also observed. The care and education of young children, more commonly known as child care, is a ubiquitous experience in US across geographies 5 years of age\u2014regularly participate in out-of-home care, making early care and education $47.2 billion industry with a workforce of more than 1.5 million child care providers. Early care and education involves children from birth through kindergarten entry, a time when organized, group care, including child care centers, family child care homes, preschool, and Head Start programs represent the majority of child care arrangements. Unlike other major Western countries, the US lacks a national child care system with a comprehensive centralized mechanism for policymaking or coordinated funding. Therefore, early care in the US is fragmented, leading to substantial variability in the availability, cost, and quality of child care. This piecemeal system has been severely challenged by the global pandemic and financial problems of the early care and education system, as well as the unique epidemiology of coronavirus disease 2019 (COVID-19) disease in children. Preexisting shortcomings of the US early care education system worsened during the pandemic, the COVID-19 pandemic. We offer improving health in early at this time. Rammya Mathew:: \"Back to backed by a functioning covid-19 testing programmeBMJ 2020;370:m3614 En este art\u00edculo de opini\u00f3n acerca de la vuelta al colegio de los ni\u00f1os se tratan temas que son un reflejo de lo que ocurre en nuestro medio en relaci\u00f3n a la incertidumbre sobre las consecuencias del inicio del curso escolar presencial. Estamos viendo ya, como en Inglaterra y Gales, el aumento de casos de enfermedades virales (rinovirus, parainfluenza) y la aparici\u00f3n de sintomatolog\u00eda leve respiratoria y gastrointestinal. Se tratan tres puntos importantes: 1) M\u00e1s del 50% de los ni\u00f1os con un test positivo presenta los s\u00edntomas cl\u00e1sicos que normalmente se observan en los adultos y su solapamiento de los s\u00edntomas COVID-19 con los de las enfermedades virales t\u00edpicas del oto\u00f1o invierno. 2) La confusi\u00f3n de los padres sobre si su hijo cumple los criterios de autoaislamiento y la realizaci\u00f3n de las pruebas de COVID. 3) Las escuelas a menudo tienen sus propias pol\u00edticas sobre cu\u00e1ndo un ni\u00f1o puede o no puede asistir, y los foros de las redes sociales est\u00e1n plagados de \"rumores\" sobre lo que es y no es COVID. Si los padres no pueden hacerse una prueba dentro de los primeros cinco d\u00edas de la enfermedad de su hijo, toda la familia debe aislarse por s\u00ed misma durante dos semanas. No se puede subestimar la presi\u00f3n que esto ejerce sobre las familias. Esta presi\u00f3n es a\u00fan m\u00e1s aguda en los hogares de bajos ingresos, cuyos salarios a menudo no est\u00e1n protegidos si tienen que aislarse. Cada vez que un ni\u00f1o da positivo, toda su burbuja (los grupos estables de convivencia en nuestro medio) debe aislarse durante dos semanas desde el inicio de los s\u00edntomas del caso \u00edndice. Si no se reciben y asimilan nuestros mensajes de salud p\u00fablica correctamente, y no se tiene la capacidad de realizar las pruebas para respaldar lo que se le pide a los padres, se ver\u00e1 muy r\u00e1pidamente que esta situaci\u00f3n se sale de control, con los padres forzados a enviar a sus hijos a la escuela sin estas pruebas. RESULTADOS: Desde marzo de 2020, el 27% de los padres informaron un empeoramiento de su salud mental y el 14% informaron un empeoramiento de la salud conductual de sus hijos. La proporci\u00f3n de familias con inseguridad alimentaria moderada o severa aument\u00f3 del 6% antes de marzo de 2020 al 8% despu\u00e9s de que la cobertura de seguro infantil patrocinada por el empleador disminuy\u00f3 del 63% al 60%, y el 24% de los padres informaron una p\u00e9rdida del cuidado infantil regular. El empeoramiento de la salud mental de los padres se produjo junto con el empeoramiento de la salud del comportamiento de los ni\u00f1os en casi 1 de cada 10 familias, entre las cuales el 48% inform\u00f3 p\u00e9rdida del cuidado infantil regular, el 16% inform\u00f3 cambios en el estado del seguro y el 11% inform\u00f3 un empeoramiento de la seguridad alimentaria. CONCLUSIONES: La pandemia de la enfermedad del coronavirus ha tenido un impacto en t\u00e1ndem sustancial en padres e hijos en los Estados Unidos. A medida que los formuladores de pol\u00edticas consideren medidas adicionales para mitigar los efectos econ\u00f3micos y de salud de la pandemia, deben considerar las necesidades \u00fanicas de las familias con ni\u00f1os. COVID-19 and Parent-Child Psychological CONCLUSIONES: De acuerdo con nuestras hip\u00f3tesis, en familias que han experimentado m\u00faltiples dificultades relacionadas con la crisis de la enfermedad del coronavirus de 2019, la salud mental tanto de los padres como de los ni\u00f1os es peor. A medida que la crisis contin\u00faa desarroll\u00e1ndose, los pediatras deben evaluar la salud mental, con especial atenci\u00f3n a los ni\u00f1os cuyas familias son especialmente vulnerables a los aspectos econ\u00f3micos y de enfermedad de la crisis. Knowledge of transmission dynamics of severe acute respiratory syndrome coronavirus 2 from adults to children in household settings is limited. We found an attack rate among 213 children in 137 households to be 6.1% in households with confirmed adult 2019 novel coronavirus disease index case(s). Transmission from adult to child occurred in only 5.2% of households. Young children <5 years old were at lowest risk of infection (1.3%). Children were most likely to be infected if the household index case was the mother. Parec\u00eda una verdad universalmente reconocida que la poblaci\u00f3n no ten\u00eda inmunidad preexistente al SARS-CoV-2, pero \u00bfes realmente as\u00ed? Peter Doshi explora las investigaciones emergentes sobre las respuestas inmunol\u00f3gicas. Incluso en las \u00e1reas locales que han experimentado algunos de los mayores aumentos en el exceso de muertes durante la pandemia de covid-19, las encuestas serol\u00f3gicas desde el pico indican que, como m\u00e1ximo, solo alrededor de una quinta parte de las personas tienen anticuerpos contra el SARS-CoV-2: 23% en Nueva York, 18% en Londres, 11% en Madrid. Entre la poblaci\u00f3n general, las cifras son sustancialmente m\u00e1s bajas, y muchas encuestas nacionales informan de un solo d\u00edgito. Dado que las respuestas de salud p\u00fablica en todo el mundo se basan en la suposici\u00f3n de que el virus lleg\u00f3 a la poblaci\u00f3n sin inmunidad preexistente antes de la pandemia, los datos de encuestas serol\u00f3gicas llevan a muchos, como Mike Ryan, jefe de emergencias de la OMS, a concluir que el virus, tiene \"un largo camino por quemar\". Sin embargo, una serie de estudios que han documentado c\u00e9lulas T reactivas al SARS-CoV-2 en personas sin exposici\u00f3n al virus, est\u00e1n planteando preguntas sobre cu\u00e1n nuevo es realmente el virus pand\u00e9mico, con las muchas implicaciones que esto conllevar\u00eda. Covid-19: RECOVERY trial will evaluate \"antiviral antibody cocktail\" El ensayo RECOVERY, que descubri\u00f3 que la dexametasona muestra beneficios en pacientes gravemente enfermos con covid-19, investigar\u00e1 el impacto de un \"c\u00f3ctel de anticuerpos antivirales\" dise\u00f1ado espec\u00edficamente para covid-19, conocido como REGN-COV2. El ensayo de fase III en la Universidad de Oxford ha estado evaluando diferentes candidatos de tratamiento para el virus desde el comienzo de la pandemia. Sus investigadores han anunciado ahora que evaluar\u00e1n los efectos de agregar REGN-COV2 al est\u00e1ndar de atenci\u00f3n habitual, en comparaci\u00f3n con la atenci\u00f3n est\u00e1ndar sola, sobre la mortalidad por todas las causas 28 d\u00edas despu\u00e9s de la aleatorizaci\u00f3n. La investigaci\u00f3n, que tendr\u00e1 como objetivo tener al menos 2000 pacientes asignados al azar para recibir REGN-COV2, tambi\u00e9n analizar\u00e1 el impacto en la estancia hospitalaria y la necesidad de ventilaci\u00f3n. REGN-COV2 comprende dos anticuerpos monoclonales que se unen al dominio cr\u00edtico de uni\u00f3n al receptor de la prote\u00edna de pico del virus, disminuyendo la \"capacidad de los virus mutantes para escapar del tratamiento y protegiendo contra las variantes de pico que han surgido en la poblaci\u00f3n humana\". A medida que se desarroll\u00f3 la pandemia de covid-19, aument\u00f3 el inter\u00e9s en las pruebas de anticuerpos como una forma de medir qu\u00e9 tan lejos se ha propagado la infecci\u00f3n e identificar a las personas que pueden ser inmunes. 1 Las pruebas tambi\u00e9n tienen un papel cl\u00ednico, dados los diferentes s\u00edntomas de covid-19 y los resultados falsos negativos de las pruebas de reacci\u00f3n en cadena de la polimerasa de transcripci\u00f3n inversa (RT-PCR), particularmente cuando las muestras se realizan con m\u00e1s de cinco d\u00edas despu\u00e9s del inicio de los s\u00edntomas y la sensibilidad de las pruebas RT-PCR comienzan a disminuir. En este art\u00edculo se ofrece un enfoque para las pruebas de anticuerpos en personas con y sin s\u00edntomas que sugieran una infecci\u00f3n por SARS-CoV-2 actual o pasada. La interpretaci\u00f3n de los resultados de la prueba depende no solo de la precisi\u00f3n de la prueba en s\u00ed, sino tambi\u00e9n de la probabilidad de infecci\u00f3n previa a la prueba. Esto variar\u00e1 ampliamente dependiendo de la indicaci\u00f3n de la prueba: cuando se eval\u00faan individuos asintom\u00e1ticos, la probabilidad previa a la prueba ser\u00e1 relativamente baja, para aquellos con s\u00edntomas sugestivos es probable que sea mucho mayor. La calculadora interactiva en BMJ.com (https://sandpit.bmj.com/graphics/2020/c19testA/) permite a los m\u00e9dicos explorar el impacto de cambiar la probabilidad, la sensibilidad y la especificidad previas a la prueba en los resultados de la prueba. Las medidas para reducir la transmisi\u00f3n, como el distanciamiento social, deben mantenerse independientemente del resultado de la prueba y no recomendamos la prueba de anticuerpos para este prop\u00f3sito en la actualidad. -La mayor\u00eda de los estudios sobre pruebas de anticuerpos son de pacientes hospitalizados. No sabemos qu\u00e9 tan bien funcionan las pruebas en pacientes con enfermedad leve que no ingresaron al hospital o en personas asintom\u00e1ticas. -Faltan datos sobre la precisi\u00f3n de las pruebas m\u00e1s all\u00e1 de los 35 d\u00edas; no sabemos qu\u00e9 tan bien funcionar\u00e1n estas pruebas para las infecciones que ocurrieron hace m\u00e1s de cinco semanas -La evidencia es insuficiente para saber si la presencia de anticuerpos confiere inmunidad duradera para proteger contra una futura infecci\u00f3n por covid-19 CONCLUSIONES: En esta gran cohorte de ni\u00f1os a los que se les hizo la prueba del SARS-CoV-2 a trav\u00e9s de un sitio de pruebas basado en la comunidad, las minor\u00edas raciales y / o \u00e9tnicas y los ni\u00f1os en desventaja socioecon\u00f3mica tienen la mayor carga de infecci\u00f3n. Es necesario comprender y abordar las causas de estas diferencias para mitigar las disparidades y limitar la propagaci\u00f3n de la infecci\u00f3n. CONCLUSIONES: Los datos sugieren que los casos pedi\u00e1tricos de COVID-19 son menos graves que los adultos; sin embargo, la edad 1 a\u00f1o y la presencia de condiciones subyacentes representan factores de riesgo de gravedad. Una mejor comprensi\u00f3n de la infecci\u00f3n en los ni\u00f1os puede brindar informaci\u00f3n importante sobre la patog\u00e9nesis de la enfermedad, las pr\u00e1cticas de atenci\u00f3n m\u00e9dica y las pol\u00edticas de salud p\u00fablica. Resumen Conclusiones de los autores del estudio: las dosis altas de metilprednisolona son eficaces para el tratamiento de neumon\u00eda grave por Mycoplasma pneumoniae y no aumentan la incidencia de reacciones adversas. Comentario de los revisores: las limitaciones metodol\u00f3gicas de los ensayos cl\u00ednicos incluidos en esta revisi\u00f3n, su \u00e1mbito epidemiol\u00f3gico y la escasa informaci\u00f3n sobre las caracter\u00edsticas de los pacientes hacen que los resultados de esta revisi\u00f3n deban ser interpretados con cautela. Aunque el uso de corticoides en pacientes con mala evoluci\u00f3n ser\u00eda razonable, es necesario un ensayo cl\u00ednico multic\u00e9ntrico de calidad, para comprobar el efecto, antes de incorporarlo a nuestros protocolos cl\u00ednicos. The Pediatric Infectious Disease Journal. 39(10):e315-e317, October 2020. In the current study, we report on 4 children with confirmed SARS-CoV-2 infection, of which 3 of them were asymptomatic. These patients had both pharyngeal swabs and anal swabs testing during hospital or after discharge. All the 4 children showed long-time positive RNA stool specimens of asymptomatic children last for more than 54 days after admission or 30 days after discharge. El consumo total de antibi\u00f3ticos en el \u00e1mbito de la salud humana en Espa\u00f1a registr\u00f3 una bajada del 5,4 % (1,4 DHD o Dosis Diarias Definidas por cada 1.000 habitantes y d\u00eda) en 2019, mientras que las ventas de antibi\u00f3ticos veterinarios se redujeron un 13,6 % en el mismo per\u00edodo. La incorporaci\u00f3n de los datos correspondientes a 2019 al an\u00e1lisis desarrollado en el marco del Plan Nacional frente a la Resistencia a los Antibi\u00f3ticos (PRAN) del Ministerio de Sanidad confirma la tendencia decreciente registrada en ambas tasas en los \u00faltimos a\u00f1os. El c\u00e1lculo global del consumo en salud humana incluye los antibi\u00f3ticos del grupo J01 de la clasificaci\u00f3n ATC utilizados en hospitales y \u00e1mbito comunitario. En el sector comunitario (receta oficial del Sistema Nacional de Salud, receta privada y mutuas), Espa\u00f1a ha registrado una bajada del consumo de antibi\u00f3ticos del 5,4 % (1,31 DHD, 2 millones de envases menos) en 2019. Los antibi\u00f3ticos m\u00e1s consumidos en este \u00e1mbito son amoxicilina/clavul\u00e1nico, amoxicilina y azitromicina. Por otra parte, el consumo en hospitales baj\u00f3 un 4,8 % (0,08 DHD, 2 millones de unidosis menos), con amoxicilina/clavul\u00e1nico, levofloxacino y ceftriaxona como antibi\u00f3ticos m\u00e1s utilizados en esta \u00e1rea. Con los \u00faltimos datos incorporados a la estad\u00edstica, el consumo nacional de antibi\u00f3ticos en salud humana refleja una bajada del 11,8 % entre 2015 y 2019. As\u00ed, la media espa\u00f1ola de consumo total en esta \u00e1rea ha pasado de las 28,1 DHD de 2015 a las 24,9 DHD registradas en 2019 (1,6 DHD en hospitales y 23,3 DHD en \u00e1mbito comunitario). La media total espa\u00f1ola en humana contin\u00faa coloc\u00e1ndose en cualquier caso por encima de la europea (20,1 DHD en 2018), aunque cabe destacar una variabilidad entre comunidades aut\u00f3nomas que va de 19,3 a 27,3 DHD. En el \u00e1mbito de la sanidad animal, la reducci\u00f3n del 13,6 % registrada en las ventas de antibi\u00f3ticos veterinarios en 2019 (27,2 mg/PCU o miligramos de principio activo por Unidad de Correci\u00f3n de Poblaci\u00f3n) engloba datos proporcionados por todos los actores involucrados en la cadena de comercializaci\u00f3n, ya que en 2017 la recogida de datos de laboratorios farmac\u00e9uticos se ampli\u00f3 con los de entidades minoristas y farmacias. Con las \u00faltimas cifras a\u00f1adidas a la estad\u00edstica, las ventas totales de antibi\u00f3ticos de uso veterinario muestran una reducci\u00f3n del 58,8 % entre 2014 y 2019. Espa\u00f1a pasa as\u00ed de los 418,8 mg/PCU contabilizados en 2014 a los 172,4 mg/PCU de 2019, m\u00e1s cerca de la media europea en esta \u00e1rea (107 mg/PCU en 2018). There are many questions and concerns about the coronavirus disease 2019 (COVID-19), including implications and recommendations recently issued by the Regional Office for Europe of the World Health Organization with the contribution of the European Pediatric Association-Union of during COVID-19, particularly in instances where a mother has or may have COVID-19. Children with coronavirus disease 2019 (COVID-19) are more likely to have mild or no symptoms compared with adults and may vectors virus. Little is known about the duration of respiratory and gastrointestinal viral shedding in children with COVID-19. Objective: To determine the average shedding times of severe acute respiratory syndrome coronavirus 2 tracts in children. Methods: We performed a systematic search of extracted and data on duration of viral from 69 pediatric cases, the duration of viral shedding through the respiratory tract is up to 24 days from symptom onset with a mean of 11.1 \u00b1 5.8 days. Of the children who underwent testing with stool PCR, rectal swab mean duration of viral shedding via the gastrointestinal tract was 23.6 \u00b1 8.8 days from symptom onset. In 89% of cases, viral shedding via the gastrointestinal tract persisted after nasopharyngeal or throat swabs became negative, for as long as 4 weeks. Conclusions: To our knowledge, this is the first attempt to systematically review the duration of respiratory and shedding accuracy point-of-care compared with RT-PCR tests to detect current COVID-19 infection. We were interested in two types of rapid point-of-care tests, antigen and molecular tests. Antigen tests identify proteins the the virus's genetic material, using small portable or table-top devices. Both test the same nose or throat samples as RT-PCR tests Studies or molecular point-of-care test, compared with a reference standard test. The reference standard is the best available for we and clinically defined COVID-19 as reference tests. People could be tested in hospital or the community. Studies could test people with or without symptoms. We found 18 relevant studies. Ten studies took place in North America, four in Europe, two in South America, one in China and one in multiple countries. Nine studies deliberately included a high percentage of people with confirmed COVID-19 or included only people with COVID-19. Fourteen studies did not provide any information about the people providing the samples for testing and 12 did not provide any information about where people were tested. None of the studies reported included Main studies reported eight evaluations of five different antigen tests. Overall, there was considerable variation between the results of the antigen tests in how they four different molecular tests correctly detected an average of 95% of samples with COVID-19 infection. Around 1% of samples gave false positive results. If 1000 people had molecular tests, and 100 (10%) of them really had COVID-19: - 105 people would test positive for COVID-19. Of these, 10 people (10%) would not have COVID-19 (false positive result). - 895 people would test negative for COVID-19. Of these, 5 people (1%) would actually have COVID-19 (false negative result). We noted a large difference in COVID-19 detection between the two most commonly evaluated molecular tests. How reliable were the results of the studies? Our confidence in the evidence is limited. What are the implications of this review? Studies provided little information about their participants, so it is not possible to tell if the results can be applied to people with no symptoms, mild symptoms, or who were hospitalised with COVID-19. Accurate rapid tests would have the potential to select people for RT-PCR testing or to be used where RT-PCR is not available. However, the evidence currently not strong enough and more studies are urgently needed to be able to say if these tests are good enough to be used in practice. The individual signs and symptoms included in this review appear to have very poor diagnostic properties, although this should interpreted signs or symptoms are accurate to rule in SARS-CoV-2. Cochrane sensitivity of antibody tests is too low in the first week since symptom onset to have a primary role for the diagnosis of COVID-19, but they may still have a role complementing other testing in individuals presenting later, when RT-PCR tests are negative, or are not done. Antibody tests are likely to have a useful role for detecting previous SARS-CoV-2 infection if the duration of antibody rises is currently unknown, and we found very little data beyond 35 days post-symptom onset. We are therefore uncertain about the utility of these tests for seroprevalence surveys for public health management purposes. Concerns about high risk of bias and applicability make it likely that the accuracy of tests when used in clinical care will be lower than reported in Sensitivity has hospitalised are to detect lower execution and of COVID-19 tests requires considerable improvement. Studies must report data on sensitivity disaggregated by time onset of symptoms. COVID-19-positive cases who are RT-PCR-negative should as well as those confirmed RT-PCR, in accordance with the World Health Organization (WHO) and China National Health Commission of the People's Republic of China (CDC) case definitions. We were only able to obtain data from a small proportion of available tests, and action is needed to ensure that all results of test evaluations are available in the public domain to prevent selective reporting. This is a fast-moving field and we plan ongoing updates of this living systematic review. For many shown to be different to no antibiotics in terms of symptom control and disease complications. Where feel it is safe not to antibiotics immediately for people with respiratory infections, no antibiotics with advice to return if symptoms do not resolve is likely to result in the least antibiotic use patient safety satisfaction levels. We found 138 studies with more than 23 million children. Fifty-one studies (10 million children) assessed how effective the vaccines were at preventing the 87 studies (13 million children) assessed unwanted effects. In this 2020 update we have included 74 new studies published since 2012. Conclusions: Our review shows that MMR, and MMR+V vaccines measles, mumps, rubella and chickenpox, with no evidence of an increased risk of autism or encephalitis and a small risk of febrile seizure. Our aim was to HCoV infections in hospitalized children in a prospective surveillance study for 14 years and compare them with other respiratory viruses. Methods: As a part of an ongoing to identify the etiology of viral respiratory in Spain, we performed the analysis of HCoV infections in children hospitalized in a secondary hospital in Madrid, between October 2005 and June 2018. Clinical data of HCoV compared with 5131 hospitalizations for in of 3901 cases (75.9%) had a positive viral identification and 205 cases (4.1%) were positive for HCoV. Only 41 cases (20%) of detected as single infections. Episodes of recurrent wheezing were the most common diagnosis, and 112 children (54%) had hypoxia. Clinical data in HCoV cases were similar to those associated with rhinovirus; however, patients with HCoV were hypoxia more frequently than cases with HCoV; high fever was more common in influenza infections and bronchiolitis in respiratory syncytial in children from other respiratory fatal, but mortality the chronic valve lesions heart disease (RHD) are much attributable to failure and stroke. The lesions are thought to be caused by recurrent of ARF due to repeated group A streptococcal infections. In the second half of the 20th century, the global burden of ARF Australians and New Zealand out of sight of wealthy populations persistent global burden of more than 300, 000 incident cases of ARF and more than 30 million prevalent cases of RHD.1 Prevention and control efforts for ARF and RHD are focused on primary prevention and a well-known cause of lymphadenitis, skin and soft tissue infections. The aim of this study was to evaluate the epidemiology of extrapulmonary pediatric NTM Methods: All cases of NTM and TB are notifiable under the Queensland Public Health Act (2005) and associated regulations (2005). Data from 2000 to 2017 inclusive was collected from the Notifiable Conditions Database, a laboratory based notification system that covers private and public laboratory systems. Pediatric population demographic data were obtained from the Australian Bureau of Statistics by researching the number of children 0-14 years of age in Queensland from 2000 to 2017; both annual and averaged population was determined. The statistical software SPSS and Tableau was used for analysis. Results: The mean age of diagnosis was 2.5 years with a majority of the cohort being women. Mycobacterium avium was commonly diagnosed pathogen. Geographic regions with the highest numbers of were predominantly tropical and coastal areas. M. haemophilum emerged as a more common pathogen from 2011 following a period of major flooding. Conclusion: Characteristics of species, and geographic distribution) in children may be linked to environmental and weather factors., The reports of Chao et al and DeBiasi et al from the Children's Hospital at Montefiore in New York City (NYC) and Children's National Hospital in Washington, DC (DC) provide their SARS-CoV-2 experience over 4- and 6-week periods, respectively, beginning on March 15, 2020. Although SARS-CoV-2 generally has been said to be a mild infection in the pediatric age group, a picture of severe COVID-19 in US children and youth emerges through these reports. Together, 91 hospitalized patients with 22 and DC communities served, with high proportion of Hispanic/Latinos in NCY and Hispanic/Latinos and African Americans in DC. Obesity (BMI >30kg/m2) was present in 26% of Bronx patients and 2% of DC patients. Although underlying medical conditions were common in hospitalized of hospitalized and 22% of critically ill patients in DC had no underlying 22 were male were >10 years of age. PICU admission predominantly was due to compromise were comprised of patients outpatients was occurring in DC (1804 tests over 6 weeks), we also know that 21% of infected outpatients had asthma. Taken together, there likely is a signal that SARS-CoV-2 may exacerbate asthma but itself is not a major risk factor for the severe COVID-19 pulmonary syndrome. Additionally, from the DC study, we see that although children <1 year and >15 years of age were over-represented among hospitalized patients with only MIS-C associated with SARS-CoV-2 infection in the US put meat on the bones of news reports and individual case notes. Several aspects of the studies make them clean same period from mid-March through mid-April, 2020 (ie, weeks following the peaks of Study Children with MIS-C admitted to pediatric intensive care units in New York City between April 23 and May 23, 2020, were included. Demographic and clinical data were collected. Results Of 33 children with MIS-C, the median age was 10 years; 61% were male; 45% were Hispanic/Latino; and 39% were black. Comorbidities were present in 45%. Fever (93%) and vomiting used in 18 (54%), corticosteroids in 17 (51%), tocilizumab in 12 (36%), remdesivir in 7 (21%), vasopressors in 17 (51%), mechanical ventilation in 5 (15%), extracorporeal membrane oxygenation in 1 (3%), and intra-aortic (3%). The left ventricular ejection in intensive care unit stay of 4.7 days (IQR, 4-8 days) and a hospital stay of 7.8 days (IQR, 6.0-10.1 days). One patient (3%) died after universal.OK In late April 2020, alarming news emerged from Europe that a group of children with evidence of recent severe acute is the demographic and disease-related parameters in the COVID-19 era, compared with children diagnosed with Kawasaki disease in the pre-COVID-19 era? Children with Kawasaki disease in the COVID-19 era, 80% of whom were were older and compared with those with Kawasaki disease prior to era. A thirty-fold the 10 patients with Kawasaki disease tested positive for COVID-19 with a high incidence (6/10) of cardiac involvement. News from New York, England also showed an increased incidence and severity of Kawasaki disease. to COVID-19, coronavirus had been previously isolated in 7.1% of patients with Kawasaki disease. The incidence of Kawasaki disease is not increasing in Japan, Taiwan, Korea, Hong-Kong, or China, suggesting the importance of genetic issues in the relationship between Kawasaki disease and COVID-19. In this study, the Kobayashi score, which identifies patients at high risk of IVIG resistance,revealed that of 10 patients with Kawasaki disease, Results from this study suggest that COVID-19 may be one of the triggers of Kawasaki disease. Kawasaki disease in older patients with COVID-19 is incidence cardiac involvement, lower these COVID-19 Kawasaki disease. There has been a rise in the number ill patients presenting unusual all in features of Kawasaki disease and a confirmed or suspected coronavirus disease 2019 (COVID-19) infection. According to et of delayed owing doctors focused on treating patients with COVID-19. A similar concern was shared by adult cardiologists... We thank Bassareo et al for their comments and agree that our community needs to come together to improve timely diagnosis and treatment of children with Kawasaki disease and Kawasaki disease-like illnesses during the 2019 novel coronavirus the development of coronary artery aneurysms. We would like to use this opportunity to provide context for writing our original letter and what we have learned in the interim. Between January 1, 2020, and April 1, 2020, we noted a decrease in the number of children presenting to large academic centers with Kawasaki disease. We read with interest the article by Jiao et al discussing the behavioral and emotional impact on children and adolescents imposed by the 2019 novel coronavirus disease (COVID-19) pandemic.1 Here we intend to share our personal observations regarding difficulties their daily routine, and a sedentary lifestyle, similar to other children, children of frontline COVID-19 workers are going through unique experiences. in recent decades threatens the mental where duties in hospitals and subsequent quarantine of their parents make them feel deserted. Although know that children are probably the least physically affected group, a fear of transmitting the virus to their children is lurking in their minds, which may prevent them from interacting with their children.2 Children less than 3 years of age who are dependent on their mothers for breast milk and other activities of daily living pass their lives in torment. Although, as a positive effect of lockdown, most children are getting more time to mingle with their parents, the story of the children of frontline COVID-19 warriors is different.3 Young children may not understand why their parents are not returning. Older children respect toward their parents for being involved in the fight against the deadly COVID-19. Incidences of eviction from homes or discrimination against their medical professional parents4 creates a sense of toward society at Experts have recommended strategies to combat the psychological toll of COVID-19 among children in general.5, 6, 7 In addition, we hope that government and society will be... Dubey et al bring attention to the emotional and other difficulties of family members of the medical staff, especially those serving in the front line of the coronavirus disease-2019 battle. This demonstrates that these difficulties, families. A recent survey among physicians infrequent osteoarticular infection, and its diagnosis is a challenge in young children. A series of 20 cases is described. The median age was 15 months, 75% of them being under 2 years old. Fourteen (70%) reported fever. Refusal to sit was the main reason for consultation. Final diagnosis was confirmed by bone scintigraphy. arm, gait and speech abnormalities. Two weeks noted nonsuppressible movements constant, writhing movements that did not occur during sleep. The movements had not changed in character had progressively increased in intensity. He had decreasing dexterity at and occasionally slurred words the ends of sentences. He and history sore throat. papules blisters on the hands and forearms for three months. She was seen hands and was worse at night. No close contacts experienced pruritus. She had no history of inflammatory dermatoses or other medical problems. A 10-month-old, fully vaccinated, infant boy was admitted to our hospital in rural Laos with respiratory distress that ultimately was diagnosed as due to beriberi. At the time of admission, a firm mass was noted in the right 1) during routine physical examination. His parents reported that the mass was first palpable at about 4 months of age, had progressively increased in size until about chest of age confirmed that this calcification was not visible at that time (Figure 3). An 8-month-old child under tuberculosis treatment presented with multiple ecchymotic lesions. A severe coagulopathy was evidenced compatible with vitamin K deficiency [II (3%), VII (2%), IX (3%) and X (1%)]. It was reversed with vitamin K and plasma administration. Rifampicin-induced vitamin K deficiency is very rare, reported only once before, possibly related to an inhibition of vitamin K cycle. We describe 3 cases of adolescent varicella-zoster virus reactivation, complicated by aseptic meningitis, presenting to institution in a 3-year period. These cases highlight varicella-zoster virus reactivation as an important cause in the differential diagnosis of management recommendations are needed. Since the emergence of a cluster of viral pneumonia cases in Wuhan, Hubei Province, People's Republic of China, at the caused by severe as of 7 April 2020, more than 1,214,466 cases of COVID-19 have been reported in more countries The disease was recognized by World Health Organization (WHO) as a pandemic on 11 March 2020. Published reports of adult of smell were seldom reported. In this paper, we report three cases of pediatric patients with COVID-19 infection who these have been proven to be the result of vertical transmission of SARS-CoV-2. Methods: We describe the probable vertical transmission of SARS-CoV-2 in a neonate born to a mother with coronavirus disease 2019 (COVID-19). blood, were initially negative, but positive on a nasopharyngeal aspirate on the third day of life. On day 5, the neonate developed fever and coryza, which spontaneously resolved. the identical sequences for implications for infection control and clinical management of pregnant women with COVID-19 and their newborns. Coronavirus disease 2019 outbreak has a growing impact health; transmission of severe acute respiratory syndrome coronavirus 2 infection is still controversial. In this article, we describe a case of vertical transmission of severe acute respiratory syndrome coronavirus 2 Nonspecific (IgG) serology or a history of clinical LB. Methods: We included children (<18 years) suspected of LB who visited the Lyme Center of Hospital nonspecific symptoms compared between patients with positive versus negative IgG serology and between patients with versus without previous LB with the 2 and Fisher exact tests with Bonferroni correction. A history of LB active Lyme children age 13 years); 29 (19%) had positive IgG serology; 36 (24%) had previous LB; 12 (8%) had both. nonspecific (58%), The nonspecific symptoms was similar in children with positive negative serology. None of the nonspecific more frequently in with previous LB compared with children without. More prevalent in children without previous LB were sleep disturbances (40 vs. 66%; P = 0.002) and 34%; 0.001). Conclusions: symptoms not more prevalent in children with positive IgG serology nor in children with previous LB, national trends in pediatric severe sepsis in the United States from 2003 to 2014. Study design: For this study, we included nonoverlapping years of Kids database and National Inpatient Sample database while including hospitalizations of children between 1 and 20 years of age from more than 4200 hospitals across the death as outcome variable was done to evaluate for in hospital 2014. Incidence of severe sepsis hospitalizations increased by 2.5 times (0.64-1.57 per 10,000 population) over the study period with notable concurrent significant decrease in mortality by more than 50%. Lower associated with mortality. There is a significant increase in use of healthcare notable decrease in mean length of stay (22 vs. 16 days, P < 0.001) over the study period. Conclusion: Incidence of pediatric severe sepsis is high leading to a significant use of healthcare resources. This study provides a detailed analysis of associated factors with mortality. OK Acute otitis media (AOM) is the most common reason for antimicrobial use, and tympanostomy tube placement (TTP) is the most common reason general anesthesia in to May 2010) were followed-up during 2012-2016 (target cohort, age 1.5-7 years). season-matched Antimicrobial purchase data were obtained from benefits of in Finnish guidelines. Data on all TTP procedures were obtained from national hospital discharge register and health care resource setting of grey matter lesions of the spinal cord, became increasingly recognised in 2014 following outbreaks in Colorado with an outbreak of enterovirus D68 respiratory disease. then, there have in late summer/early fall. A viral infectious likely enteroviral, is strongly suspected, but connection has demonstrates T2/FLAIR abnormalities in the central of the cord, and cerebrospinal fluid typically shows a lymphocytic pleocytosis protein. The weakness involvement. this time, although intravenous exchange outcome, including host efforts will be required to this rare but serious disorder. Influenza infection is a common cause of respiratory disease and hospitalization in children. Neurologic manifestations of the have been increasingly reported and may have an impact on the severity of the disease. The aim of this study is to describe neurologic events in pediatric patients hospitalized complications. Demographic, laboratory and as past history, were recorded. Descriptive and analytic statistical study was performed using R statistical software. Results: Two hundred with a previous sex (OR, 3.21; CI 95%, 1.22-8.33), influenza B virus (OR, 2.82; CI 95%, 1.14-7.14) and neurologic events (OR, 3.34; CI 95%, 1.10-10.19) were found to be risk factors pediatric increase disease severity. Streptococcus pneumoniae is the most common cause complicated pneumonia in children, but its incidence is children, but its relative incidence is rising. Methods: The medical records of all children 0-18 years of age from 2004 to 2019, with discharge diagnoses of pleuropneumonia S. pneumonia reviewed. A comparison of clinical and for were included: 20 GAS and 70 SP. Compared with children with SP, those with GAS were more likely to have larger pleural effusion requiring drainage and longer blood culture. The relative portion of GAS Compared with patients with SP empyema, GAS appears to cause more morbidity and a longer hospital stay. This organism is more cases of Staphylococcus aureus bacteremia were identified from our with high MSSA-prevalence. Half of the cases were uncomplicated. The Nasopharyngeal and Gut Microbiota in Children in The contributions from antibiotics exposure, genetics, immunomodulators and the environment. A high antibiotics in pediatric outpatient settings has been well documented, and in is required to reduce the microbiome of children (n = 50) age 1-6 years of age in a pediatric otolaryngology in children <2 years old was different compared with children 2 years age. Gut bacterial diversity increased with an increase in age of the children. Children taking probiotics had a notable increase in abundance the 3 months before sample collection compared with those that did not. Haemophilus spp. was highly abundant in children who received sampling suggests impact of antibiotics in colonization with the otopathogen and may be relevant clinical practice. The outbreak of severe acute respiratory syndrome coronavirus 2 or coronavirus 2019 (COVID-19)1 in the city of Wuhan, China, in December 2019 rapidly affecting national communities throughout the world.2 As of May 17, 2020, more than 4.5 million people have been infected globally at a pace of 100 000/d, and 307 395 have died.3 We will briefly discuss the effects of COVID-19 pediatric have surfaced during the months after onset of the pandemic and the implications for children's health. Our aim is to raise awareness about the likely need to remodel routine pediatric practice, both in hospital and ambulatory services, in light of COVID-19, and in the event of future similar infectious emergencies. We report on the presentation and course of 33 children with for critical illness in hospitalized children and adolescents with coronavirus disease 2019 (COVID-19). Study design Children 1 month to 21 years of age with COVID-19 from a single tertiary care children's hospital between March 15 and April 13, 2020 were included. Demographic and clinical data were collected. Results In total, for were managed 46 admitted patients, 33 (72%) were admitted to the general pediatric medical unit and 13 (28%) to the pediatric intensive care unit (PICU). Obesity and asthma were highly prevalent but not significantly associated with PICU admission (P = .99). Admission to the PICU was significantly (P < .05 for all). Patients in the PICU were more likely to require high-flow nasal cannula (P = .0001) and were more likely to have received Remdesivir through compassionate release (P < .05). Severe shock syndromes were invasive mechanical ventilation for a median of 9 days. Of the 13 patients in the PICU, 8 (61.5%) were discharged home, and 4 (30.7%) patients remain in the pediatric infected and young adults, including 44 hospitalized and <1 year and adolescents and of were over-represented hospitalized among the critically (P features respiratory syndrome 2003 (SARS) and 2019 2 Chinese pediatric cohorts, given that the causative pathogens and are This is a cross-sectional study reviewing pediatric patients with SARS (n = 43) and COVID-19 (n = 244) who were admitted to the Princess Margaret Hospital in Hong Kong and Wuhan Children's Hospital in Wuhan, respectively. Demographics, hospital were compared. Results Overall, 97.7% of patients with with had epidemiologic associations with No patients were at the time of admission, whereas 29.1% and 20.9% patients with COVID-19 admission and throughout their .004). Only 1.6% of patients with COVID-19 and 2.3% of required = P < .01), and thrombocytopenia (41.9% vs 3.8%; P < .001) were significantly more common in patients with SARS than in patients with COVID-19. The duration between positive and negative nasopharyngeal aspirate and the length in hospital stay were similar in patients with COVID-19, regardless of whether they were asymptomatic suggesting a similar duration viral shedding. Conclusions Children with COVID-19 were less symptomatic and had hematologic findings than children SARS. Suspected antibiotic hypersensitivity in children is a frequent reason for Skin test performance and drug provocation test (DPT) duration are controversial issues. The objective this study was to assess the effectiveness of diagnostic tests used in the studied. Skin tests were performed on all patients. In the case of negative results, DPTs were performed for a duration similar to the time elapsed from the start of treatment until the onset of the reaction. Results: The hypersensitivity in the study 8.1% (5 of 62). Only 1 patient showed positive skin tests. The other by DPT, which reproduced the reaction within the first 6 hours in all but one of them. Conclusions: Shortening DPT duration may decrease the of non-IgE-mediated hypersensitivity; however, it should be considered the resulting microbial resistances. Objective To evaluate the number of visits and the kilometers from their homes to the clinic. Finally, indirect costs were evaluated by or other companions who took the children to the clinic. Results A total of 40 children with suspected allergy to -lactams were evaluated in our outpatient clinic from June 1, 2017 to May 31, 2018. Total direct healthcare costs were $5038.03, with an average not allergic is not expensive. In addition, it could save future expenses because of an unnecessary lifelong use of alternative antibiotics are usually more less effective, and more frequently associated with effects. neonates. We detected human herpesvirus 6, a virus we did not routinely test for previously, in the cerebrospinal fluid of 7 neonates. In all 7 cases, detection of the virus did not warrant antiviral treatment. In 2016, a new interferon-gamma release assay, QuantiFERON-TB Gold Plus, was introduced. We cross-sectional study, involving 158 children and adolescents with tuberculosis of the assay was 82.9% (IQR 77.0%-88.8%), indicating that higher sensitivity than presumed should be based on the solely an Xpert Ultra, limits our confidence in the precision of these estimates. We are uncertain about the effectiveness of topical antibiotics with steroids in low-certainty evidence available. Amongst this uncertainty, we found of steroids to topical antibiotics discharge. evidence that some types of the relative effectiveness of different types of antibiotics; it is not possible to determine with any certainty whether or not quinolones are better or worse than two groups of compounds have different adverse effect profiles, but there is insufficient evidence from the included studies to make any comment about these. In general, adverse effects were poorly reported. a assessed effectiveness of cranberry juice for the treatment of UTIs were found. Therefore, at the present time, there is no good quality evidence to suggest that it is effective for the treatment of parallel welcome evidence from these studies. Objectives To determine the prevalence of vaccine hesitancy and refusal among parents of children with Down syndrome well the Parent Attitudes about Vaccines Survey (PACV) among with Down syndrome. Study design We mailed the PACV to parents of children with Down syndrome who attend the Down Syndrome Clinic and examined associations between PACV scores and immunization status at 19 age. Of 120 which 60 were linked to vaccination records. Of these 60 respondents, 55 children were 19 months old. PACV scores were significantly correlated with days of at months of All parents who refused all vaccines had PACV scores of 50. Only 58% of children were up to date for the combined 7 vaccine series at 19 months of age. Conclusions The PACV may be a valuable tool to identify vaccine hesitancy among parents of young needed to increase adherence with recommendations for children with Down to optimize their health and to as the community. Related research has been performed largely in the general Two studies their lenses on subtle of vaccine hesitancy, in special groups\u2014children with Down syndrome and the general adolescent population. In this volume of The Journal Langkamp et al administered the Parental Attitudes about Childhood Vaccines (PACV) (a tool for the general pediatric population) to 55 parents of children 8 years of age attending the Down Syndrome Clinic at Akron Children's Hospital and matched results with their child's immunization record to assess association with up-to-date status for standard vaccines at 19 months of age. In all, 7% of parents refused all vaccines, and almost reported that they were concerned that their child would have a serious side effect, thought it better to have fewer vaccines at the same time, and had decided not to have their child receive an injection for reasons other than illness or allergy. Not surprisingly at 19 months, only 58% of children with Down syndrome were up to date for all 8 vaccines and only 31% also had had no delays. The percentage of children up to date declined with higher PACV scores. The commentary in this volume of The Journal by Williams et al validates, through evidence, the trusted role that trust. They hope that this approach will curb the growing trend for dismissals from and US from are an experiential reality rather than a theoretical risk. Only the development... To evaluate a Kaiser Permanente Northern California physician threat. Recent data suggest that only one-half of children in the US are up-to-date for all recommended vaccines by 19-35 months, and more than one-third on alternative or shot-limiting vaccine schedules.1 Measles infected 1282 Americans in 2019\u2014the most the US nearly lost its measles elimination status.2 One 40 kindergartners attends school vaccine exemption, and many attend doubt about vaccines through film of severe acute respiratory and pharmaceutical rapidly to design and test such vaccines; the World Organization has listed more than 120 candidates in various stages of development. As we quickly embark on the pursuit of vaccines to prevent coronavirus disease 2019 (COVID-19), many are concerned that the rapidity with which these studies are being conducted will mean that vaccine safety will be sacrificed. However, the past several decades... The of children affected by coronavirus disease-2019 does not mean that there was no impact on children's health. Using data on pediatric healthcare visits and after the and historical data, we identified pediatric that were affected the pandemic and epidemic control measures during the pandemic. This is a single-center US case series of 18 infants <90 of age, with suspected RSV infection between 2014 and 2018, were enrolled study. Following informed consent, nasal samples were collected at (with 0-9 days gap). RSV-A or Clinical symptoms visit, and fever and symptoms were recorded at home for up to 8 days. Association between clinical symptoms and patient characteristics, 205 cases the study, no difference was found in patient characteristics between RSV-A and cough was shorter in than in males and in groups with birth weight 3 kg than in those with <2.5 kg. viral reduction increased and estimated viral elimination period decreased with age. duration found increase viral age. Acute are the most common disease for hospitalized children in Japan. The aim of this study was to identify viruses in children hospitalized for ALRIs almost all hospitalized children with ALRIs in Nagasaki, a regional city of Japan, and its environs. Viruses were detected by detected or more viruses from 259 (69%) of 374 patients, 227 of whom were infected with a single virus, 30 with 2, and 2 with 3 viruses. Detected viruses in this virus outbreaks from the 2013-2014 to the with ALRIs in Nagasaki, Japan, was similar to that in many other countries. Enterovirus D68, which ED were discharged virus was associated with the highest ED 1000) and hospitalization varied significantly by and virus. Mori and children had significantly higher ED visit and hospitalization rates virus resulting in measurements of ARI disease burden. Our objectives were to determine the prevalence of and to identify risk factors for coexisting bacterial meningitis (BM) in neonates with urinary tract infection Methods: A cross-sectional pediatric emergency department teaching hospital from 2001 to 2017. Infants <29 days of age with UTI (10,000 colony-forming units/mL of a single pathogen from a catheterized specimen in association with positive urinalysis) were included. Definite BM was defined as growth of a single bacterial pathogen from a cerebrospinal fluid (CSF) sample and probable BM as (1) positive blood culture with CSF pleocytosis and treatment consistent with or (2) antibiotic pretreatment before lumbar puncture, CSF pleocytosis and was used constructed Results: Three had BM: and probable BM. Risk factors detected for BM were classified as procalcitonin value puncture in these the disease has not been previously documented. Four of the cases were confirmed SARS-CoV-2 infection and 1 probable. All of them were previously healthy and needed a pediatric critical care unit symptoms not dominant or and inotropic almost always necessary. In all of them, deterioration occurred on the day of admission. We examined the dynamics of coronavirus 2019 (COVID-19) transmission within families. Our investigation demonstrated significantly lower children compared with adults residing in the same household. Children of 5-17 years of age were 61% and children of 0-4 years of age were 47% less likely to have positive polymerase chain reaction results compared with adults residing in the same household. In the US, 40% of families have school-aged children and in more than 90% of these households, at least 1 parent is employed outside the home. Schools play an important role in these working families. Yet, schools have been closed for approximately 2 months in an effort to curb the coronavirus 2019 (COVID-19) pandemic, and closing has had a profound influence on family health and well-being. When and how should they reopen? We approach these questions with limited data, and past epidemics provide little guidance for COVID-19. However, we know this: reopen. Their closure burdensome put, fully reopen society without reopening schools. This requires that children will be part of the first wave to re-emerge from shelter-in-place policies. With fast-approaching preparations required for of clinicians, scientists, and educators developed this ensure a safe and strategically planned reopening recently posted considerations important to the curb spread of severe K-12 schools occurred deliberate, delineating precisely how, when, under what conditions, and base reopening on available data. School reopening can mitigate risks to children, families, and school personnel only if it is sensitive to community needs. Models such as the Center for Disease Control and Prevention's Whole School, Whole Community, Whole Child and the School Health Index can provide a helpful framework. Systematic review of the early Chinese experience reveals that patients younger than 19 years accounted 672 confirmed cases. Although severe COVID-19 is uncommon in children, a picture of critically ill children in the US is emerging, with up to 22% having no underlying medical condition and the actually or, if infected, largely are asymptomatic. frequently require hands-on care, asymptomatic infection may susceptible individuals than might exposure to an asymptomatic adult. In addition, be standardized, large-scale viral nucleic acid and serologic testing in children is needed to guide safe school reopening. This activation of and \"child-friendly\" self-collection methods. Testing capability is only the first step. The second is understanding the test results in the appropriate context. As large-scale testing is implemented, care must be taken to ensure that these test results are interpreted families, school personnel, and communities. I n just a matter of weeks, the coronavirus disease-2019 (COVID-19) pandemic has led to huge societal public health and economic challenges worldwide. The clinical effects of COVID-19 on young children are uncertain when compared with older age groups, with lower morbidity and mortality and no conclusive evidence supporting transmission pregnancy; however, there is emerging evidence of increasing rates of child hyperinflammatory shock.1-3 Research prior pandemics and disasters clearly indicates be both immediate and consequences for many children, with particular risks faced early childhood, when brain architecture to environmental mortality among children less than 5 age and 8.3% increase in maternal mortality.5 Before the pandemic, 43% of all children less than 5 years of age in the world were estimated to be at risk of not achieving Coronavirus diease-2019 has had unintended consequences on standard pediatric care. We describe cases of delayed diagnosis of diabetes leading to severe diabetic ketoacidosis; our aim is to highlight the pediatric principles for optimal with trimethoprim-sulfamethoxazole (TMP-SMX) in adults. No studies to date have looked at the risk of this association in children. We systematically reviewed the evidence for a potential association between TMP-SMX and DILI in the pediatric PubMed, Medline, Embase, Cochrane Database of and Web of hepatic events occurring with 5, possible in 4, and doubtful in 1 case report. Conclusions: Evidence regarding DILI associated with TMP-SMX exposure studies may reveal the association between TMP-SMX and DILI in pediatrics. Estudio restrospectivo de cohortes en ni\u00f1os de 2-12 meses. Miden indicaci\u00f3n de los tests y tratamiento antibi\u00f3tico Conclusiones: La tasa de uso de antibi\u00f3ticos en la bronquiolitis fue baja en todas las redes y se asoci\u00f3 con CXR, fiebre y apnea. Las pruebas no indicadas eran comunes fuera del Reino Unido e Irlanda y variaban a trav\u00e9s de las redes, independientemente de las caracter\u00edsticas del paciente. (Ponen en resultados que en Espa\u00f1a y Portugal se realizaron pruebas no indicadas en alrededor del 50% de los ni\u00f1os testados) Se valora el efecto que la ITU durante la infancia puede tener en complicaciones renales posteriores durante el embarazo Conclusiones: las infecciones urinarias infantiles no aumentaron el riesgo de complicaciones relacionadas con el embarazo en este estudio poblacional controlado. Por tanto, las infecciones urinarias en la infancia sin anomal\u00edas graves del tracto urinario parecen tener un efecto m\u00ednimo sobre la salud renal en la edad adulta temprana. Casi 6 meses despu\u00e9s de la pandemia, la evidencia acumulada y la experiencia colectiva argumentan que los ni\u00f1os, particularmente los ni\u00f1os en edad escolar, son impulsores de la transmisi\u00f3n del SARS-CoV-2 mucho menos importantes que los adultos. Por lo tanto, se debe considerar seriamente las estrategias que permiten que las escuelas permanezcan abiertas, incluso durante los per\u00edodos de propagaci\u00f3n de COVID-19. Al hacerlo, podr\u00edamos minimizar los costos sociales, de desarrollo y de salud potencialmente profundos y adversos que nuestros hijos seguir\u00e1n sufriendo hasta que se pueda desarrollar y distribuir un tratamiento o vacuna eficaz o, en su defecto, hasta que alcancemos la inmunidad colectiva. While the FilmArray Respiratory Panel EZ has been proven as provider visits and telephone calls. This analysis will help pediatricians make more informed decisions on the implementation and judicious use of the Respiratory Panel EZ in their clinical practice. Since human coronavirus particles were detected stool pediatric gastrointestinal been recognized. In recent years, the overall detection rates have been low and have varied by region. HCoVs have not been considered as the major pathogens in pediatric acute gastroenteritis. HCoVs in children. Although digestive tract has been recognized as an infection route, it has not been possible to fully investigate the association between HCoVs infection and the gastrointestinal symptoms pediatric cases. Furthermore, pathologic features have not is in pediatric cases, particularly in newborns and infants. It has been necessary to pay more attention on gastrointestinal transmission to identify the infected children early and avoid the children in With Coronavirus Disease Importance: Coronavirus disease 2019 (COVID-19) is a global and can involve the gastrointestinal (GI) tract, patients with COVID-19. Data Sources: An electronic literature search was performed for published 95% level of heterogeneity (I2). Main 1484 records reviewed, 23 published and 6 preprint studies were included in the analysis, with a total of 4805 patients (mean [SD] age, 52.2 tests that were positive for SARS-CoV-2 were reported in 8 studies, and viral RNA shedding was detected in feces in 40.5% (95% CI, 27.4%-55.1%) of patients. There was high level This the prevent further spread of this highly contagious pathogen. Desde la aparici\u00f3n de los primeros casos en diciembre de 2019 hasta el momento actual, m\u00e1s de tres millones de personas se han infectado por SARS-CoV-2 en el mundo. Los s\u00edntomas m\u00e1s frecuentes son fiebre, tos, mialgias y dificultad respiratoria. No obstante, al progresar la pandemia, se ha prestado una atenci\u00f3n creciente a los s\u00edntomas gastrointestinales. Entre ellos, destacan hiporexia, n\u00e1useas, v\u00f3mitos y diarrea. Tambi\u00e9n puede haber hipertransaminasemia. Desde el punto de vista digestivo, cabe tener en cuenta que ciertas patolog\u00edas cr\u00f3nicas, como la enfermedad inflamatoria intestinal, pueden beneficiarse de ciertas modificaciones en cuanto a tratamiento se refiere. Por \u00faltimo, cabe reflejar que ha de extremarse la precauci\u00f3n durante la realizaci\u00f3n de endoscopias. En esta revisi\u00f3n se ahonda en todos estos aspectos. Inmunidad innata frente a SARS-CoV-2. La activaci\u00f3n de la v\u00eda del IFN limita la replicaci\u00f3n viral e induce la posterior respuesta inmune adaptativa. El SARS-CoV y el SARS-CoV-2 parecen compartir como receptor la ACE2, que se expresa principalmente en las c\u00e9lulas alveolares tipo 2 del pulm\u00f3n y tambi\u00e9n se encuentran en monocitos, macr\u00f3fagos o c\u00e9lulas endoteliales habi\u00e9ndose descrito tambi\u00e9n neurotropismo . Los macr\u00f3fagos, tras verse infectados, realizan presentaci\u00f3n de ant\u00edgenos a las c\u00e9lulas T. Este proceso, en el que se a\u00f1ade la presencia de PAMP (patrones moleculares asociados a pat\u00f3genos) derivados de viru ( y que reconocen las c\u00e9lulas de la inmunidad innata) , conduce a la activaci\u00f3n y diferenciaci\u00f3n de c\u00e9lulas T, incluida la producci\u00f3n de citocinas asociadas con los diferentes subconjuntos de c\u00e9lulas T- Se especul\u00f3 que en la infecci\u00f3n por SARS-CoV o MERS-CoV, el retraso en la respuesta IFN tipo 1 compromet\u00eda el control de la replicaci\u00f3n viral. Esto provocaba la citada afluencia de neutr\u00f3filos y monocitos-macr\u00f3fagos9. El aumento y activaci\u00f3n persistente de estas c\u00e9lulas derivar\u00eda en da\u00f1o pulmonar, incluida la neumon\u00eda o el s\u00edndrome de dificultad respiratoria aguda. En la infecci\u00f3n por SARS-CoV-2, ser\u00eda esperable un escenario similar. Papel de linfocitos T en la inflamaci\u00f3n por coronavirus En la respuesta inmune a coronavirus, el papel de los linfocitos T es predominante. En el caso de MERS CoV los linfocitos CD4+ eran m\u00e1s susceptibles a la infecci\u00f3n y su da\u00f1o condicionaba una peor evoluci\u00f3n. Dicha susceptibilidad se observ\u00f3 tambi\u00e9n en el caso de SARS-CoV9. En este caso la depleci\u00f3n de CD4+ se traduc\u00eda en un menor reclutamiento de linfocitos en territorio pulmonar, lo que condicionaba una importante neumonitis intersticial con un menor aclaramiento del viru. A consecuencia de esta disregulaci\u00f3n, los linfocitos T CD4+ presentes generaban un aumento de citocinas que se traduc\u00eda en un c\u00famulo de monocitos y neutr\u00f3filos que activaban a su vez otras cascadas citocinas (IL-1, y MCP-1). Mecanismos de evasi\u00f3n inmunitaria Los coronavirus est\u00e1n particularmente adaptados para evadir la detecci\u00f3n inmune en el reconocimiento de interfer\u00f3n, el cross-talking intercelular y la se\u00f1alizaci\u00f3n intracelular suponen los 3 modos fundamentales para lograr evadir la actividad inmunitaria. Los coronavirus infectan de forma primaria a macr\u00f3fagos. Estos presentan los ant\u00edgenos sobre las c\u00e9lulas T, lo que provoca su activaci\u00f3n y la producci\u00f3n de citocinas asociadas a los diferentes subtipos de estos (destacando Th17). Posteriormente estas citocinas amplificar\u00e1n la respuesta inmune9. La producci\u00f3n de IFN tipo 1 es de gran importancia c para optimizar la liberaci\u00f3n de prote\u00ednas antivirales, promover la fagocitosis por macr\u00f3fagos y facilitar la protecci\u00f3n de c\u00e9lulas no infectadas. Las prote\u00ednas accesorias de los coronavirus pueden interferir la se\u00f1alizaci\u00f3n v\u00eda PAMP de los receptores de tipo toll (toll-like receptors o TLR) durante la replicaci\u00f3n para evitar as\u00ed la activaci\u00f3n. Con ello, Por un lado, se facilita la persistencia viral. Por otro, se genera un efecto negativo en c\u00e9lulas natural killer (NK) o macr\u00f3fagos y se altera la activaci\u00f3n de las c\u00e9lulas T CD8+. Ambos fen\u00f3menos se pueden acompa\u00f1ar de una producci\u00f3n inadecuada de citocinas ( IL-1, IL-6, IL-8, IL-21, factor y prote\u00edna quimioatrayente de monocitos 1 (MCP-1) que provoca el reclutamiento de linfocitos y leucocitos en el lugar de infecci\u00f3n Patr\u00f3n de respuesta inmune a coronavirus SARS-CoV-2 La mayor\u00eda de pacientes con COVID-19 y necesidad de ingreso hospitalario mostraron linfopenia. Esto se justificar\u00eda, como se ha explicado, por la migraci\u00f3n a territorio pulmonar de linfocitos T, que se apreciar\u00eda como . neumon\u00edas bilaterales con im\u00e1genes en vidrio esmerilado constituir\u00edan ( en RxT y Tc T\u00f3rax). En relaci\u00f3n con las poblaciones leucocitarias, y dada la linfopenia, se ha propuesto el ratio neutr\u00f3filo-linfocito como un posible marcador de evoluci\u00f3n. El descenso relativo de linfocitos ser\u00eda un marcador indirecto de la inflamaci\u00f3n pulmonar subyacente. En pacientes COVID-19 hospitalizados con mala evoluci\u00f3n, se han descrito niveles de citocinas un aumento de d\u00edmero D, troponina I, IL-6 en suero y de prote\u00edna C reactiva3. En relaci\u00f3n con la IL-6, esta es producida por macr\u00f3fagos, c\u00e9lulas T, c\u00e9lulas endoteliales y fibroblastos y su expresi\u00f3n exacerbada no solo condiciona un estado proinflamatorio , sino tambi\u00e9n fen\u00f3menos de activaci\u00f3n macrof\u00e1gica Tratamientos Lopinavir/ritonavir: El uso de ambos antivirales se plantea en COVID-19 como resultado de su anterior utilidad frente a SARS-CoV y MERS-CoV. No existe evidencia actual que sustente su uso y los primeros trabajos realizados indican que puede no tener influencia sobre la mortalidad de estos pacientes. Remdesivir: posee actividad antiviral frente a un n\u00famero amplio de virus ARN. Su efecto y utilidad frente a SARS-CoV-2 se encuentra en estudio. Hidroxicloroquina: alcaliniza el medio dificultando la acci\u00f3n del fagolisosoma viral y, por lo tanto, enlentece o dificulta la replicaci\u00f3n de coronavirus. Recientemente se ha demostrado su utilidad in vitro contra el SARS-CoV-2. Dicha utilidad a\u00fan no dispone de evidencia cl\u00ednica siendo por lo tanto su uso emp\u00edrico. Se debe prestar atenci\u00f3n a los posibles efectos secundarios. Macr\u00f3lidos: Se atribuye a este grupo de antibi\u00f3ticos cierto perfil inmunomodulador (sobre la acci\u00f3n de neutr\u00f3filos o la liberaci\u00f3n de citocinas como IL-8) . No existe a\u00fan evidencia que confirme que su uso individual o en combinaci\u00f3n con HQ permita una mejor evoluci\u00f3n35. Interfer\u00f3n alfa y beta: objetivo mitigar la posible disrupci\u00f3n que en esta v\u00eda de respuesta innata produce el virus. En anteriores epidemias por coronavirus ofreci\u00f3 resultados controvertidos. Corticoides: su uso en COVID-19 resulta discutido. Por un lado, tiene efecto inmunosupresor que ante una disregulaci\u00f3n inmune proinflamatoria pudiera ser \u00fatil. Por otro lado, incrementan y perpet\u00faan la linfopenia pudiendo interferir en una respuesta dirigida a aclarar la presencia viral. Las recomendaciones realizadas por los cl\u00ednicos que atendieron COVID-19 en Wuhan pivotan sobre 5 claves: (1) Se debe valorar cuidadosamente el beneficio/riesgo de su uso. (2) Se deben considerar sobre todo en pacientes cr\u00edticos. (3) En pacientes con hipoxemia debida a enfermedades subyacentes o con tratamiento con corticoides de forma regular debe considerarse su uso. (4) Las dosis deben ser bajas o moderadas (0,5-1mg/kg por d\u00eda de metilprednisolona o equivalente), y (5) la duraci\u00f3n debe ser corta (7d\u00edas)37. Tocilizumab: anticuerpo monoclonal humanizado dirigido contra el receptor de la IL-6. Su uso podr\u00eda frenar la activaci\u00f3n inmunitaria subyacente siendo por lo tanto una opci\u00f3n terap\u00e9utica en pacientes con cr\u00edtica o mala evoluci\u00f3n. En el caso de no disponer de la determinaci\u00f3n de esta mol\u00e9cula, se puede utilizar como biomarcador la ferritina. Suero de convaleciente: Planteado su uso en epidemias previas por SARS-CoV y MERS-CoV, en el momento actual existen pocos datos acerca de su beneficio. Solo un trabajo sobre 5 pacientes parece ofrecer resultados. Debe ser valorado su uso con precauci\u00f3n . Schistosomiasis, also 230 million people worldwide, accounting for 1.44 million disability-adjusted life years lost.1,2 by parasites intricate life cycles requiring human freshwater contact and the a vector. Transmission occurs during freshwater contact, as human skin major blood vessels final venous plexuses. The lifespan of a schistosome ranges between 3 and 10 years but can live up to 40 years Information regarding viral shedding in children with coronavirus disease 2019 (COVID-19) was limited. This study aims to investigate the clinical and laboratory characteristics associated with viral shedding in children with mild COVID-19. Methods: The clinical and laboratory information of 110 children with COVID-19 at Wuhan Children's Hospital, Wuhan, China, from January 30 to March 10, 2020, were analyzed retrospectively. Results: The median age was 6 years old. The median period of viral shedding of COVID-19 was 15 days range as odds 9 /L ( P = in children with COVID-19 were associated with prolonged duration of viral shedding in children with COVID-19. Conclusion: Prolonged duration of viral shedding in children with COVID-19 was associated with symptomatic infection, fever, pneumonia and 9 /L. Monitoring of symptoms could help to know the viral shedding in children with COVID-19. Background: IgM titers of Mycoplasma pneumoniae can remain high for months or years, and specific DNA can be detected in asymptomatic people. Methods: We compared the performance of serology and PCR in children with and without community-acquired pneumonia (CAP) for the diagnosis of M. pneumoniae. Results: In children with CAP, a positive test by M. pneumoniae (PCR and/or paired serology or both) were found in Of 6.7% exhibited quadrupled titers (22 for IgG, 6 for IgM and 5 for both). Both tests were positive in 2.8% of cases. In the group without CAP, 3.3% were positive by PCR. Thirty-two percent of children with CAP and 38.3% of healthy had IgM titers >11 in the phase. M. pneumoniae infection, and a positive PCR result can be due to colonization and not infection. New and better diagnostic techniques are manifestations of M. pneumoniae pneumonia in children of different age groups and by the presence of co-detected respiratory virus. Methods: This study included children hospitalized with M. pneumoniae pneumonia between 2010 and 2015. At the time of diagnosis, a were reviewed from medical records. Results: Of the 286 children with M. pneumoniae pneumonia, 84 (29.4%) had a co-detected respiratory in (51.9% of children <2 years; P = 0.002). In children <2 years, with occurred in 35.7% and 15.4%, respectively. without any virus detected, only 6.4% were <2 years. These young children showed fewer median days of fever than the children 2 years (8 vs. 11 days; P = 0.022). Children 2 years tended to have with macrolide compared with Conclusions: The clinical manifestations M. pneumoniae children are milder than those in older children. A high prevalence of co-detected respiratory virus in young children suggests a role in making pneumonia clinically apparent in this age group. Objetivos: analizar el empleo de los test de detecci\u00f3n r\u00e1pida de ant\u00edgeno estreptoc\u00f3cico en Pediatr\u00eda de Atenci\u00f3n Primaria (AP), su impacto en la prescripci\u00f3n de antibi\u00f3ticos y la reducci\u00f3n de costes del tratamiento antibi\u00f3tico. Material y m\u00e9todos: estudio descriptivo transversal, en menores de 15 a\u00f1os atendidos en AP, en 24 centros de salud, desde abril de 2017 hasta febrero de 2018. Se elabor\u00f3 un protocolo de utilizaci\u00f3n del test de detecci\u00f3n r\u00e1pida de ant\u00edgeno estreptoc\u00f3cico (TDRS). Se incluyeron pacientes con escala Centor mayor o igual a 2 puntos. Se extrajeron del sistema de facturaci\u00f3n de recetas datos del n\u00famero de dosis diaria definida (DDD) e importe de antibi\u00f3ticos en dicha temporada, compar\u00e1ndose con el gasto en los 12 meses previos. Resultados: se realizaron 819 TDRS. Resultaron positivos 250 (30,5%), negativos 557 (68%) y 12 no valorables (1,5%). Se prescribi\u00f3 antibi\u00f3tico al 33% de los pacientes (todos los positivos, 18 negativos, 3 no valorables). En 539 pacientes (97%) con resultado negativo no se instaur\u00f3 antibi\u00f3tico. El n\u00famero de DDD total disminuy\u00f3 en 21 960 (12%), de las cuales 19 023 (86,6%) corresponden a los antibi\u00f3ticos m\u00e1s utilizados (penicilinas, amoxicilina, amoxicilina-clavul\u00e1nico y azitromicina). La reducci\u00f3n econ\u00f3mica fue de 11 320 \u20ac (12,5%) y el gasto en TDRS fue de 991 \u20ac, lo que supone un ahorro de 10 329\u20ac. Conclusiones: la introducci\u00f3n del TDRS en consultas de Pediatr\u00eda de AP ha permitido que se eviten un elevado n\u00famero de tratamientos antibi\u00f3ticos. Su utilizaci\u00f3n ha demostrado ser eficiente en la optimizaci\u00f3n del consumo de antibi\u00f3ticos, consiguiendo reducir su utilizaci\u00f3n, evitar efectos adversos y reducir el gasto farmac\u00e9utico innecesario. An otherwise healthy 8-year-old girl presented with a 2-month history the alopecic patch showed multiple black dots, comma hair, and corkscrew hair along with peripilar scales (Figure, Wet any A 2-year-old girl is admitted to the paediatric critical care unit following a traumatic pneumothorax as a result of a road traffic collision. After a few days, the chest drain is removed, and she is transferred to the ward for further observation. You clerk the patient on admission to the paediatric ward and are pleased to note that she is well, with no signs of respiratory distress and all observations within normal limits for her age. A senior colleague that you a Search OR infants). We identified 98 articles, English which reviewed case reports and conference abstracts were excluded. A further search of the Cochrane Library was performed using the search terms, total relevant studies were identified as described in table 1. The level of evidence was classified according to Oxford Centre for Evidence-Based Medicine 2009.1 A 6-month-old infant and her family administered to all members, and repeated five times at a once every week regimen. The examination was negative for active skin burrows, though an elongated, lesion around 1). Topical treatment with 5% permethrin under led to the definitive resolution of the scabies. ... We report the first Mycobacterium infection following a published cases of M. abscessus soft tissue infection and review the current evidence on management. la sintomatolog\u00eda gastrointestinal est\u00e1 presente de forma relevante, seg\u00fan un metaan\u00e1lisis, con una incidencia acumulada del 17,6% y en el subgrupo de poblaci\u00f3n pedi\u00e1trica del 24,8%. Posible fisiopatogenia : elevada expresi\u00f3n del receptor de la enzima convertidora de angiotensina 2 en las c\u00e9lulas intestinales, el cual modula la inflamaci\u00f3n gastrointestinal. Ni\u00f1o de 11 a\u00f1os, sin antecedentes , con dolor abdominal en FII, fiebre, v\u00f3mitos y diarrea de 5 d\u00edas, sin otra sintomatolog\u00eda y sin ambiente epid\u00e9mico familiar.EF: REG, sin aspecto s\u00e9ptico, normotenso, sin signos de distr\u00e9s, auscultaci\u00f3n cardiopulmonar normal, abdomen distendido, blando, depresible con dolor a la palpaci\u00f3n en hemiabdomen izquierdo y defensa abdominal. PPCC: hemograma coprocultivo y toxina de difficile de anticuerpos para SARS-CoV-2 y PCR-SARS-CoV-2 nasofar\u00edngea positivos. Rx T\u00f3rax normal y ecograf\u00eda abdominal con engrosamiento parietal difuso de colon descendente e hiperecogenicidad de la grasa adyacente. Con diagn\u00f3stico de infecci\u00f3n por SARS-CoV-2 con afectaci\u00f3n gastrointestinal se inicia tto con hidroxicloroquina, lopinavir/ritonavir y metilprednisolona intravenosa. Ante la sospecha de sobreinfecci\u00f3n bacteriana abdominal, por elevaci\u00f3n PCR y PCT, se asocia amoxicilina-clavul\u00e1nico iv.Tras 24 h, mejor\u00eda cl\u00ednica y descenso de los marcadores inflamatorios hasta su normalizaci\u00f3n al alta, completando 7 d\u00edas de tto, momento en el que se repite PCR-SARS-CoV-2 nasofar\u00edngea siendo negativa. Se ha descrito la posibilidad de su transmisi\u00f3n por la excreci\u00f3n fecal, por la detecci\u00f3n del ARN viral en las heces de pacientes infectados, incluso varias semanas tras su negativizaci\u00f3n en muestras respiratorias El parvovirus B19 generalmente infecta a ni\u00f1os y adultos j\u00f3venes, presentando cuadros exantem\u00e1ticos caracter\u00edsticos, como el eritema infeccioso. Dentro de las manifestaciones hemorr\u00e1gicas con erupci\u00f3n purp\u00farica-petequial, est\u00e1 el s\u00edndrome papular-purp\u00farico en guantes y calcetines. En ocasiones, distribuciones at\u00edpicas con erupciones petequiales asim\u00e9tricas podr\u00edan complicar el diagn\u00f3stico, llevando a plantear diagn\u00f3sticos diferenciales y a realizar pruebas de laboratorio. Se describe un caso inusual de parvovirus B19 con erupci\u00f3n petequial at\u00edpica, y se hace una revisi\u00f3n de la literatura m\u00e9dica reciente. Las adenopat\u00edas son la tumoraci\u00f3n cervical benigna m\u00e1s frecuente en los ni\u00f1os, pero se deben sospechar otras patolog\u00edas en caso de localizaci\u00f3n at\u00edpica, crecimiento r\u00e1pido, consistencia p\u00e9trea, signos inflamatorios o supuraci\u00f3n espont\u00e1nea. La f\u00edstula del seno piriforme es una malformaci\u00f3n cong\u00e9nita infrecuente de los arcos branquiales. Tras una infecci\u00f3n, da lugar a una pseudotumoraci\u00f3n que normalmente cursa con signos inflamatorios locales, fiebre y odinofagia, por lo que el tratamiento del proceso agudo es la antibioterapia sist\u00e9mica de amplio espectro asociada en ocasiones a drenaje. El estudio de toda masa cervical debe iniciarse con una ecograf\u00eda, a completar con una tomograf\u00eda computarizada con contraste en caso de hallazgos sugestivos de absceso adyacente al tiroides o inflamaci\u00f3n del mismo, que pueden orientar hacia f\u00edstula del seno piriforme. El m\u00e9todo diagn\u00f3stico de confirmaci\u00f3n es el examen endosc\u00f3pico en el quir\u00f3fano bajo anestesia general, que permite adem\u00e1s realizar el tratamiento quir\u00fargico definitivo. Presentamos el caso cl\u00ednico de una paciente que acude remitida desde Atenci\u00f3n Primaria tras detect\u00e1rsele una tumoraci\u00f3n indurada a nivel paramedial izquierda como \u00fanica manifestaci\u00f3n, consecuencia de una f\u00edstula de seno piriforme. Las complicaciones supurativas de la faringoamigdalitis aguda no tratada o inadecuadamente tratada son infrecuentes. Destacan, por su potencial gravedad, el absceso retrofar\u00edngeo y parafar\u00edngeo. Por su presentaci\u00f3n cl\u00ednica como limitaci\u00f3n de movilidad cervical o rigidez de nuca en contexto infeccioso, pueden plantear la sospecha inicial de meningitis aguda. Por ello, es necesario que los profesionales sanitarios conozcan las caracter\u00edsticas cl\u00ednicas y la evoluci\u00f3n de estas complicaciones, para as\u00ed actuar de manera correcta, precoz y eficaz, debido a su potencial gravedad. A continuaci\u00f3n, se presentan dos casos de complicaciones supurativas del \u00e1rea otorrinolaringol\u00f3gica que debutaron con cl\u00ednica cervical: rigidez de nuca o limitaci\u00f3n de la movilidad, y que suponen un reto diagn\u00f3stico La infecci\u00f3n por el nuevo coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]), identificado en 2019 en Wuhan (China), es el causante de la denominada enfermedad por coronavirus 2019 (COVID-19)1. Actualmente se ha extendido provocando una pandemia mundial que, seg\u00fan la Organizaci\u00f3n Mundial de la Salud, afecta a m\u00e1s de un mill\u00f3n y medio de personas en el mundo2. Al inicio del brote de COVID-19, la afectaci\u00f3n en pacientes pedi\u00e1tricos fue descrita solo excepcionalmente, pero con la extensi\u00f3n progresiva del brote, cada vez se han comunicado m\u00e1s casos en ni\u00f1os, siendo la mayor parte de ellos leves o asintom\u00e1ticos3. Las manifestaciones cl\u00ednicas comunes incluyen fiebre, tos seca, odinofagia, cefalea, astenia, mialgias y dificultad respiratoria. Hasta el momento, las manifestaciones cut\u00e1neas relacionadas con la COVID-19 han sido descritas solamente en la poblaci\u00f3n adulta3,4. Dada la escasa informaci\u00f3n sobre esta cl\u00ednica en pediatr\u00eda se presentan 2 casos de pacientes pedi\u00e1tricos con infecci\u00f3n por SARS-CoV-2 y afectaci\u00f3n cut\u00e1nea. Desde la descripci\u00f3n de lesiones acroisqu\u00e9micas asociadas a COVID-19 en la poblaci\u00f3n pedi\u00e1trica1 y su extensa difusi\u00f3n a trav\u00e9s de medios de comunicaci\u00f3n y redes sociales, son numerosas las asistencias diarias en consultas de pediatr\u00eda y dermatolog\u00eda por estas lesiones. Hydroxychloroquine (HCQ) suppresses of rheumatic fever patients ex vivo . describe HCQ and a associated with control of inflammatory markers, control of pericarditis in first patient and stabilization progressive carditis in the second patient National guidelines 10 of antibiotics for children with community-acquired pneumonia (CAP), acknowledging that the of CAP who shorter study of children aged 6 months hospitalized at The Johns Hopkins Hospital who short-course days) vs prolonged-course (8-14 days) antibiotic therapy CAP between probability of treatment weighted propensity score children and radiographic criteria with CAP, emergency visits, outpatient visits, hospital readmissions, or determined to be likely attributable to bacterial pneumonia) within 30 therapy (median, 10 days). Four percent of children experienced treatment failure, with no differences not increase odds 30-day treatment failure compared with longer courses for hospitalized children with uncomplicated CAP. Starting from 2 pediatric cases of COVID-19, with confirmation at nasopharyngeal with rectal swabs might be extended to infants for for household contacts and isolation timing. The Corona Virus 19 had several consequences worldwide and on the Italian Health System. We report our experience in the reorganization of our Pediatric Department to prevent the risk of infection for both children and staff. We strongly believe that the need to face an unpredictable emergency situation should not affect the non-Corona Virus Disease patients. La pandemia de COVID-19 ha planteado a nivel epidemiol\u00f3gico, cl\u00ednico y preventivo inc\u00f3gnitas a\u00fan no resueltas por la comunidad cient\u00edfica. El impacto directo de la infecci\u00f3n en los ni\u00f1os es muy bajo en comparaci\u00f3n con el que ha supuesto en poblaci\u00f3n adulta. A fecha de 31 de mayo de 2020, los menores de 14 a\u00f1os suponen el 0,6% de los pacientes totales confirmados en Espa\u00f1a, la afectaci\u00f3n que han presentado ha sido m\u00e1s leve y mejor el pron\u00f3stico de la enfermedad, registr\u00e1ndose hasta la fecha tres fallecimientos1. Sabemos que, durante el momento m\u00e1s duro de la pandemia, muchos pediatras, tanto de hospital como de Atenci\u00f3n Primaria, colaboraron activamente en la atenci\u00f3n a adultos enfermos de COVID-19, pero a continuaci\u00f3n voy a referirme exclusivamente a las condiciones de atenci\u00f3n a los pacientes pedi\u00e1tricos y a los condicionantes que, derivados de esta situaci\u00f3n, pueden influir en la salud de los ni\u00f1os. The World Health Organization Pneumonia Expert Group (WHO-PEG) most likely to be pneumococcal, not ruling out other bacteria or coinfecting viruses. We aimed to determine the characteristics associated with children <5 years old the pediatric emergency room (PER) with RD-CAAP. Methods: This study was a part of an study conducted in prepneumococcal conjugate the era of the pneumococcal vaccine, what is the evidence for bacterial has been an increase in recovery of Haemophilus influenzae and a sources, that preference resistant However, as the paper by Wald and DeMuri point out the situation is dynamic. Since publication of our paper, we have observed a dramatic increase pneumococcal (Kaur et al, manuscript submitted) and rising. In particular, we found that serotypes 35B and 35F are increasing Merck (PCV15) or Pfizer (PCV20). Also, we and others have found that H. in nasopharynx and middle ear, leading false impression of a \"spontaneous cure\" rate, microbiome in the nasopharynx by class for children, as well as the leading cause of emergency department visits for adverse drug events in children. is for caution, due to significant heterogeneity of included studies and a high risk activity of the pneumoniae, also and who antibiotics, is still the best choice. better question, then, may be whether antibiotics are at all. Observation is a guideline-recommended option for select groups of children with AOM, and it is also the best way to avoid antibiotic AEs. This study is an important reminder that even the \"best\" antibiotics carry risk, and the need for judicious antibiotic prescribing is paramount. Introducci\u00f3n y objetivos: analizar las caracter\u00edsticas cl\u00ednico-epidemiol\u00f3gicas de la dermatitis perianal por estreptococo betahemol\u00edtico del grupo A (SBHGA). Material y m\u00e9todos: serie de casos con recogida prospectiva de datos durante un periodo de ocho a\u00f1os en una consulta de Pediatr\u00eda. Resultados: se diagnosticaron 95 episodios (1/298 consultas) en 76 ni\u00f1os (varones/mujeres: 1,6/1). Edad media 4,5 a\u00f1os. Padecieron m\u00e1s de un episodio 13 pacientes con un total de 19 episodios sucesivos: 10 de ellos en un periodo inferior a 6 meses respecto al anterior (11% del total de episodios). Los motivos de consulta m\u00e1s frecuentes fueron: prurito, sangrado, dolor, estre\u00f1imiento y eritema perianal. El tratamiento se realiz\u00f3 por v\u00eda t\u00f3pica en el 70% de los primeros episodios y combinado (t\u00f3pico y sist\u00e9mico) en el 68% de los sucesivos. Se constat\u00f3 un fracaso terap\u00e9utico inicial en tres episodios. La distribuci\u00f3n estacional fue similar a la de faringoamigdalitis y escarlatinas por SBHGA diagnosticadas en el mismo periodo. Conclusiones: cinco motivos de consulta (prurito, sangrado, dolor, estre\u00f1imiento y eritema perianal), solos o combinados, estuvieron presentes en el 92% de los episodios. En solo el 17% de los primeros episodios el eritema perianal fue motivo de consulta. Puede ser tenue, sus bordes no siempre son n\u00edtidos y en ocasiones asocia lesiones sat\u00e9lites. Streptococcus pyogenes (S. pyogenes) es un importante pat\u00f3geno humano responsable de una gran diversidad de infecciones, algunas de las cuales presentan un car\u00e1cter severo con elevada morbimortalidad asociada. La prote\u00edna M es un determinante de virulencia cr\u00edtico de este microorganismo. Diferentes estudios comunican un incremento de enfermedad invasora por S. pyogenes (EISP) relacionado con un aumento de serotipos M1 y M3, de reconocida virulencia. El objetivo del trabajo es confirmar el incremento observado de las enfermedades invasoras por S. pyogenes durante 2011-2018, y conocer qu\u00e9 serotipos pudieran estar implicados. Material y m\u00e9todos: La identificaci\u00f3n de los aislados se realiz\u00f3 mediante pruebas fenot\u00edpicas convencionales: morfolog\u00eda de las colonias, -hem\u00f3lisis, pruebas A de Strep Kit, DiaMondiaL, determin\u00f3 mediante microdiluci\u00f3n (Vitek\u00ae2 Compact, bioMeri\u00e9ux, Inc., Durham, NC). La caracterizaci\u00f3n genot\u00edpica incluy\u00f3 el gen emm y el perfil de superant\u00edgenos. Resultados: Entre 2011-2018 se recuperaron 29 S. pyogenes invasores de sangre (16), l\u00edquido pleural (9), l\u00edquido sinovial (3) y l\u00edquido cefalorraqu\u00eddeo (1). Entre 2011 y 2013, se cuantific\u00f3 una cepa por a\u00f1o. Entre 2014 y 2018 se aislaron 2, 5, 4, 6 y 9 cepas, respectivamente. Las entidades cl\u00ednicas m\u00e1s frecuentes fueron bacteriemia y neumon\u00eda (10 y 9 casos). Los serotipos mayoritarios fueron M1 (11) y M3 (3), asociados predominantemente a neumon\u00eda (6/7 casos) e infecci\u00f3n profunda de partes blandas (3/3 casos). Conclusiones: Se constata un incremento de las enfermedad invasora por S. pyogenes en el periodo estudiado resultando mayoritarios, conforme a la bibliograf\u00eda, los serotipos M1 y M3, los cuales se asocian con neumon\u00eda e infecci\u00f3n profunda de partes blandas. Outcomes: >1 studies (49 806 children) demonstrated an overall AB prevalence of 0.37% (95% CI, 0.09-0.82) and 0.47% (95% CI, 0.36-0.59), and and AB prevalence without pyuria of 0.18% (95% CI, 0.02-0.51) and 0.38% (95% CI, 0.22-0.58), in boys and girls, respectively. Median AB duration from one study was 1.5 - 2 months. Conclusions: AB prevalence is notably lower than that tract infection (UTI) in most subgroups, and therefore, a negative urinalysis (UA) with growth on urine culture not a positive urine culture with a negative UA as a true UTI, though these findings could also represent a false positive urine from either contamination or AB. Shaikh et al conclude that the prevalence of AB is too low to use it as an explanation for proportion of positive urine cultures caused by AB of AB is 0.4-0.5%, then AB would account for in 13/14 studies in the meta-analysis al, the of collection was As such, the pooled prevalence in their study does not factor in contamination, an important cause of false positive urine cultures in the real world. Shaikh et reconsidering the AAP guideline recommendation to incorporate pyuria in that treating all positive urine cultures without hospitalization, imaging. Importance: smell and taste has been reported to be associated with coronavirus disease 2019 (COVID-19). To understand the evolution of these symptoms during the course To evaluate the of the loss of sense of smell and taste in a years) consecutively assessed at Treviso Regional Hospital, Italy, between March 19 and March 22, 2020, who tested positive for SARS-CoV-2 RNA by from median 56 years). The evaluation of the evolution of altered sense of smell or taste in the improvement severity, only SARS-CoV-2 infection. Conclusions and Relevance: At 4 89% of the SARS-CoV-2-positive mildly symptomatic patients who sense of smell or taste symptoms. Persistent loss coronavirus disease (COVID-19) have been reported, but information on immune associated April COVID-19, 60 (38.2%) mild clinical 88 (56.1%) had cases, (3.8%) had severe cases, and 3 (1.9%) were critically ill. The 148 children with disease (18-123) months, and 88 (59.5%) were girls. The most common in absolute number of lymphocytes B cells) between mild and moderate cases, but moderate cases were associated with and the neutrophil to lymphocyte ratio were negatively the role of neutrophils, CD4+ T cells, and B cells in the pathogenesis of SARS-CoV-2 infection could be important for the clinical management of COVID-19. Hemos le\u00eddo con atenci\u00f3n el art\u00edculo de Rey Gal\u00e1n et al. expresando la necesidad de comunicar experiencias cl\u00ednicas con respecto a la poblaci\u00f3n pedi\u00e1trica en relaci\u00f3n al virus SARS-CoV-2 (COVID-19)1. El actual estado de urgencia sanitaria y social, entre otros aspectos, ha desembocado en un aumento de la investigaci\u00f3n sobre el virus. En este contexto se han ido reportando nuevas manifestaciones cl\u00ednicas ligadas al COVID-19, algunas como la anosmia, parecen ser distintivas, permitiendo el diagn\u00f3stico aun en individuos asintom\u00e1ticos2. Entre ellas se han descrito lesiones cut\u00e1neas Hemos le\u00eddo con inter\u00e9s el art\u00edculo \u00abAbscesos cervicales profundos infantiles: experiencia de una unidad de ORL infantil de referencia durante 15 a\u00f1os\u00bb, publicado recientemente en su revista1. Los autores refieren que el 88,9% de los ni\u00f1os (64/72) requirieron cirug\u00eda como parte del tratamiento. Los \u00fanicos casos que no precisaron tratamiento quir\u00fargico fueron las adenopat\u00edas abscesificadas menores de 1,5cm. El art\u00edculo concluye que la realizaci\u00f3n de cirug\u00eda precoz en abscesos grandes o profundos disminuye el n\u00famero de complicaciones graves y recidivas. Un dato muy llamativo en la serie mencionada es que la totalidad de los ni\u00f1os con abscesos periamigdalinos y para/retrofar\u00edngeos se intervinieron1, situaci\u00f3n que dista mucho de nuestra pr\u00e1ctica habitual. Routine rotavirus (RV)-vaccination is recommended in Germany since August 2013. Five years later, we evaluated the recommendation by impact on RV-gastroenteritis (RVGE) burden all pre-vaccination period, of intussusception the first year of decreased by 28% (IRR = 0.73; 95% CI: 0.68-0.79) while at age of the first vaccine-dose (7th-12th week of age) increase in herd protection. The decline of the first a vaccination-associated of more infants. Question: Among children living in Europe, what is between mandatory vaccination and vaccine-preventable disease reduction? Design: Data analysis from data banks of the European Centre for Disease Prevention and Control and the World countries. Participants: Children pertussis, these diseases. maximum demonstrated with not mandatory policies vary not only in the presence or absence of a mandate but also in the implementation and enforcement of the mandates as as consequences fail to comply This found that mandatory vaccination against both measles and pertussis was associated higher prevalence of vaccination when with countries that did not have mandatory vaccination. Moreover, the magnitude of fines (in those European imposed them) was associated with higher vaccination Currently, within strategies. respiratory (25%) had neutropenia and many countries begin lift some of the restrictions to contain COVID-19 spread, lack of evidence of transmission in the school setting remains. We examined Irish notifications of SARS-CoV2 in the school setting before school closures on 12 March 2020 and identified no paediatric transmission. This adds to current evidence that children do not appear to be drivers of transmission, and we argue that reopening schools should be considered safe accompanied in Spain (2013-2018). During the study period, 7 of 737 test results were considered false-positives: 4 children with chronic medical conditions, 1 Mycobacterium lentiflavum lymphadenitis, 1 infant born to a mother with pulmonary tuberculosis, and 1 child exposed to a noninfectious tuberculosis patient. Data regarding interferon-gamma release assays false-positive children are scarce, and determine the rates false-positive in infants born preterm over time, age admitted to 289 neonatal intensive care units from 1997 to 2016. We evaluated the type of probiotics given and prevalence of exposure to probiotics over time and by site. We matched received units. We matched 33 without exposure. Probiotic administration was associated with a decrease in NEC (OR 0.62, 95% CI 0.48-0.80) and death (OR 0.52, 95% CI 0.39-0.70), an increase in Candida infection bloodstream infection (OR 0.86, 95% CI 0.70-1.05) or (OR 1.18, 95% CI 0.40-3.46). Conclusions Probiotic use increased over time and was associated decreased odds of and preterm infants. To estimate the and/or defects reported to reviewed and classified by a panel of clinical matter evidence. Results Among 858 reported cases with information supporting 124 (24.7%) cases; in 232 limited Of the herpes 2 viruses only, n = 32 [3.7%]; genetic, n = 16 [1.9%]; multifactorial, n n young children. However, few community-based studies have published and cohort study. Methods Australian children (n = the Observational Research in Weekly stool symptom detected in 1423 124 17 of (0.2%) stool summer breastfeeding at age <3 months, children. El molusco contagioso (MC) es una enfermedad cut\u00e1nea com\u00fan con una prevalencia que oscila entre el 5,1 y el 11,5% en ni\u00f1os de 0 a 6 a\u00f1os de edad. Los ni\u00f1os con enfermedades cut\u00e1neas cr\u00f3nicas, como la dermatitis at\u00f3pica, son m\u00e1s propensos a desarrollarlo. Serie de 5 casos en ni\u00f1os de 4 a 10 a\u00f1os de edad, 3 de ellos diagnosticados previamente de dermatitis at\u00f3pica. Acudieron S, Urgencias con lesiones inflamatorias muy pruriginosas en los codos y las rodillas de inicio abrupto en las \u00faltimas 48-72 h. No ten\u00edan fiebre ni otros s\u00edntomas generales, y no hab\u00edan tomado medicaci\u00f3n con anterioridad a la aparici\u00f3n de las lesiones. Todos hab\u00edan consultado previamente a su m\u00e9dico por motivo de MC (2 no recibieron tto, 2 fueron tratados con hidr\u00f3xido de potasio al 10% y uno con cantaridina. EF p\u00e1pulas edematosas de color rojizo/ros\u00e1ceo localizadas en los aspectos extensores de las extremidades, en 3 casos restringidos a las rodillas y los codos. La erupci\u00f3n apareci\u00f3 al inflamarse el MC, lo que suger\u00eda una posible asociaci\u00f3n. TTO: corticoterapia t\u00f3pica u oral, dependiendo de la extensi\u00f3n y el grado de inflamaci\u00f3n de las lesiones. Las lesiones desaparecieron entre los d\u00edas 7 y 15 del tratamiento, al igual que el MC. Las reacciones inflamatorias secundarias a MC no est\u00e1n bien estudiadas, pero son comunes y causa frecuente de dolor y prurito. En muchos casos hay inflamaci\u00f3n local que puede malinterpretarse como sobreinfecci\u00f3n bacteriana. En pacientes con dermatitis at\u00f3pica, las lesiones de MC tienden a aparecer en zonas de dermatitis eccematosa. Con menor frecuencia, los pacientes afectados desarrollan una reacci\u00f3n inflamatoria grave consistente en un exantema papular pruriginoso en los codos y las rodillas conocido como reacci\u00f3n al s\u00edndrome de Gianotti-Crosti-like (RSGC-L). Un estudio retrospectivo reciente en 696 pacientes con MC encontr\u00f3 RSGC-L en 35 pacientes (4,9% de los casos): en 23 (67,6%) localizadas exclusivamente en los aspectos extensores de las extremidades, y en los 12 restantes (35,3%) restringidas a las rodillas y/o los codos. Las RSGC-L se caracterizan por p\u00e1pulas liquenoides alrededor de los codos, las rodillas y las nalgas. La aparici\u00f3n de estas reacciones no est\u00e1 relacionada con el n\u00famero de lesiones de MC.Esta reacci\u00f3n puede estar presente en la visita inicial (50%) o desarrollarse uno o 2 meses despu\u00e9s de iniciarse el tratamiento de MC (38%), independientemente del tratamiento recibido. En ni\u00f1os, las RSGC suelen asociarse a infecciones virales (virus de Epstein-Barr o hepatitis), en las que el desarrollo de lesiones cut\u00e1neas asintom\u00e1ticas suele ir precedido de febr\u00edcula, dolor de garganta o malestar general. Estos pacientes sufren una respuesta inflamatoria seria y muy pruriginosa al MC, con desarrollo de estas lesiones t\u00edpicas y en la mayor\u00eda de los casos con resoluci\u00f3n espont\u00e1nea del MC en pocos d\u00edas o semanas. CDC (Centers for Disease Control and Prevention), COVID-19 SARS-CoV-2 pathogen virus has now the globe with more than 1.8 million individuals affected and more than 110 000 deaths internationally.1, 2, 3, 4 As of April 12, 2020, there are 530 830 cases in the US with more than 20 000 deaths.2,3 The Institute for Health Metrics and Evaluation has predicted that this pandemic could exceed current healthcare capacity in the US with a total of 81 114 deaths (95% CI, 38 242-162 106) through August 2020.5 Asthma is one of the most common chronic diseases of childhood in the US. Data from the US Department of Health and Human Services notes that asthma prevalence increased between 2001 and 2010 and is now at its highest prevalence ever (overall 8.4% in 2010).6 In the US, 7 million children have asthma.6 The morbidity of asthma in the US is high, and is higher in children than adults. Children missed 10.5 million school days owing to asthma in 2008; there were 6.7 million primary visits to asthma and 600 000 for children in 2007.7 Multiple guidelines have emerged from international societies on the management of medical care during the COVID-19 pandemic, which include a section asthma management during the COVID-19 pandemic.8,9 Owing to the high prevalence of asthma in the US, which is at the current epicenter of a global pandemic, the goal of this commentary is to provide an overview of what is known, and what is yet to be learned, about COVID-19 and pediatric asthma. Differentiating Asthma from COVID-19 Symptoms of COVID-19 can be similar to those of worsening asthma, or an asthma exacerbation. are among the most common presenting symptoms of COVID-19 in case series of children admitted to the hospital in China, as well as in available data from the Centers for Disease Control and Prevention (CDC) in the US.10, 11, 12 Fever, a common presenting symptom of COVID-19, may help to differentiate COVID-19 from an asthma exacerbation, although fever can be in other virus-triggered asthma exacerbations as well.3,10, 11, Importance: to every 12 hours \u00d7 2 doses followed by 200 mg every 12 hours \u00d7 8 doses) and a single 200-mg intravenous dose and and pediatric to mediate antiviral For remdesivir, the 1000 and time curve 0 than suggest that as likely as adults to become infected with the virus but have fewer and severe disease. of children infected with also the perinatal outcomes of neonates born to women infected with SARS-CoV-2 in pregnancy. We found 11 case series including a total of 333 infants and children. Overall, 83% of the children had a positive contact history, mostly with family members. The incubation period varied between 2 and 25 days with a mean of 7 days. The virus could be isolated from nasopharyngeal secretions for up to 22 days and from stool for more than 30 days. Co-infections were reported in up to 79% of children (mainly mycoplasma and influenza). Up to 35% of children were The most findings were unspecific and included unilateral or infiltrates with, in some cases, ground-glass opacities or admission to intensive care units (3%), and to date, only a small number of deaths have been reported in children globally. Nine case series and 2 described outcomes of maternal SARS-CoV-2 infection during pregnancy in women and 67 neonates. Two mothers (3%) were admitted to intensive care unit. Fetal distress was reported of mother and neonates, meaning vertical transmission could not be excluded. Yellow fever vaccine contains ovalbumin, egg widely. We present our experience of administering yellow fever vaccine to 11 egg-allergic children, including 3 with anaphylaxis to egg, in 2 Australian tertiary events were reported. We included five trials (2891 children and adult participants in total; 2545 participants after adjusting for clustering). Management in the intervention group was as follows: in three trials rapid tests were used in combination with a clinical scoring system; in one trial, some physicians were asked to use rapid tests alone, while others were asked to use rapid tests in combination with a clinical scoring system; in one trial, rapid tests were used alone Participants in the rapid test group were 25 percentage points) in antibiotic prescription rates is likely to be achieved by using rapid testing in people with sore throat in primary care. However, there may be little reduction between groups dispensed cases, patients may not present to the pharmacy to get their prescription filled. Four trials reported the (e.g., tonsil abscess): complications were rare (0 to 3 per trial), and there may be little or no difference between people managed on clinical grounds alone and those managed with rapid testing but the evidence is very uncertain. Among children with pharyngitis who test positive for group A Streptococcus (GAS), longitudinal studies of children with carriers were categorized as a GAS carrier with a new emm-type or a GAS carrier with a previous emm-type based and those with (N 75 were classified as acutely infected versus 13% carriers. Carriers were more and 21% be carriers with a previous detected emm-type were more likely to have URI symptoms compared with those with acquisition of a new emm-type. with GAS on throat culture identified as carriers were more likely to present with URI and atypical symptoms than children who were acutely methods are available and how are they in the diagnosis of CE? Re conventional and rapid diagnostic tests have a low sensitivity in the case of inactive cysts (A-I). with alveolar echinococcosis and cysticercosis. They are usually more sensitive in multiple CE (A-I). 2. Are molecular methods useful in the diagnosis of CE?Do the new parasitological tools help in the diagnosis? Molecular techniques may be helpful in the future for the diagnosis ofCE, but they are still in the process of optimisation 3. What is the best follow-up schedule for CE? The optimal follow-up hepatic CE: when and how? Surgical the treatment of choice and should be assessed on an individual basis (A-II). Open surgery is the most accepted procedure for treatment of CE, (B-II The (i) patients who are unsuitable for surgery due to their general status or associated comorbidities, (ii) multiple cysts, (iii) very small, difficult-to-access cysts that are partially or completely calcified (B-II). techniques in hepatic techniques of the cyst without rupture. All efforts In hepatic CE, how effective ar e techniques and what are their complications? laparoscopic surgery have any benefit over Patients with deep cysts, cysts in posterior vena cava, multiple (>3) cysts or may not be candidates not recommended high risk of cyst rupture and secondary dissemination and what are the possible complications? s Surgery is one of the best treatment options for pulmonary CE. It has a low rate of associated hepatic and pulmonary sites? Most multi-organ CE? Patients with hepatic CT, patients ultrasound or CT (B-II). A standardised medical treatment regimen has not yet fully established. When medical treatment is the only option, it should be prolonged, or even indefinite or a midline CE and abdomen (A-III). Wherever surgical it, patients with large cysts centre or close to the splenic hilum (A-II). Anthelminthic treatment must be given for at least 2 weeks before and for up to 3 months after surgery (B-III). In renal CE, Echocardiography the technique of cardiac CE, (B-II). cardiac CE, antiparasitic treatment prior to surgery can increase the risk of damage to the cyst wall and of cyst rupture (B-I). The treatment of choice in cerebral the cyst intact, using the should remove the affected bone renal, or bronchial tree must be excluded (CIII). 14. What is the best scolicidal solution? Currently no the scolicidal agents choiceTheir use is limited by their sclerosing out (B-III). 15. What for indicated for cysts between 5 and 10 cm that are stage CL, CE1 or used in women and older than 3 What factors influence the choice of antiparasitic treatment? Which, when, how for how long? Pharmacological treatment is recommended for inoperable or multi-organ CE an (B-II). choice (A-I). Better results are when PAIR combined and/or after the procedure on duration of treatment prior to intervention range from 1 day to 3 months, and for after the intervention, from 1 to 3 months (B-II). . 17. anthelminthic The sterilising effect of the combination may be superior to that of monotherapy (C-II). A longer duration of combined treatment appears to be associated with a greater reduction in the viability of the cysts (C-II). Treatment dose and duration are not well defined, but it is recommended to give atleast 4 weeks of combined treatment prior to intervention (C-II). The use of combined medical treatment may have some benefit in patients with (i) disseminated disease, (ii) previous treatment failure, (iii) poor disease whensurgery Drugs such as may some efficacy in CE (B-III). 19. In which patients is a watch and wait strategy recommended? The W&W strategy is in these patients is important be long-term, for at least 3-5 years 20. follow-up is needed after a therapeutic procedure: which patients, how, and for at least 3 years, in patients reduction in titres can be associated with cure, and an increase can be associated with a recurrence (B-III). for follow-up, as it can differentiate infection in the liver, abdomen, soft-tissues, and lungs with cysts in contact with the pleura, and any location that is accessible with ultrasound (B-II). If there are limitations to and MR can be used for aimed risk factors in acquiring CE are linked to dogs, which represent the most common primary source infection impact Interventions achieving a good implementation of the guide consisted of the development of electronic decision support tools, local training meetings, rates of antibiotics use, calculated into daily doses per 1,000 inhabitants-day (DID). An interrupted time-series analysis was conducted. The study ran from Overall antibiotic rates dropped by 28% in the Aljarafe Area and 22% in Andalusia between 2011 and 2018, at rates of -0.90 DID per year (95%CI:-1.05 to -0.75) in DID the strong decline of penicillins use (33% in more downward trend 2011 to 2018. Multifaceted reductions in antibiotic prescribing in Primary Care. In the late 1970s and early 1980s, an epidemic of silent, post-transfusion hepatitis directly led to the discovery of a novel, hepatotropic agent of the flavivirus family aptly named These highly effective antiviral agents are now approved for use in children as young as 3 years of age. No virus to date has been globally eradicated without the development of a prophylactic vaccine; however, an opportunity hepatitis C. To analyze host and pathogen factors related to disease severity of pediatric patients from 13 centers in 7 European countries. A total of 85 children were included, 11 (13%) had a severe infection. Panton-Valentine leukocidin-positive isolates were P = the only independently associated with severe outcome, regardless of methicillin household presented to dermatology clinic for evaluation of worsening rash on the right eyelid. He had developed an erythematous plaque with a peripheral on the lower eyelid 2 months prior A with superficial involving lower eyelids and loss of eyelashes (Figure 1, B). The constellation physical examination findings in resolution of the eruption (Figure 2). OK Ni\u00f1a angolana 16 a\u00f1os, remitida a Portugal con hinchaz\u00f3n progresiva de la cadera derecha y p\u00e9rdida de 30kg de peso en 18 meses. No s\u00edntomas respiratorios. Al ingreso present\u00f3 con delgadez extrema y deshidrataci\u00f3n; estaba febril, con m\u00faltiples \u00falceras de dec\u00fabito y una masa il\u00edaca dura de 30cm que se extend\u00eda al abdomen. La auscultaci\u00f3n pulmonar fue anodina. Las pruebas de sangre revelaron anemia grave (6g/dl) y un \u00edndice de parasitemia (Plasmodium falciparum) del 0,5%. El cribado del VIH fue negativo. La tomograf\u00eda computarizada (TC) abdominal revel\u00f3 una masa il\u00edaca de 30cm con fragmentaci\u00f3n cortical (fig. 1) invadiendo la aorta, la vena cava, el colon y la vejiga. El examen histol\u00f3gico de una muestra obtenida por biopsia identific\u00f3 un condrosarcoma de grado 1. Por a\u00f1adidura, la TC tor\u00e1cica revel\u00f3 cavitaci\u00f3n extensa apical en ambos pulmones adyacente a los bronquios de drenaje (signo de la raqueta de tenis [fig. 2]). El examen microsc\u00f3pico de un frotis te\u00f1ido de aspirado g\u00e1strico objetiv\u00f3 una alta concentraci\u00f3n de bacilos \u00e1cido-alcohol resistentes, aisl\u00e1ndose Mycobacterium tuberculosis en cultivo. La paciente desarroll\u00f3 v\u00f3mitos fecaloideos. Al ser imposible la cura, se iniciaron cuidados paliativos y la paciente muri\u00f3 el octavo d\u00eda. SARS-CoV-2, the RNA coronavirus etiologic agent of pneumonias that December 2019 was sequenced and confirmed in January 2020 by the Chinese Center for Disease Control and Prevention.1 The World Health Organization on March 11 officially designated COVID-19 a pandemic as it spread rapidly to 196 countries with over 54,000 confirmed cases in the United States alone.2 While reports about the virus have focused on the adult population, the largest study on children to date has been reported from China by Dong et al. Their clinical severity analysis, which included both COVID-19-positive patients and those with a high index of suspicion, revealed that severe (ie, respiratory distress) and critical shock) in children compared 58-day-old male who presented fever. On the day of admission, he was sleeping longer than normal, had were softer and greener for been paid we reported a case of recovered who was rehospitalized again because aureus colonization, household contamination, tissue infection largely aureus household contacts, and 154 pets enrolled from January 3, 2012, through October 20, 2015. A total of 5 quarterly home visits were made to 150 households in the St Louis, Missouri, region. Statistical analysis was performed from September 18, 2018, to January included S and contamination measures, personal hygiene and sharing habits, health history, activities chain reaction. Individual colonization was defined as colonization by an Among household members in 150 households, 326 (47%) were male and 366 (53%) were female, with a median age of 14.82 years (range, 0.05-82.25 years). Of 540 completing all samplings, (39%) were persistently colonized with S aureus, most often in the nares and with the strain infecting the index patient at enrollment. colonization (OR, 1.17; 95% CrI, 1.06-1.30). Strains with higher pressure 95% and MRSA strains (OR, 1.57; 95% 1.16-2.19) were more likely to persist. Seventy-six index patients those with a history of SSTI (OR, 2.55; 95% CrI, 1.88-3.47), and index patients (OR, 1.54; 95% CrI, 1.07-2.23) were more likely to report an interval SSTI. Relevance: The associated with persistent household and contamination of studies mupirocin and chlorhexidine washes has been suggested. His parents ask how effective this or other interventions are likely to be (or not to be). Structured clinical question. In an otherwise healthy will help inform clinical, and of patients with COVID-19 hospitalized at a children's hospital and to compare these and Participants This retrospective review records from a tertiary care academically affiliated children's hospital in New York City, New York, included hospitalized children and adolescents (21 years) who were tested based on suspicion for COVID-19 between March 1 to April 15, 2020, and had positive mechanical ventilation. Results: Among 50 patients, 27 (54%) were boys and 25 (50%) were Hispanic. The median days from onset of symptoms to admission was (interquartile range, [80%]) respiratory symptoms (32 [64%]), but 3 patients (6%) with only gastrointestinal tract presentations were identified. Obesity (11 [22%]) was the required 16 patient (2%) died. of severe disease. Obesity was significantly associated with mechanical ventilation in children 2 years or older (6 of 9 [67%] vs 5 of 25 [20%]; P = .03). Lymphopenia was commonly observed at admission (36 [72%]) but did differ significantly between those with and could not be completed for 3. Prolonged test positivity (maximum of 27 days) was observed in 4 patients (8%). Conclusions and Relevance: In this case series study of children and adolescents hospitalized with COVID-19, the disease had disease. Resultados: Hubo 728 (34,1%) casos confirmados por laboratorio y 1407 (65,9%) casos sospechosos. La mediana de edad de todos los pacientes fue de 7 a\u00f1os (rango intercuartil: 2-13 a\u00f1os), y 1208 pacientes de casos (56,6%) eran ni\u00f1os. M\u00e1s del 90% de todos los pacientes eran casos asintom\u00e1ticos, leves o moderados. La mediana del tiempo desde el inicio de la enfermedad hasta el diagn\u00f3stico fue de 2 d\u00edas (rango: 0-42 d\u00edas). Hubo un r\u00e1pido aumento de la enfermedad en la etapa temprana de la epidemia, y luego hubo una disminuci\u00f3n gradual y constante. La enfermedad se propag\u00f3 r\u00e1pidamente de la provincia de Hubei a las provincias circundantes con el tiempo. Se infectaron m\u00e1s ni\u00f1os en la provincia de Hubei que en cualquier otra provincia. CONCLUSIONES: Los ni\u00f1os de todas las edades fueron susceptibles a COVID-19, y no hubo diferencias significativas de sexo. Aunque las manifestaciones cl\u00ednicas de los casos de COVID-19 de los ni\u00f1os fueron generalmente menos graves que las de los pacientes adultos, los ni\u00f1os peque\u00f1os, especialmente los lactantes, fueron vulnerables a la infecci\u00f3n. La distribuci\u00f3n de los casos de COVID-19 de los ni\u00f1os vari\u00f3 con el tiempo y el espacio, y la mayor\u00eda de los casos se concentraron en la provincia de Hubei y sus alrededores. Adem\u00e1s, este estudio proporciona una fuerte evidencia de transmisi\u00f3n de persona a persona. Pediatrics June 2020, 145 (6) e20200834; DOI: https://doi.org/10.1542/peds.2020-0834 COMENTARIO FINAL: Aunque el foco de las pandemias a menudo est\u00e1 en el impacto en las personas que usan los recursos m\u00e1s altos o en los grupos de edad econ\u00f3micamente favorecidos, habr\u00e1 que ser rigurosos en medir el impacto de COVID-19 en los ni\u00f1os para modelar/evaluar con precisi\u00f3n la pandemia y asegurar que los recursos apropiados son asignados a ni\u00f1os que requieren determinados cuidados. Muchas enfermedades infecciosas afectan a los ni\u00f1os de manera diferente a los adultos, y comprender estas diferencias puede proporcionar informaci\u00f3n importante sobre la patog\u00e9nesis de la enfermedad, el manejo y el desarrollo de la terap\u00e9utica. Esto probablemente ser\u00e1 cierto para COVID-19, tal como lo fue para las enfermedades infecciosas m\u00e1s antiguas. Importance: The recent and ongoing coronavirus disease on adults critically ill with COVID-19 infection. While there is evidence that the burden of COVID-19 infection in hospitalized children is lesser than in their adult counterparts, to date, there are only limited reports describing pediatric intensive care an early characterization of COVID-19 infection in North American PICUs, focusing on study included children positive for COVID-19 admitted to 46 North American PICUs between March 14 and April 3, 2020. with follow-up to April with confirmed COVID-19 infection. Results: Of the 48 children with COVID-19 admitted to participating PICUs, 25 (52%) were male, and the (range) invasive ventilation. Eleven patients (23%) had failure of more organ systems. Extracorporeal membrane oxygenation or At the completion of the follow-up period, 2 patients (4%) had died and 15 (31%) were still hospitalized, with 3 still requiring ventilatory (range) PICU and hospital lengths of stay for those who had been discharged were 5 (3-9) days and 7 (4-13) days, respectively. Conclusions and Relevance: This early report describes the burden of COVID-19 infection in North American PICUs and confirms that severe for infection. the were positive for SARS-CoV-2 and 318 non-SARS-CoV-2 Of specimens positive for SARS-CoV-2, 24 were positive for 1 or more additional pathogens, compared with 294 of the 1101 for SARS-CoV-2 were significant at P < .05. Of 318 specimens positive for 1 or more analysis 1 specimen (defaulting to second (7.3%) compared with in patients with without other pathogens. The presence of a non-SARS-CoV-2 pathogen may not provide reassurance that a patient does not also have SARS-CoV-2. The study is limited to a single Given were 1070 specimens collected from 205 patients with COVID-19 who were a mean age of 44 years (range, 5-67 years) and 68% male. Most of the patients with fever, 398; 32%), feces (44 of 153; 29%), and blood (3 of 307; None (<2.6 \u00d7 104 (Figure). Viral (respiratory specimens, in respiratory tract specimens and in feces (n = 5) or blood (n = 2). Live SARS-CoV-2 was observed in the stool sample from 2 patients who did not have diarrhea. Discussion In this study, SARS-CoV-2 was detected in specimens from multiple sites of 205 patients with COVID-19, with lower respiratory tract samples most often testing positive for the virus. Importantly, the live virus was detected in feces, implying that SARS-CoV-2 may be transmitted by the fecal route. A small percentage of blood had positive results, suggesting that infection sometimes may be Transmission of virus by respiratory and extrarespiratory routes may help explain the rapid spread disease. addition, testing of specimens from multiple may smaller studies reported the presence of SARS-CoV-2 in anal or oral swabs and blood from 16 patients in Hubei Province,3 and viral load in throat swabs and sputum from 17 confirmed cases.4 The limitations of this study include that some patients did not have detailed clinical information available, so the data could not be correlated with symptoms or disease course and that the number of some types of samples was small. Further investigation of patients from sites is 98 consecutive cases of acute rheumatic fever (ARF) observed in a single hospital in the Emilia-Romagna Region of Italy.1 They concluded that 49% of the antibiotics is needed to prevent ARF. The design of the study, a case series, does not allow an inference to be drawn about the association between the duration of antibiotic treatment and the development of ARF. The number of patients treated for pharyngitis who have not developed ARF is unknown in this type of study. In addition, the study design does not allow an evaluation of whether the observed cases of ARF are above the expected number or the direction of the temporal trend. There is a lack of description of the review methods for data extraction from medical records and there is a risk of misclassification, because the presence of symptoms related for 71 patients whereas antibiotic treatment is reported for all specifying the timing of antibiotic treatment: patients may have been treated for other causes and/or at other times and may have been incorrectly classified as being treated for pharyngitis. Di Mario concerns finding showing that in 49% despite the antibiotic treatment and debate 1 potential explanation these results. Because we documented duration of antibiotic treatment for primary prophylaxis was 5.9 \u00b1 3.1 days, we speculated that the duration could partially explain treatment and, considering the incidence of ARF in our area, we suggested 10 days of antibiotic treatment, according to American Academy of Pediatrics1 and Infectious Disease Society of America.2 We underlined can (6) e20193728; DOI: https://doi.org/10.1542/peds.2019-3728 Los biomarcadores del hu\u00e9sped predicen la gravedad de la enfermedad en adultos con neumon\u00eda adquirida en la comunidad (NAC). Evaluamos la asociaci\u00f3n del recuento de gl\u00f3bulos blancos (WBC), el recuento absoluto de neutr\u00f3filos (NT)), la prote\u00edna C reactiva (PCR) y la procalcitonina con el desarrollo de resultados graves en ni\u00f1os con NAC. CONCLUSIONES: El recuento de leucocitos, NT, PCR y procalcitonina generalmente no son \u00fatiles para discriminar la enfermedad severa y no severa en ni\u00f1os con NAC, aunque la PCR y la procalcitonina podr\u00edan tener alguna utilidad para predecir los resultados m\u00e1s severos. Resultados. Evaluamos a 231 pacientes que cumpl\u00edan con la definici\u00f3n de caso de encefalitis, entre los cuales el 42% no ten\u00eda una etiolog\u00eda reconocida. Entre aquellos con una etiolog\u00eda identificada, los m\u00e1s comunes fueron infecciosos (73; 31%), incluyendo virales (n = 51; 22%), siendo los m\u00e1s frecuentes el virus del Nilo Occidental (VNO; n = 12) y bacterianos (n = 19; 8%), siendo los m\u00e1s frecuentes Bartonella henselae (n = 7). Entre los casos de encefalitis autoinmune (n = 60; 26%), la causa m\u00e1s frecuente fue la encefalitis anti-N-metil-D-aspartato (NMDAR) (n = 31). Las causas autoinmunes se observaron con mayor frecuencia en pacientes de sexo femenino (P <.01). Las pruebas para detectar el virus del herpes simple y el enterovirus fueron casi universales; las pruebas de encefalitis anti-NMDAR, VNO y Bartonella fueron menos comunes. CONCLUSIONES: El VNO fue la causa infecciosa m\u00e1s com\u00fan de encefalitis en nuestra poblaci\u00f3n pedi\u00e1trica a pesar de la menor frecuencia de pruebas de VNO que el virus del herpes simple o el enterovirus. El aumento de las pruebas de encefalitis anti- NMDAR result\u00f3 en la identificaci\u00f3n frecuente de casos de este tipo autoinmune. El aumento de la sensibilizaci\u00f3n a esta causa y las pruebas para detectar el VNO y Bartonella probablemente resulten en un aumento de causas identificadas de encefalitis pedi\u00e1trica. El diagn\u00f3stico etiol\u00f3gico m\u00e1s precoz de encefalitis puede conducir a mejorar los resultados cl\u00ednicos. Coronavirus disease 2019 (CoVID-19) is a new infectious has globally. despite concern focused continues to circulate and cause disease. Here we report a mixed infection. Physicians should be alert that a positive test for influenza does not rule out the possibility of COVID-19 disease. an infection chain that represents the largest coronavirus disease 2019 (CoVID-19) outbreak in Europe to date. Nowadays, few SARS-Cov-2-positive children have been admitted to pediatric departments. care professionals, other patients and visitors. The aim of this report is to document our experience in facing pediatric CoVID-19 emergency in Milan. We performed to investigate whether children hospitalized with measles (cases) between 2000 and 2015 in Switzerland would have a higher frequency other infectious diseases thereafter than children who did not by and/or keyword matched to 2 controls by time of hospitalization, age and sex. All hospitalizations 3 years after original admission, infectious or noninfectious in origin, were identified in cases and controls. Results: One hundred thirteen cases (56% males), mean age 9.0 years (range 2 weeks-17.8 years), and 196 controls were identified. Twelve rehospitalizations due to an infectious disease occurred in 11 cases and 6 in 6 controls (episode rates 0.106 versus 0.031 per person; ratio 3.47; 95% P = 0.012) in 3 years of follow-up. Of these, 9 and 3 occurred in cases and controls, respectively, during year Universal immunization against measles provides additional benefit beyond measles itself. compared clinical We analyzed the clinical presentation, outcomes and management of all children <16 years of age admitted to Turku University Hospital, Finland, with virologically confirmed influenza A or B infection during the 14-year period of 1 July 2004 to 30 June 2018. All comparisons between influenza A and B were performed both within predefined age groups (0-2, 3-9 and 10-15 years) and in all age groups combined. Results: Among 391 children hospitalized with influenza A or B infection, influenza A was diagnosed in 279 (71.4%) and influenza B in 112 (28.6%) children. Overall, there were no significant differences in any clinical features or outcomes, management, treatment at intensive care unit or length of stay between children with influenza A and B, whether analyzed by age group or among all children. As indicators of the most severe clinical presentations, blood cultures were obtained from 101 (36.2%) children with influenza A and 39 (34.8%) with influenza B (P = 0.80), and lumbar puncture was performed to 16 (5.7%) children with influenza A and 11 (9.8%) children with influenza B (P = 0.15). Conclusions: The clinical severity of influenza A and B infections is similar in children. For optimal protection against severe illnesses, the viruses seems warranted in children. OK When faced with an infant between the ages of 29 and 60 days presenting with a fever, there are various prediction rules or risk assessment tools that can be used to identify those at low risk of serious bacterial infection (SBI). The Boston and Philadelphia criteria were developed over twenty years ago to identify young, febrile infants at low risk for SBI some hospital guidelines. The epidemiology of SBI has changed since the conjugate How useful are J Pediatrics 2020; 221: 1-3. The study by Miranda-Katz et al from Kaiser Permanente Northern California incidence of community-associated Clostridioides difficile diarrheal disease\u201413.7 per 100 000 per year for the population aged 1 to 17 years. Compared with previous studies, this study has several strengths large number of subjects, testing limiting cases to ages 1 year and older and to those with diarrhea and 2) excluding patients hospital-acquired risk factors for C difficile as in case incidence (70 cases/100 000/year) occurred in children in the community between 1 and 2 years of age without remarkable healthcare-related risk factors. This previously or definitively shown. Here is an alert to the up-to-date consumer of the medical literature. The gurus of medical microbiology have still works. To are associated with community-associated Clostridioides difficile infection (CDI) in children. Study design. This case control study was a retrospective review of all children 1-17 years of age with stool specimens sent for C difficile testing from January 1, 2012, to December 31, 2016. Cases and controls were children who had C difficile testing performed in the community or first 48 hours of hospital admission and >12 weeks after hospital discharge, with no prior positive C difficile testing in last 8 weeks, without other identified causes of diarrhea, and with clinical symptoms. Cases had positive confirmatory testing for C difficile. Controls had negative testing for C difficile and were matched to cases 1:1 by age and year of specimen collection. Results. The overall incidence rate of community-acquired CDI in this cohort was 13.7 per 100 000 children per year. There was a substantial increase in community-acquired CDI from 9.6 per 100 000 children per year in 2012 to a peak of 16.9 per 100 000 children per year in 2015 (Cochran-Armitage test for trend P = .002). The risk factors for community-acquired CDI included non-Hispanic ethnicity; positive C difficile test within 6 months; and increased health care visits in the last year. Conclusions. As rates of community-acquired CDI are increasing, enhanced of CDI. Chagas problem, with the pediatric population being especially vulnerable. Our aim was to describe the clinical-epidemiologic aspects of disease in this population, as well as tolerance and adherence to treatment and the subsequent evolution of the disease. Methods: A prospective study involving 949 children 0-14 years of age screened from 2007 to 2018. Diagnosis was performed by reaction and/or microhematocrit in <1-year-old children or serology in those 1 year of age. After diagnosis, children were examined for the clinical manifestation to 14-year-olds) were in the chronic (6 mild, 2 moderate and 2 severe reactions), leading to treatment interruption in 3 of them. No side effects were detected in 1-year-old children (P < 0.05). Cure was confirmed in 29.4% of the children during follow-up, and the age of the children at treatment (1 year) was clearly associated with the effectiveness of treatment (P < 0.05). Conclusions: Effectiveness and safety of treatment were older children, highlighting the need for early screening. Cephalexin is for the treatment of methicillin-susceptible Staphylococcus population pharmacokinetic model of cephalexin in a administered cephalexin in 12 children 1-16 years of age with bone and joint infections. Simulations were performed to determine a BID and TID dosing regimen so that 90% of children in this age group would achieve the pharmacodynamic target for MSSA (ie, drug concentration exceeds the minimum inhibitory concentration of least 40% of the dosing interval). Results: The final model was 1 compartment with a transit compartment model to account for delay in oral absorption. For BID dosing, doses of 22-45 and 80 mg/kg were required for MSSA with minimum inhibitory concentrations of dosing, the respective required doses were 15-25 and 45 Our study proposes a BID and TID cephalexin dosing frequency treatment compliance for MSSA Osteoarticular infections the infections encountered in children. There exist significant practice the diagnosis and treatment of such infections. However, the practice of transitioning from parenteral sought to review our retrospective, uncontrolled data on four times daily (QID) versus three daily (TID) dosing of osteoarticular Rady arthritis between January 1, reported. Only patients culture-positive report. Demographic and clinical data were manually extracted from the electronic medical record. Fifty-nine patients were treated with cephalexin and had records available for review through our electronic medical record. Thirty-eight patients one adverse event occurring in the QID group. In this retrospective of children with for the management of children with febrile neutropenia (FN) have been published, with special focus in bacterial and fungal infections. established. The aim this study was to clinical presentation and age admitted to the Pediatric Unit after developing FN between November 2010 and December 2013, were prospectively included in the study. Children were evaluated by clinical examination and laboratory for detection of RV. Results: There was a total of 112 episodes of FN in 73 children admitted to the hospital during a 32-month period. According 33.3%; P = 0.08). Conclusions: A great proportion of children with FN admitted to a tertiary hospital had a RV of this RV isolation was active agent of acute infection was not clear. Children with FN and a isolate had a lower rate of surveillance conducted by Public Health England (PHE). Rotavirus-positive samples from vaccine-eligible children are routinely submitted to PHE for confirmation, and general practitioners are requested to complete a surveillance for vaccination and were responsible for 82% (107 of 130) of rotavirus-positive samples in 2-month-old infants and 13 samples were obtained more than 7 after the last vaccination date; 10 of these specimens were from six subsequently diagnosed with severe combined experience prolonged gastroenteritis symptoms. Most infants with vaccine strains in their more 7 after study of infants born at the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network centers (2006-2014) at 22-26 Early-onset sepsis defined pathogen from blood or cerebrospinal fluid culture 72 hours Prolonged early defined as antibiotics initiated infants (1:1) with and without prolonged antibiotic exposure. Log binomial models were April 1, 2018, in New York State and Colorado. There were 61 931 children in New York (136 practices) and 23 845 children in Colorado (42 practices) who were randomized to different centralized reminder/recall modalities\u20144 arms in New York (autodialer, text, mailed, and no reminder control) and 3 arms in Colorado (autodialer, mailed, and no reminder control). The message content was similar across modalities. Up to 3 reminders were for intervention arms. The main outcome measure was receipt of 1 influenza vaccine. Results. In New York, compared with the control arm (26.6%), postintervention influenza vaccination rates higher (adjusted risk ratio, 1.06; 95% CI, 1.02-1.10), but the rates for text (27.6%) and mail (26.8%) arms were not different from controls. In Colorado, compared with the control arm (29.9%), postintervention influenza vaccination rates for the autodialer arms were 3.0 percentage points (adjusted risk ratio, 1.08; 95% CI, 1.03-1.12) and 1.6 percentage 1.06; 95% CI, 1.02-1.10) higher, respectively. Compared with the control arm, the incremental cost per additional vaccine delivered was $20 (New York) and autodialer, less effective via mail, and The impact of each modality was modest. Compared with no reminders, the incremental cost per additional vaccine delivered was also modest for autodialer messages. We conducted a secondary analysis of a prospective study of infants 60 days of age who were febrile to assess the diagnostic accuracy Israel is known. Methods: Records of CT were collected from the National Toxoplasmosis Reference Laboratory and from 15 medical centers across Israel between or infants the time of diagnosis. Results: Of the 43 CT cases identified, 24 (55%) were in Jews and the remaining 19 cases were in patients of Arab (non-Bedouin) origin. overall was calculated as or more severe clinical manifestations were reported in 12 (46%) of the 28 live-born infants and included cerebral calcifications (7 cases), chorioretinitis (4 cases), hydrocephalus (2 cases) and 1 case of death. Sensitivities of blood polymerase chain reaction (PCR), cerebrospinal fluid each. However, analyzing PCR samples from both sites, greater disease severity observed in Israel is in part due to the lack of systematic antenatal treatment and screening. Arab diagnosis. This study demonstrates an educational program to target high-risk BSIs to from in 2009 1.0 in 2016 per 10,000 admissions. Risk factors differed aged 4 to 60 years was balanced with regard to sex (48.9% male). Because the 95% 2.07-2.72) in younger children (n = 45) and increased with age, with mean log2 counts per million of 2.77 (95% CI, 2.64-2.90) for older children (n = 185), 3.02 (95% CI, 2.78-3.26) for young adults (n = 46), and 3.09 (95% CI, 2.83-3.35) for adults (n = 29). Linear regression with ACE2 gene expression as the dependent variable and age group as the independent variable showed that compared with younger children, ACE2 gene expression was higher in older children (P = .01), young adults (P < .001), and adults (P = .001) (Figure). As the distributions of sex and asthma varied among the age groups, a linear regression Regression () coefficients for age groups from the unadjusted and are shown in per million) between a given age group and the group of children younger than 10 years. Tests with advancing age group (P .05). Discussion The results from this study show age-dependent expression of ACE2 in nasal epithelium, the first point of contact for SARS-CoV-2 and the human body. Covariate-adjusted models showed that the positive association between ACE2 gene expression and age was independent of sex and asthma. Lower ACE2 expression in children relative to adults COVID-19 is less prevalent in children.3 A limitation of this study the sample did not include individuals older than relationship between ACE2 in the airway and age. A study differences in gene results ACE2 gene expression in nasal epithelium and its relationship with age. We case-series and one prospectively planned study) with a total of 32 (range 1 to 10). Most studies assessed intervention; reporting two adverse events (potentially grade 3 or 4), one of which was a serious adverse event. We are very uncertain whether convalescent plasma is effective for people admitted We identified very low-certainty evidence on the effectiveness and safety of convalescent plasma therapy for people with COVID-19; all studies were at high risk of bias and are 47 ongoing studies evaluating convalescent plasma, of 22 are RCTs, and one trial evaluating hyperimmune immunoglobulin. We will update this review as a living systematic review, based on monthly These are likely to show different results to those reported here. Introducci\u00f3n Evaluamos la presencia de inmunoglobulina secretoria A (sIgA) frente a prote\u00ednas secretadas por E. coli (Esp) relacionadas con el sistema de secreci\u00f3n tipo III (T3SS) en saliva, y su concentraci\u00f3n semicuantitativa en ni\u00f1os menores de 2 a\u00f1os (no lactantes) colonizados o infectados previamente con E. coli enteropat\u00f3gena (EPEC). M\u00e9todos. Analizamos la presencia de sIgA en 40 ni\u00f1os con cultivos positivos previos para EPEC asociados (n=17) o no (n=23) con diarrea, mediante la t\u00e9cnica de Western-blot frente a las prote\u00ednas secretadas por E. coli (EspABCD), realizando mediciones semicuantitativas de la reacci\u00f3n de cada prote\u00edna mediante sus picos de densidad (OD). Resultados. Ambos grupos presentaron sIgA frente a las prote\u00ednas EspABCD, aunque los pacientes enfermos presentaron mayores concentraciones de estos anticuerpos que los colonizados Importance The current rapid worldwide spread medical management. data are available for adult patients with coronavirus disease 2019 was designed to retrieve all articles published from December 1, 2019, to March 3, 2020, by combining the terms coronavirus and coronavirus infection in several electronic databases (PubMed, Cochrane Library, and national reports about the pediatric SARS-CoV-2 1065 participants (444 younger than 10 years, and 553 were aged 10 to 19 years) with confirmed SARS-CoV-2 infection were included in the final analysis. All articles reflected research performed in China, except for 1 clinical case in Singapore. Children at any age were mostly to respiratory Among the included there only 1 case of severe COVID-19 infection, which occurred in a 13-month-old infant. No deaths were reported in children aged 0 to 9 years. Available data about therapies were limited. Conclusions and Relevance To our knowledge, this is the first systematic review that assesses and summarizes clinical features and management of children with SARS-CoV-2 infection. The rapid spread of COVID-19 across the globe and the lack of European and US on strategies. A fecha 10 de marzo de 2020, el nuevo coronavirus 2019 (SARS-CoV-2) ha sido responsable de m\u00e1s de 110,000 infecciones y 4000 muertes en todo el mundo. Hasta el momento, los datos sobre epidemiologia y cl\u00ednica de los ni\u00f1os infectados son limitados. Una revisi\u00f3n reciente de 72,314 casos realizada por el Centro Chino para el Control y la Prevenci\u00f3n de Enfermedades mostr\u00f3 que menos del 1% de los casos correspond\u00eda a ni\u00f1os menores de 10 a\u00f1os. Para determinar el espectro de la enfermedad en ni\u00f1os, este art\u00edculo eval\u00faa caracter\u00edsticas de la infecci\u00f3n ni\u00f1os tratados en el Hospital de Infantil de Wuhan. Data on features of severe acute respiratory report of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, experimental treatments bacteria. However, to spread specifically address the factors that promote of AR bacteria in this population. The objective of this review was to Identify risk factors for carriage of AR bacteria by healthy children. Methods: We did a systematic search of MEDLINE, Embase and PubMed for studies in developed (OECD) countries that assessed risk factors for carriage of AR bacteria in healthy children in the community. We excluded studies done before 1998 and studies studies impact of factors were assessed 2 or fewer studies per pneumoniae, H. influenzae); however, it was not consistently associated with carriage of AR bacteria in skin or stool (S. aureus and E. coli). For AR S. aureus, transmission within households appeared to have a greater Conclusions: The factors AR bacteria by healthy children differed between bacterial species. To reduce reservoirs of AR bacteria in the community, it is essential for intervention strategies to target the specific risk factors complex (cc11) was observed from October 2015 in the Netherlands. We compared the clinical picture and disease outcome of Methods. We included IMD cases reported from January 2015 to June 2018 in the Netherlands and assessed clinical manifestation adjusting for age, gender, and comorbidities. Results. A total of 565 IMD cases were reported, of which 204 were IMD-W, 270 63 septicemia (46%) or pneumonia (12%) and less often with meningitis (17%, P < .001). IMD-W cases presented more often with respiratory with diarrhea without IMD-specific symptoms (P = .061). The CFR for IMD-W was 16% (32/199, P < .001). The differences between IMD-W and other remained and comorbidities. Almost all our IMD-W cases were caused by cc11. research is and MMRV vaccines stop measles, mumps, rubella and chickenpox. vaccines cause unwanted effects We found 138 studies with more than 23 million children. Fifty-one studies (10 million children) assessed how effective the vaccines were at preventing the 87 studies (13 million children) assessed unwanted effects. In this 2020 update we have included 74 new studies published since 2012. Measles: results from seven studies (12,000 children) showed that one dose of vaccine was 95% effective in preventing measles. Seven per cent of unvaccinated children this number from six studies (9915 children) showed that of vaccine was 72% effective in preventing mumps. This rose to 86% after two doses, (3 studies, 7792 children). In unvaccinated children, 7.4% would catch mumps and this would fall to 1% if children were vaccinated with two doses. The results for rubella (1 study, 1621 children) and chickenpox (one study, 2279 children) also showed that 89% effective in preventing rubella, and after 10 years the at preventing did 1,194,764 children), studies very small to high temperature or fever (febrile seizures) around two weeks after vaccination, and of a condition where blood does not clot normally (idiopathic thrombocytopenic purpura) in vaccinated children. safety and effectiveness of MMR/MMRV vaccines support their use of MMR/MMRV could wane with time since immunisation. El v\u00ednculo epidemiol\u00f3gico m\u00e1s importante en este momento es el contacto con personas con infecci\u00f3n confirmada sin menospreciar la importancia de haber viajado a una zona considerada de alto riesgo como es en este momento el norte de Italia, Se han publicado varias series pedi\u00e1tricas en China confirm\u00e1ndose que los casos pedi\u00e1tricos oscilan entre el 0,8 y el 2% de los contabilizados. Los cuadros cl\u00ednicos son leves en la mayor\u00eda de los ni\u00f1os, incluso en lactantes, con fiebre de corta duraci\u00f3n y s\u00edntomas catarrales3-6. No se refiere en los art\u00edculos publicados que se asocie a sibilancia.s La anal\u00edtica de los ni\u00f1os es generalmente anodina y en la tomograf\u00eda computarizada (TC) se observan infiltrados parcheados (no siempre en la radiograf\u00eda de t\u00f3rax). Se ha documentado que los ni\u00f1os, aun siendo casos leves, pueden ser una importante fuente de transmisi\u00f3n del virus con una tasa de infecci\u00f3n entre sus contactos de un 7,4% en los ni\u00f1os menores de 10 a\u00f1os, similar a la media de la poblaci\u00f3n adulta con un 7,9%. Se ha detectado, adem\u00e1s, que pueden excretar virus fundamentalmente en heces durante un tiempo prolongado, incluso un mes, y que los ni\u00f1os pueden tener altas cargas virales en secreciones respiratorias. No se ha descrito mortalidad en menores de 10 a\u00f1os, y la recuperaci\u00f3n es la norma entre 14 y 30 d\u00edas. No hay datos de la infecci\u00f3n en ni\u00f1os inmunodeprimidos. Respecto al tratamiento, algunos de los pacientes publicados han sido tratados con lopinavir/ritonavir a pesar de tener cuadros leves. Se esperan los resultados de un ensayo cl\u00ednico con este f\u00e1rmaco que arrojar\u00e1 luz a la posibilidad de emplear este antirretroviral como tratamiento, pues actualmente hay dudas de su posible eficacia. Numerosos estudios en adultos est\u00e1n comparando tratamientos combinados con los antipal\u00fadicos cloroquina e hidroxicloroquina, junto a otros antivirales, si bien no hay ning\u00fan dato en ni\u00f1os. Remdesivir, el antiviral an\u00e1logo de nucle\u00f3tido desarrollado para el virus del Ebola, contin\u00faa siendo en el momento actual el f\u00e1rmaco que se posiciona con mayores posibilidades de eficacia, teniendo dosis pedi\u00e1tricas establecidas. Su uso para esta indicaci\u00f3n es compasivo, a trav\u00e9s de (AEMPS). En el momento de redactar esta carta se han detectado 6 casos de infecci\u00f3n COVID-19 en ni\u00f1os, 2 en la Comunidad de Castilla-La Mancha y 5 en la Comunidad de Madrid, de un total de m\u00e1s de 500 casos, lo que supone alrededor de un 1% A fecha de 7 de marzo de 2020, menos de 10 d\u00edas despu\u00e9s de que se hiciera p\u00fablico el primer caso de COVID-19 en Madrid, se ha realizado reacci\u00f3n en cadena de polimerasa (PCR) de SARS-CoV-2 al menos a 63 pacientes menores de 14 a\u00f1os (54% varones). La media de edad ha sido de 4,5 a\u00f1os, y 10 de ellos (16%) ten\u00edan enfermedad previa. De los 63 pacientes a los que conocemos que se ha hecho el an\u00e1lisis, 13 (20%) eran contactos de casos confirmados de COVID-19, 15 (28%) eran pacientes con s\u00edntomas compatibles y datos de riesgo (viaje a zona de riesgo o contacto estrecho con adultos con cl\u00ednica compatible y viaje a zona de riesgo) y 35 (63%) eran pacientes ingresados con un cuadro respiratorio grave sin datos epidemiol\u00f3gicos de riesgo. El cuadro cl\u00ednico m\u00e1s frecuente entre estos pacientes fue la neumon\u00eda (n=32/35, 91%), con o sin sibilancias asociadas (tabla 1). Se ha confirmado presencia de SARS-CoV-2 en el aspirado nasofar\u00edngeo en 5 pacientes (8%). De ellos, 2 eran contactos de casos confirmados, 2 pacientes eran familiar en primer grado de un contacto de caso confirmado, y en un caso no hab\u00eda un contacto epidemiol\u00f3gico. Se confirma por el momento con estos resultados que alrededor de un 1% de los casos de infecci\u00f3n COVID-19 son ni\u00f1os, tal y como se describe en otros pa\u00edses. Sin embargo, las cifras deben ser interpretadas con precauci\u00f3n, dado que la incidencia var\u00eda en funci\u00f3n del n\u00famero de casos analizados, y por ahora se ha realizado cribado en un peque\u00f1o porcentaje de pacientes pedi\u00e1tricos. Esto podr\u00eda enmascarar un porcentaje superior de casos que pueden pasar desapercibidos por ser cuadros leves, con el consiguiente riesgo de transmisi\u00f3n comunitaria. Pneumonia is considered as the single largest cause of death in children under the age of five years, causing more than 800,000 deaths every year worldwide. In of community-acquired pneumonia (CAP) hospitalizations decreased to 2014, mainly in than 2 years old. Overall crude in-hospital mortality fell from 4.1 to 2.8. Once again, in PCV vaccination coverage seems to have an effect on hospitalizations and outcomes for CAP in children. The PERCH study was an impressive effort of collaboration that enrolled or according WHO classification with a positive chest-X-ray in seven countries of Africa and Asia from 2011 to 2014. Viruses caused most of the severe pneumonia cases (61%), and Streptococcus pneumoniae represented 6.7% of community-acquired pneumonia requiring hospitalization among children in the United States of America from 2010 to 2012. Among 2222 children with radiographic evidence of pneumonia, a viral or bacterial pathogen was detected in 1802 (81%), one or more viruses in 1472 (66%), bacteria in 175 (8%), and both bacterial and viral pathogens in 155 (7%). The most commonly detected pathogen was RSV (in 28% of the S. aureus, and S. pyogenes were detected in 4%,1% and 1% respectively.5 The that currently the pneumonia in any child who requires admission to a hospital worldwide. The rapid identification of respiratory viruses in children with pneumonia presenting for hospital care may result in favorable interventions, such as a prescription of and setting. antibiotic prescribed with a infection is Nasrint et al. observed a prospective children that the carriage of penicillin-resistant pneumococci was significantly associated with the two months. Several studies of RDT to achieve stewardship principles in children. A Cochrane review published in 2014 and based on four studies involving 759 previously healthy children coming the Emergency Department with fever and respiratory symptoms, observed that the use of rapid viral tests showed fewer antibiotic prescriptions trend, but recently, a controlled clinical acute respiratory infections (mainly RSV) in the Netherlands, could not show either a benefit in antibiotic use when RDT results and finally, there are also favorable international recommendations for the use of RDT; the guidelines of the Infectious Diseases Society of America for the management of CAP in children stated that testing for issue of Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica, Aguilera Alonso et al.13 described the experience of early identification of respiratory viruses in 100 children (median age of 21 months) with 105 episodes of CAP in a tertiary hospital in Madrid. This was an observational, retrospective study of children admitted to care management from 2014 to 2018. In a step-by-step approach, a rapid antigen-based test, for RSV and influenza A and B, and a multiplex molecular diagnostics respiratory viruses were used. pneumonia. S. pneumoniae was isolated in blood culture of one child. There was an identification of a respiratory virus in 93 (88%) cases, mainly RSV in 37 (35%) cases, and influenza in 21 (20%) cases. Patients with RSV detection had in cases with no viral identification was higher those = 0.017). Prescriptions of antibiotics to children Spain remains also high and antibiotics for respiratory infections are of the most prescribed. Aguilera Alonso et al reported that empiric antibiotics were used in 51 cases (48.6%). Interestingly, viral tests were done in the first 48 h after admission and the testing TAT had a maximum time of 24 h. Shorter TATs have been in adults.16, addition, about 15% of the cases with RSV or influenza identification were admitted co-detection was observed in half of the patients with bacterial pneumonia in EPIC study, and specifically, in 82% of the cases of pneumococcal pneumonia a virus was also identified. The main limitation of etiologic pneumonia studies is that it is very hard to identify the final cause of pneumonia in children. Only in a minority of cases, we can isolate or identify the pathogen in the lung, lower respiratory tract or blood. The detection of pathogens in nasopharyngeal or oropharyngeal swabs with the use of a molecular method could represent infection limited to the upper respiratory thus detection adequately sensitive to bacterial-viral coinfection as procalcitonin in ruling out bacterial infection when the levels are low. It is also important to consider that the impact of influenza be vaccine a phase III, observer-blind trial, including more than 12,000 children from 6 to 35 months of age, IIV4 was related to the reduction of antibiotic use associated with influenza illness by 71% in the group of European children. The impact of PCV in pneumonia, previously commented, maybe notorious in Spain with the recent inclusion of PCV13 in the National Immunization Program. There are also an urgent need and an important pipeline of development with RSV vaccine candidates that are been evaluated in children but also in pregnant women, which could lead to safeguarding their infants in the first few vulnerable months of life. Introducci\u00f3n. Los virus son una de las causas m\u00e1s frecuentes de neumon\u00eda adquirida en la comunidad (NAC) en ni\u00f1os. La identificaci\u00f3n precoz de virus respiratorios podr\u00eda suponer una disminuci\u00f3n en el consumo de antibi\u00f3ticos. M\u00e9todos. Estudio observacional, retrospectivo, desde enero del 2014 hasta junio del 2018, que incluy\u00f3 a los pacientes pedi\u00e1tricos ingresados en un hospital terciario con diagn\u00f3stico de NAC, a los que se realiz\u00f3 test antig\u00e9nico o PCR viral en muestra respiratoria. Resultados. Se incluyeron 105 episodios de NAC, identific\u00e1ndose alg\u00fan virus respiratorio en 93 (88,6%) casos. Los pacientes con detecci\u00f3n de virus respiratorio sincitial (VRS) presentaron menor inicio de antibioterapia emp\u00edrica (35,1% vs. 55,9%, p valor: 0,042). Adem\u00e1s, los casos con identificaci\u00f3n de VRS o influenza precisaron menor duraci\u00f3n de antibioterapia (recibiendo el 45,6% 2 d\u00edas frente al 68,8% de los que no se identific\u00f3, p = 0,017). Conclusi\u00f3n El uso de t\u00e9cnicas diagn\u00f3sticas de virus respiratorios en nuestro medio puede optimizar el consumo de antibi\u00f3ticos en ni\u00f1os ingresados con NAC. A 9-year-old boy was brought to us with the complaint of a lump over the lateral side of the right elbow for the past 1 month. The swelling was slowly progressive and tender to touch, accompanied by a low-grade fever. There was no history of trauma, weight loss, cough, or dyspnea. Contact history with tuberculosis was negative. Examination revealed a 9 \u00d7 8 \u00d7 8 cm swelling over the proximal and lateral aspect of the right forearm without any obvious joint involvement, slightly tender on palpation with no other signs of inflammation. A clinical possibility of extrapulmonary tuberculosis His routine blood investigations were normal. Tuberculin skin test was positive and HIV serology was negative. An anteroposterior and lateral radiograph of the right elbow showed a large osteolytic lesion of the proximal end of the ulna (Figure 1). Manifestaciones cut\u00e1neas en contexto del brote actual de enfermedad por coronavirus 2019 DOI: 10.1016/j.anpedi.2020.04.013 CASO 1: ni\u00f1o de 6 a\u00f1os ingresado para estudio de una hepatopat\u00eda colest\u00e1sica no filiada. A las 2 semanas de su ingreso, en contexto de febr\u00edcula y un empeoramiento de los marcadores hep\u00e1ticos de colestasis y citolisis, se le realiz\u00f3 estudio de SARS-CoV-2 que result\u00f3 positivo. A las 48h, inici\u00f3 un exantema maculopapular eritematoso, confluente y no pruriginoso, en el tronco y el cuello, que progresivamente se extendi\u00f3 a mejillas y extremidades superiores e inferiores, con afectaci\u00f3n palmar . La duraci\u00f3n total de la cl\u00ednica cut\u00e1nea fue de 5 d\u00edas, y se resolvi\u00f3 sin otras complicaciones y sin necesidad de tratamiento espec\u00edfico. Se acompa\u00f1\u00f3 de mejor\u00eda anal\u00edtica (bilirrubina, transaminasas y par\u00e1metros de coagulaci\u00f3n). Dado el empeoramiento de la afectaci\u00f3n hep\u00e1tica coincidiendo con la obtenci\u00f3n del resultado positivo de la PCR para SARS-CoV-2 en aspirado nasofar\u00edngeo, se realiz\u00f3 PCR al virus en el tejido hep\u00e1tico obtenido por biopsia en el estudio inicial del paciente, que result\u00f3 negativa. Durante su evoluci\u00f3n no present\u00f3 otra cl\u00ednica asociada a la infecci\u00f3n por coronavirus CASO 2: lactante de 2 meses que acudi\u00f3 a urgencias por febr\u00edcula y un cuadro de urticaria aguda, aparentemente pruriginoso, de 4 d\u00edas de evoluci\u00f3n. Inicialmente afectaba la cara y las extremidades superiores, extendi\u00e9ndose en pocas horas al tronco y las extremidades inferiores. No hab\u00eda afectaci\u00f3n palmoplantar. Estas manifestaciones no se acompa\u00f1aban de angioedema acral, labial ni lingual. La paciente conviv\u00eda con 2 personas con COVID-19 demostrada, por lo que se realiz\u00f3 PCR a SARS-CoV-2 en aspirado nasofar\u00edngeo, que fue positiva. Se paut\u00f3 tratamiento sintom\u00e1tico v\u00eda oral con buena respuesta. La duraci\u00f3n de la mayor\u00eda de las lesiones fue inferior a 24h, resolvi\u00e9ndose la cl\u00ednica cut\u00e1nea en 5 d\u00edas, sin otras manifestaciones asociadas. Seg\u00fan lo descrito en la literatura, hasta el momento, las manifestaciones cut\u00e1neas del nuevo coronavirus son similares a las producidas por otras infecciones virales comunes. No se ha observado relaci\u00f3n entre la magnitud de la cl\u00ednica cut\u00e1nea y la gravedad de la enfermedad. Debemos tener presente que, adem\u00e1s de los exantemas propios de la fase aguda de la infecci\u00f3n descritos en este art\u00edculo, recientemente se han descrito lesiones acrales y/o perniosiformes en ni\u00f1os y j\u00f3venes, por lo dem\u00e1s asintom\u00e1ticos, que podr\u00edan ser una manifestaci\u00f3n tard\u00eda reflejo de fen\u00f3menos inflamatorios o microtromb\u00f3ticos en la fase de respuesta inmunol\u00f3gica. A diferencia de nuestros casos, todos los pacientes adultos descritos desarrollaron sintomatolog\u00eda respiratoria durante la evoluci\u00f3n de su enfermedad y podr\u00edan haber recibido tratamiento para la misma. En este contexto, hay que valorar tambi\u00e9n la posibilidad de manifestaciones cut\u00e1neas por reacci\u00f3n adversa a f\u00e1rmacos. Primer caso de infecci\u00f3n neonatal por SARS-CoV-2 en Espa\u00f1a Madre de 41a\u00f1os , ces\u00e1rea urgente por preeclampsia grave a la semana 38+4. Gestaci\u00f3n por FIV e hipotiridismo en tto. Rn bajo peso (2.500g) y APGAR 7/9requiriendo una reanimaci\u00f3n con aspiraci\u00f3n de secreciones en orofaringe. Fue trasladada a la unidad neonatal por dificultad respiratoria inmediata con un dispositivo de presi\u00f3n continua nasal (CPAP). La asistencia respiratoria se retir\u00f3 a las 2horas de vida, siendo la exploraci\u00f3n f\u00edsica a las 9horas normal. Este cuadro se interpret\u00f3 como un distr\u00e9s de adaptaci\u00f3n a la vida extrauterina, traslad\u00e1ndose posteriormente a las plantas de maternidad con su madre. Al tercer d\u00eda del ingreso, la madre comenz\u00f3 con febr\u00edcula descart\u00e1ndose complicaciones obst\u00e9tricas. Dos d\u00edas despu\u00e9s present\u00f3 picos febriles y cl\u00ednica respiratoria, objetiv\u00e1ndose en la radiograf\u00eda de t\u00f3rax una neumon\u00eda bilateral grave. NO refer\u00eda viajes a zonas de riesgo de Coronavirus ni contacto con personas infectadas, aunque su pareja presentaba desde el d\u00eda de la ces\u00e1rea un cuadro febril con gastroenteritis asociada. Tras descartarse infecciones v\u00edricas habituales se solicit\u00f3 RT-PCR COVID-19 que fue positiva. El test de su pareja tambi\u00e9n fue positivo posteriormente. Hasta ese momento la ni\u00f1a permaneci\u00f3 asintom\u00e1tica con su madre en las plantas de maternidad alimentada con lactancia mixta. Debido a la situaci\u00f3n cl\u00ednica de la madre, que requiri\u00f3 asistencia en una unidad especial, se procedi\u00f3 a la separaci\u00f3n y se realiz\u00f3 a la reci\u00e9n nacida una RT-PCR COVID-19 de una muestra extra\u00edda por aspirado nasofar\u00edngeo que fue negativa (6.o d\u00eda de vida). A pesar de la negatividad del test de la ni\u00f1a, se mantuvo en aislamiento en planta de maternidad bajo los cuidados del personal sanitario hasta la obtenci\u00f3n de una segunda muestra a las 36horas (mediante exudado nasofar\u00edngeo) que result\u00f3 positiva (8.o d\u00eda de vida). En ese momento se traslad\u00f3 a la unidad neonatal sin realizarse pruebas complementarias por permanecer asintom\u00e1tica. Se mantuvo una vigilancia estrecha y al noveno d\u00eda de vida se observ\u00f3 polipnea intermitente con leve tiraje intercostal y 2 desaturaciones de ox\u00edgeno autolimitadas con el sue\u00f1o profundo y durante la alimentaci\u00f3n. Se realiz\u00f3 una gasometr\u00eda capilar con leve acidosis transitoria (pH 7,27, pCO2 49, bicarbonato 22, EB 4, l\u00e1ctico normal), una radiograf\u00eda de t\u00f3rax con tenue opacidad en vidrio deslustrado de predominio perihiliar derecho y una prote\u00edna C reactiva negativa (0,06mg/dl). Transcurridas 24horas la cl\u00ednica desapareci\u00f3 manteni\u00e9ndose asintom\u00e1tica hasta el momento actual (d\u00eda 13 de vida) en el que se ha repetido la RT-PCR COVID-19 que sigue positiva. La madre est\u00e1 en cuidados intensivos con ventilaci\u00f3n mec\u00e1nica. En este caso sospechamos que la transmisi\u00f3n ha sido horizontal, ya que el primer test realizado fue negativo. Seg\u00fan el \u00faltimo informe de la Red Nacional de Vigilancia Epidemiol\u00f3gica4, la tasa de incidencia total de tuberculosis en Espa\u00f1a en 2016 fue de 10,38 casos/100.000 habitantes (4,10 en menores de 15 a\u00f1os de edad). La tasa de incidencia en menores de 15 a\u00f1os en Espa\u00f1a de los a\u00f1os 2013, 2014 y 2015 fue de 5,33; 4,35 y 5,05 casos/100.000 habitantes, respectivamente. A pesar de que la tendencia de la tasa de incidencia total nacional de tuberculosis es descendente en los \u00faltimos a\u00f1os, su ritmo de descenso es inferior al 11% anual (objetivo marcado por la OMS). Con el objetivo de analizar la distribuci\u00f3n de los casos de tuberculosis de la poblaci\u00f3n menor de 15 a\u00f1os residente en la ciudad de Sevilla en funci\u00f3n del NSE de las \u00e1reas de residencia, se calcularon las tasas de incidencia anuales de los casos de tuberculosis en ni\u00f1as y ni\u00f1os declarados al Servicio de Epidemiolog\u00eda del Distrito Sevilla del Servicio Andaluz de Salud durante los a\u00f1os 2013, 2014 y 2015 - Las tasas de incidencia anuales de tuberculosis de la poblaci\u00f3n menor de 15 a\u00f1os de la ciudad de Sevilla para los 3 a\u00f1os estudiados superan la media nacional para este grupo de edad: 6,61 casos por 100.000 habitantes menores de 15 a\u00f1os en el 2013, 14,71 en el 2014 y 8,54 en el 2015 . Las diferencias m\u00e1ximas en el c\u00e1lculo de tasa de incidencia por subdistritos del a\u00f1o 2014 tomando la poblaci\u00f3n por subdistritos del a\u00f1o 2013 y la del 2015 fueron de+/ 3 casos por 100.000 habitantes, sin cambios en las tasas de incidencia por subdistritos con y sin ZNTS (Zonas de Necesidad de Transformaci\u00f3n Social) de ese a\u00f1o. Las RI(raz\u00f3n incidencia) anuales entre los subdistritos de Sevilla con zonas estructurales de pobreza y los que no las contienen muestra diferencias importantes de hasta casi 9 veces superior en las zonas m\u00e1s desfavorecidas (RI-2013=8,73; RI-2014=3,13; RI-2015=4,47) for children 2 of age with acute otitis media and examine patient and system level factors that contributed to these outcomes.Study design. Children age 2 years with acute otitis media seen at Denver Health Medical Center outpatient locations from January to December 2018 than the institution recommended 5 days and 54.3% were 10 days. Private insurance was associated with non-first-line antibiotics (aOR, 1.89; 95% CI, 1; younger (2-5 years; aOR 2.01; 95% CI, 1.32-3.05; P < .001) or seen in emergency/urgent care sites (aOR, 1.73; 95% CI, 1.26-2.38; P < .001) were more likely to receive 10 days of antibiotic are associated with off-guideline prescribing. Background: standard for the diagnosis of acute pyelonephritis (APN) in children is bacteriuria we investigated APN patients hospital specific clinical of APN(P();B()). Results: A total of 171 APN patients were included in the study, and of these 29 were APN(P();B()). Of the APN(P();B()) patients, 25.9% pyuria nor bacteriuria, but as these patients have the same risk for VUR as APN patients of features viral in a national sample group patients with features of viral illness who were at low risk of having group A Streptococcus and for whom laboratory avoided. STUDY DESIGN: Retrospective validation using data electronic patients 3-21 years old evaluated for sore throat in a national network of retail health clinics (n = 67 127). We determined the prevalence of features of viral illness in to identify viral risk (<15%) of having group A Streptococcus. RESULTS: Overall, viral illness, those without who were 11 years or older and either lacked cervical adenopathy or had cervical adenopathy and lacked fever were identified as at low risk for group A Streptococcus according to the decision rule. This patients with viral illness, or all with features of viral illness who are at of having group A Streptococcus. Improved identification such patients testing high rate, estimated to cause more than 150,000 deaths per year worldwide. The clinical presentation of this infection is variable, and early diagnosis can be challenging. There are few data on its short- and longer-term outcomes, especially in children. The aim of this study was to assess the clinical presentation, management and streptococcal Australia. Methods: We undertook a prospective surveillance study between and June We collected demographic and clinical We enrolled 181 children, 7 days to 16 years of age. The principal site of invasive infection was blood (126 children, 69.6%), and the most clinical presentation including (2.8%). At discharge and 6 months, 29.3% Conclusions: and has long-term of middle ear 18 months 17 years old undergoing ear, nose, and throat surgery for those with middle-ear-related system was respectively. Area under the curve (AUC) was 0.898 for middle ear fluid. This compares favorably with an AUC of 0.776 for Middle researchers with detector. Conclusions : A smartphone-based middle ear fluid detector may be an effective screening tool. Commentary : Acute otitis media (AOM) is one of the leading causes of urgent care visits and the most common reason for administration of antibiotics in children.1 Detecting media, ear conditions in children.2 Visual assessment is the current standard diagnostic method, but it is more accurate when pneumatic otoscopy is used to assess mobility and is or tympanometry, which is more accurate but of age.3 In report, evaluated a new technology that will permit both physicians and parents to detect and monitor middle ear fluid in children with nothing more than a smartphone and a piece of paper. Their results are encouraging and demonstrate the potential for standard smartphones (using standard speakers and microphones) to be an effective tool for detecting the presence of middle ear fluid. Further testing, especially in infants less than is necessary to confirm the sensitivity and specificity as it is most challenging to make the diagnosis at this age. Carta al editor. Resultados de un ensayo clinico: La vacuna tetravalente contra el dengue (TAK-003, Takeda) en el ensayo de Biswal et al. (N\u00famero del 21 de noviembre) 1 parece prometedor y tiene una mejor eficacia general que CYD-TDV (Dengvaxia, Sanofi Pasteur) .2 Dos mejoras importantes en este ensayo son que todos los participantes se sometieron a pruebas serol\u00f3gicas antes de la aleatorizaci\u00f3n y no hubo necesidad de hacer un An\u00e1lisis post hoc seg\u00fan grupos de edad. Sin embargo, es demasiado pronto para concluir que TAK-003 ser\u00e1 mejor que CYD-TDV. Question: Among patients with influenza, what is the therapeutic efficacy of oseltamivir, compared with usual care, in time to recovery? Compared with usual care, the time to recovery with oseltamivir was 0\u00b770 days severe illness. Oseltamivir provided an overall time to recovery benefit of 1 day, with older/sicker patients deriving more benefit. Commentary: Prompt antiviral treatment recommended for all patients and significantly reduced duration of influenza illness in children by about one day and lowered risk of otitis media by a third.2 A meta-analysis observational that treatment reduced the of hospital admission by 75% in children <16 years.3 The trial by Butler et al showed benefit of oseltamivir treatment compared with usual care in a \"real-world\" primary care setting, in adults and children (14% [448] were children <12 years). It utilized patient-reported time to recovery as the primary outcome, a composite of return to usual activities and symptom resolution, which differs from trials that have generally used one or the other. Unexpectedly, benefit from oseltamivir was similar in participants with and without RT-PCR-confirmed influenza, which has not been shown previously. However, this study lacked a placebo group, raising questions about a placebo effect and other unknown factors was increased slightly in oseltamivir recipients (21% vs 16% in usual care group); few serious adverse events were reported (similar to previous Although the pediatric population was small, this study provides additional evidence of the clinical benefit of oseltamivir treatment for uncomplicated influenza. The conclusions in this commentary are those of the authors and do not necessarily represent the official position of in the pediatric emergency department (ED) and urgent care (UC) within a health system, and identify factors associated with overall and broad-spectrum antibiotic review health system. Visits of patients, 3 months- 17 years old, with a discharge diagnosis of a vARTI from 2010 to 2015. Data collected included specific vARTI diagnosis, site type (ED or 4.3 years. Fifty-three percent were treated in an ED. encompassing nurse practitioners and 16.5% were CI in China based on the World Health Organization (WHO) Access, Watch, and Reserve (AWaRe) metrics and to detect potential each sampled for and emergency departments of 16 tertiary care Anatomical Therapeutic (ATC) classification. Results A total of 260 001 pediatric encounters were assessed, and antibiotics were prescribed in 94 453 (36.3%). In 35 167 encounters (37.2%), at least 1 intravenous was administered. WHO Watch group antibiotics accounted for (n = 84 176) of all antibiotic therapies. Azithromycin (n = 15 most commonly prescribed antibiotic class. 66 prescribed for infection (n = 392; WHO respiratory tract conditions and viral infectious novel acute respiratory effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people clinicians vitro activity not US Food and Drug Administration has been and corticosteroids are currently not recommended. clinical and Relevance The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918. The speed volume of trials launched to investigate potential therapies for the need and capability to produce high-quality evidence even in the middle of a pandemic. No therapies have been December 8, 2019, epidemic of disease 2019 (COVID-19) has spread rapidly.1 As of February 6, 2020, China reported 31 211 confirmed cases of COVID-19 and 637 fatalities. Previous studies suggest that COVID-19 is more likely adult men, particularly those with chronic comorbidities.2-4 Few children have been reported. with COVID-19 infection between December 8, 2019, and February 6, 2020, in China. The summary number and geographic location of new COVID-19 infections, released the central government, were screened to identify infants (aged 28 days to 1 year). information, including age, sex, and geographic location, released anonymously by local health departments, were then retrieved and local hospitals and the Centers for Disease Control and Prevention were family clustering (1 infected member residing with infant), linkage to Wuhan (residing in or visiting Wuhan or contact with visitors from Wuhan 2 weeks onset complications, according to the recommended protocol. Infection was defined as at least 2 positive test results. This study was approved by the institutional review board of Wuhan University School of Health Sciences. Informed consent was waived as part of a Results: Nine infected infants were (Table). patients hospitalized. 1 month and the oldest was 11 months. There were 2 patients from Beijing, 2 from Hainan, and 1 each from Guangdong, Anhui, Shanghai, Zhejiang, and Guizhou. Four patients were reported to have fever, 2 had mild upper respiratory tract symptoms, 1 had no symptoms but tested positive for COVID-19 in a designated screening because of exposure to infected family members, and 2 had no information on symptoms available. The time between admission and diagnosis was 1 to 3 days. Families of all 9 infants had at least 1 infected family member, be or having family members who visited Wuhan, 1 had no direct linkage to Wuhan, and 1 had no information available. None of the 9 infants required intensive Discussion: Based on the sources of data used in this study, 9 infants were infected with COVID-19 and were hospitalized in China between December 2019 and February 6, 2020. of infected infants identified was small. This may be due to a lower risk of exposure or incomplete be infected to a male infants requires further sample size, inclusion only of infants who inclusion of asymptomatic patients. Although a systematic and comprehensive the epidemic quarantined at home with COVID-19 were treated at Zhongnan Hospital of Wuhan University, Wuhan, China, from January 1, 2020, to February evaluated with reverse transcriptase-polymerase chain reaction (RT-PCR) tests for COVID-19 nucleic acid to determine if they could return to work. All the following criteria had to be met for hospital discharge or discontinuation of quarantine: (1) normal separated by at least were recommended by the Chinese Center for Disease Control and Prevention. The same technician and brand of test kit was used for all RT-PCR testing reported; both internal controls and negative controls were routinely performed with each of and radiological features were collected from electronic medical records. After recovery, patients and their families were contacted directly, and collect throat swabs for the RT-PCR tests. This study was approved by the Zhongnan Hospital of Wuhan University institutional review board and the need for informed consent was waived. Results All 4 patients were exposed to the novel 2019 coronavirus through work as medical professionals. Two were male and the age range was 30 to 36 years. Among 3 of the patients, fever, cough, or both disease was Antiviral treatment (75 mg of oseltamivir taken orally every 12 hours) was provided for the 4 patients. For 3 of the RT-PCR results. The time from symptom onset to recovery ranged from 12 to 32 days. After hospital discharge or discontinuation of quarantine, the patients were asked to continue the quarantine protocol at home for 5 days. The RT-PCR tests were repeated 5 to 13 days later and all were positive. All patients had 3 repeat RT-PCR tests performed over the next 4 to 5 days and all were positive. An additional RT-PCR test was performed using a kit from a different manufacturer and the were also positive for from images. They not report contact with any person with respiratory symptoms. No family member was infected. Discussion patients COVID-19 who met criteria for hospital discharge or discontinuation of quarantine in China (absence of clinical and positive results 5 that at least a be infected, all medical professionals and took special care during home quarantine. Current criteria for hospital discharge or discontinuation of quarantine and continued management to reevaluated. results could previous study, 2 consecutively negative qualified for hospital discharge or discontinuation of quarantine. The study was limited to a small number of care professionals and who have more severe infection after hospital discharge or discontinuation of quarantine. a larger would help to understand the prognosis of the disease. Una revisi\u00f3n sistem\u00e1tica reciente confirma la asociaci\u00f3n entre la exposici\u00f3n a contaminantes atmosf\u00e9ricos (part\u00edculas en suspensi\u00f3n <2,5 [PM2,5] y <10 [PM10], di\u00f3xido de nitr\u00f3geno [NO2] y di\u00f3xido de sulfuro [SO2]), y el riesgo de ingreso por bronquiolitis2. Un estudio realizado en centros de atenci\u00f3n primaria en Madrid concluy\u00f3 que los niveles de NO2 (especialmente aquellos mayores de 40g/m3) se asociaban a un aumento en la incidencia de problemas respiratorios en (valoren sustituir la edad pedi\u00e1trica por ni\u00f1os, el texto quedar\u00eda...respiratorios en, probable errata) ni\u00f1os3. Hasta donde nosotros sabemos, no se han llevado a cabo estudios similares en Barcelona. A modo de estudio piloto, se examin\u00f3 a 391 pacientes del \u00e1rea metropolitana de Barcelona ingresados con bronquiolitis en la unidad de cuidados intensivos del Hospital Sant Joan de D\u00e9u (Esplugues de Llobregat, Barcelona), desde 2011 hasta 2016. El c\u00f3digo postal de cada paciente nos permiti\u00f3 a\u00f1adir promedios mensuales de temperatura y humedad a la base de datos. Tambi\u00e9n se registr\u00f3 el valor del \u00edndice catal\u00e1n de calidad del aire (\u00cdndex Catal\u00e0 de Qualitat de l'Aire [ICQA]) 10 d\u00edas antes de la fecha del ingreso del paciente Ni la temperatura ni los contaminantes parecen haber influenciado la incidencia de bronquiolitis en el \u00e1rea metropolitana de Barcelona entre 2011 y 2016. Aunque no se detectaron diferencias en la distribuci\u00f3n de los principales contaminantes entre los d\u00edas en los que hubo casos de bronquiolitis y el resto del mes, cabe resaltar que el NO2 es el principal contaminante presente durante todo el a\u00f1o en el \u00e1rea metropolitana de Barcelona. Introduction: Septic arthritis (SA) and osteomyelitis (OM) can present as medical emergencies in children. Typically, antimicrobial treatment for bone and joint infections is between 1 and 2 weeks of intravenous treatment followed by an oral antibiotic course of 2-4 2 However, recent data from a large randomised controlled trial in show that intravenous therapy. stewardship improve patient quality of life. We describe the epidemiology of bone and joint infections at the John Radcliffe Hospital, Oxford, over the last decade in order to inform improved management. Methods_We identified cases of SA and OM 2009 2019 using hospital Inclusion criteria (1) age (2) with clinical or radiological features typical of SA or in pediatric population, there is evidence that Kingella kingae is 1 of the main the main causative pathogens of osteoarticular infections of the chest wall. Since 1980s, the reported number of cases advances have probably K. occur in children <4 of age, corresponding to the period of maximal oropharyngeal colonization. In fact, the main risk factor for invasive infections due to K. kingae is close, intimate contact among infants and preschool-age children as it is found in settings such as group childcare.2 In addition, the 24 investigations have revealed that the average IgG levels against K. are at birth and low levels until of 18-24 months, which point progressive increase of levels of the immunoglobulin has been reported.3 Therefore, in the period between 6 and 48 months, a child is more susceptible to invasive infections. We read with interest the case in girls and young women and has been associated with a large spectrum of acute infections, for example, to draw attention to the possibility of another important cause of this ... for January through database), which contains data from more than 20 million individuals in employer-sponsored commercial health insurance plans. Because all data were fully deidentified and no interaction occurred with humans, this analysis was deemed exempt from review and informed consent by the US Centers for Disease Control and Prevention institutional review board. Children were included if they were age eligible to receive rotavirus vaccine (with a birthdate of January 1, 2006, or later) and continuously enrolled in their Procedural (90680 To increase specificity, single T1D claim were excluded, as were those diagnosed those diagnosed before 27 weeks of age (survival curve) or before 12 months of age (measures of association). For the survival curve, follow-up began at 27 weeks of age. For measures of association, follow-up began at 12 months Extended Cox regression models with age in weeks as the time scale included rotavirus vaccination status as the time-varying from claims and control by medical conditions possibly associated with missed vaccinations and risk of T1D, only children who received at least 1 dose of diphtheria-tetanus-pertussis-containing vaccine were included. This restriction was lifted in a sensitivity analysis. In a second sensitivity analysis, children in states with universal vaccine purchase programs were excluded, since they could have been vaccinated a vaccination-associated insurance claim. Results increased with increasing age. Data were censored at the end of continuous enrollment, the end of the study period (December 31, or diagnosis of T1D, whichever came first. Analyses used SAS version 9.4 (SAS Institute) and R version 3.4.2 (the R Foundation for Statistical Computing). Data analysis occurred from January 2019 to April 2019; [alpha] was set to .05. Results Overall, 843 of 2 854 571 eligible children were diagnosed with T1D; children followed up until age 12 months or older, 1 035 198 (66.2%) were fully vaccinated (2 doses of Rotarix or 3 doses of RotaTeq), 210 057 (13.4%) were partially vaccinated, rotavirus vaccination and T1D among US children with commercial insurance who were followed up until a maximum of 12 years of age. This is consistent with results from 2 research sites located in Haiti, Dominican Republic, Martinique, Guadeloupe, and Puerto Rico. A total of 400 healthy adults aged 18 through 60 years were The first study November the final study visit, 6, 2018. Participants were randomized 1:1 2 intramuscular injections 28 days apart (20 \u00b5g, n = 201) or placebo (n = 199) and were followed up for 72 weeks. Main Outcomes and Measures The primary outcome was the safety (laboratory parameters, adverse infection) and tolerability (local outcome was by neutralization assay randomized participants [50%] primary safety analysis. All injections were well tolerated. Of the 16 serious adverse events unrelated to the study drugs, 4 (25%) occurred among 4 patients in the vaccine group and 12 (75%) occurred among 11 patients in the placebo group. Of the 16 mild to moderate unsolicited adverse events that 12 (75%) occurred among 8 patients in the vaccine group and 4 (25%) occurred among 3 patients in the placebo events concentration is the (46; 95% CI, 34-63) and the placebo group (43; 95% CI, 32-57). Eight weeks following the first administration, the EC50 GMT in the vaccine group was 2005 (95% CI, 1680-2392) vs 43 (95% CI, 32-58; P < .001) in the placebo group. Durability of the immune response was demonstrated the TBRD reports during 2010-2016 documented the presence of an eschar, 81% of cases lacked information on eschars altogether. What are the implications for public health practice? Systematic reporting of the presence or absence of eschars the TBRD case report form the of of the impact of spotted fever rickettsioses in the United States. OK Background: In children with epilepsy, fever and illness are known for could also trigger seizures. We sought to estimate the risk of emergency department (ED) visit or hospitalization for epilepsy/seizure and all causes after immunization in children younger than 7 years of age with epilepsy. Methods: We conducted a self-controlled case series of children diagnosed with epilepsy before their 7th birthday and immunized from 2005 to 2015 in Ontario (population 14.2 million) and Manitoba (population 1.3 1.5, 95% confidence interval: 1.1-1.9) and 7-10 days after live vaccines 1.4-2.7). For all-cause ED visit/hospitalization, the combined aRI estimate was days after inactivated and 1.3 (1.1-1.5) 7-10 days after live live vaccines. These risks must against the risk of complications from vaccine-preventable diseases. OK and objective Uruguay during 2010-2015 were obtained from the Perinatal for doubled based on adding or subtracting a half-centimetre from all reported head circumference measurements. If than gestational age of data collected for surveillance.OK We included nine studies, of which two were classified as ongoing studies. The seven included studies involved a of 2774 participants and were conducted in high-income countries (UK, USA and Chile) and lower-middle-income countries (Bangladesh and Pakistan). Four studies were conducted in hospital settings, two in schools, and one at a military training centre. Three studies included children under five years of age, two school-aged children, one adult participants, and one older participants aged 60 to 90 years. Two studies vitamin pneumonia treatment; and one study assessed the role of vitamin C for both prevention and treatment of pneumonia. The doses of vitamin C supplementation used were 125 mg, 200 mg, 500 mg, and 2 g We assessed the rate of pneumonia (incidence), how Only two studies (736 people) reported incidence, and one study reported one adverse effect (hives) associated with vitamin C for preventing pneumonia. No study reported on prevalence or mortality. Evidence was insufficient to determine the effect of vitamin C for preventing pneumonia. We also assessed how long people were ill (duration of illness), how many people were cured, mortality, and adverse effects associated with the use of vitamin C as a treatment for pneumonia. Although two studies reported duration of illness, No rates was insufficient the effect of vitamin C for treating pneumonia. Quality of the evidence We judged the included studies to be at overall high or unclear risk of bias. We rated the quality of the evidence as very low due to study limitations, variations amongst to small number of included studies and very low quality of the existing evidence, we are uncertain of the effect of vitamin C supplementation for the prevention and C supplementation in the prevention and treatment of pneumonia. We found 24 relevant studies with 2278 participants types PPE, procedures for putting on and removing PPE, and types of training. Eighteen of the studies not or bacteria. Most of the studies were small, and only one or two studies addressed each of our questions. We found low- to very low-certainty evidence that covering more parts of the body leads to better protection but usually comes at the cost of more difficult donning or doffing and less user comfort, and may therefore even lead to more contamination. More breathable types of PPE may lead to similar contamination but may have greater user satisfaction. Modifications to PPE design, such as tabs to grab, may compliance. Face-to-face in PPE use may reduce errors more than folder-based training. We still need RCTs of training with long-term follow-up. We need simulation studies with more participants to which and also need more real-life evidence. Therefore, the PPE HCW exposed of infection. Objective To understand the impact of the National Institute for Health and Care Excellence (NICE) bronchiolitis guidelines on the management of children referred to paediatric intensive care unit (PICU) with bronchiolitis. Design and setting Data were collected on all children referred to a regional PICU transport service with the clinical diagnosis of bronchiolitis during the winter prior to the NICE consultation period (2011-2012) and during the winter after publication initiated by the hospital were 165 infants referred with bronchiolitis in 1 and 187 2. Nebuliser use increased from 28% in epoch 1 to 53% epoch Increased use were observed. The use of antibiotics did not change between epochs. Conclusion The use of nebulised therapies has of severe bronchiolitis national guidance to the or Given the rapidity of emerging in their decisions about treatment and management of patients with COVID-19. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/APA.15270 AIM: The coronavirus disease 2019 (COVID-19) pandemic of thousands of people. Data on symptoms and prognosis in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused the severe acute respiratory databases between January 1 and March 18, 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%-5% of COVID-19 been similar to adults, with and respiratory symptoms being Newborn infants have developed symptomatic The coronavirus disease 2019 has occurred in children, but they seemed to adults. Deaths were extremely rare. Objetivos. En 1998 la Regi\u00f3n de Europa de la Organizaci\u00f3n Mundial de la Salud fij\u00f3 el objetivo de eliminar el sarampi\u00f3n. En este estudio se analiz\u00f3 la prevalencia de la inmunidad frente al virus del sarampi\u00f3n en la poblaci\u00f3n del \u00e1rea sanitaria de Santiago de Compostela a partir de los datos obtenidos entre 2008-2018. Pacientes y m\u00e9todos. Se estudiaron 7.150 pacientes diferentes que se dividieron en grupos seg\u00fan su a\u00f1o de nacimiento: 2010-2017, 2000-2009, 1990-1999, 1980-1989, 1953-1979 y <1953. La determinaci\u00f3n en suero de IgG frente al virus del sarampi\u00f3n se realiz\u00f3 mediante un inmunoensayo quimioluminiscente comercializado. Resultados. Se observ\u00f3 un m\u00ednimo (76%) para las tasas de protecci\u00f3n frente al virus del sarampi\u00f3n en los nacidos entre 1990-1999. Por grupo de edad se vio que en todos los grupos las mujeres presentaron un porcentaje superior de anticuerpos frente al sarampi\u00f3n. En un modelo de regresi\u00f3n log\u00edstica con a\u00f1o de nacimiento y sexo se obtuvo una odds ratio para el a\u00f1o de nacimiento (p<0,001) de 1,06 y para el sexo (p=0,0013) de 0,82. Conclusiones. Se observaron seroprevalencias inferiores a partir de la implantaci\u00f3n de la vacuna, un cambio m\u00e1s acusado durante el periodo de implantaci\u00f3n y desde el plan de vacunaci\u00f3n para el sarampi\u00f3n del a\u00f1o 2000 en Galicia, las tasas de protecci\u00f3n frente al virus del sarampi\u00f3n han ido aumentado en nuestra \u00e1rea. Aunque se observ\u00f3 una mayor proporci\u00f3n de mujeres protegidas frente a la de hombres, estas diferencias fueron escasas. Polysaccharide conjugate vaccines (PCVs) target the pneumococcal fatal pneumonia and sepsis. Because these types were eliminated by the PubMed for articles published from January 1930 to the present by use of specific search terms. Relevant articles were articles were in the presence of the PCVs, meningitis rates in children have been reported globally to be as high as 13 per 100,000 annually. Widespread use of vaccines resulted in the type strains generally but caused meningitis of comparable severity and levels similar to, or in excess of, prior pneumococcal meningitis rates. This is non-PCV survive well to develop a preventing regardless capsular type. Such a vaccine would need to protect against colonization with most, if not all, pneumococci. Introducci\u00f3n: la neumon\u00eda adquirida en la comunidad (NAC) sigue siendo una enfermedad frecuente en la edad pedi\u00e1trica, encontr\u00e1ndose entre las primeras causas de mortalidad. El objetivo del estudio fue conocer la incidencia de las neumon\u00edas ingresadas y describir sus caracter\u00edsticas. Material y m\u00e9todos: estudio descriptivo y retrospectivo que incluy\u00f3 a los pacientes ingresados en el Servicio de Pediatr\u00eda del Hospital Universitario Miguel Servet de Zaragoza (Espa\u00f1a), con el diagn\u00f3stico de NAC durante dos a\u00f1os para describir sus caracter\u00edsticas cl\u00ednicas, radiol\u00f3gicas, anal\u00edticas, demogr\u00e1ficas y complicaciones. Resultados: se registraron 248 casos de neumon\u00eda, con una media de edad de 37,60 \u00b1 2,20 meses, siendo significativamente mayor en neumon\u00edas bacterianas t\u00edpicas (41,98 \u00b1 37,46) y at\u00edpicas \u00b1 (p <0,0001 y p = 0,0004 respectivamente). La neumon\u00eda m\u00e1s frecuente fue la de probable origen neumoc\u00f3cico (47,6%; intervalo de confianza del 95% [IC 95]: 41,84 a 54,18) mientras que el agente identificado con m\u00e1s frecuencia el virus respiratorio sincitial (34,65%; IC 95: 26,93 a 43,26). La odds ratio de presentar patr\u00f3n radiol\u00f3gico alveolar en neumon\u00edas bacterianas frente a v\u00edricas fue de 2,98 (IC 95: 1,50 a 5,91; p = 0,0013). El antibi\u00f3tico m\u00e1s utilizado fue ampicilina intravenosa (62,87%), siendo la duraci\u00f3n mayor en las neumon\u00edas t\u00edpicas bacterianas. Conclusi\u00f3n: la NAC que precisa ingreso hospitalario es m\u00e1s prevalente en ni\u00f1os menores de cuatro a\u00f1os; con una incidencia y complicaciones similares a las descritas en otras series. El diagn\u00f3stico etiol\u00f3gico y el consiguiente tratamiento antibi\u00f3tico contin\u00faa siendo un reto dif\u00edcil de alcanzar. Resumen: revisi\u00f3n sistem\u00e1tica y metaan\u00e1lisis, que investiga el desarrollo de la tuberculosis en ni\u00f1os con contacto estrecho con enfermos de tuberculosis. 137 647 ni\u00f1os expuestos a tuberculosis fueron evaluados al inicio del estudio y 130 512 ni\u00f1os fueron seguidos durante 429 538 a\u00f1os-persona, durante los cuales se diagnosticaron 1299 casos de tuberculosis prevalentes y 999 incidentes. Los ni\u00f1os que no recibieron terapia preventiva con un resultado positivo para la infecci\u00f3n de tuberculosis tuvieron una incidencia de tuberculosis acumulativa a 2 a\u00f1os significativamente m\u00e1s alta que los ni\u00f1os con un resultado negativo para la infecci\u00f3n de tuberculosis, y esta incidencia fue mayor entre los ni\u00f1os menores de 5 a\u00f1os. La efectividad de la profilaxis con isoniacida fue del 63% entre todos los ni\u00f1os expuestos, y del 91% entre aquellos con un resultado positivo para la infecci\u00f3n tuberculosa. Entre todos los ni\u00f1os <5 a\u00f1os que desarrollaron tuberculosis, el 83% fueron diagnosticados dentro de los 90 d\u00edas de la visita inicial. El riesgo de desarrollar tuberculosis entre los beb\u00e9s expuestos y los ni\u00f1os peque\u00f1os es muy alto. La mayor\u00eda de los casos ocurrieron dentro de las semanas posteriores al inicio de la investigaci\u00f3n de contacto y podr\u00edan no prevenirse mediante profilaxis. Esto sugiere que se necesitan estrategias alternativas para la prevenci\u00f3n, como el inicio temprano de la terapia preventiva a trav\u00e9s del diagn\u00f3stico r\u00e1pido de casos de adultos con b\u00fasqueda activa en la comunidad. Objetivo. Los pat\u00f3genos se pueden transmitir a los billetes debido a los h\u00e1bitos antihigi\u00e9nicos personales. El objetivo del estudio fue buscar los posibles pat\u00f3genos en los billetes que circulan en el mercado y tambi\u00e9n observar su resistencia antibacteriana as\u00ed como sus diversos factores de virulencia utilizando m\u00e9todos genot\u00edpicos y fenot\u00edpicos. Material y m\u00e9todos. Se recogieron al azar un total de 150 muestras de billetes entre agosto de 2017 y marzo de 2018. Se utilizaron los sistemas VITEK para la identificaci\u00f3n y las pruebas de sensibilidad a los antimicrobianos, respectivamente. Los genes de resistencia a los antimicrobianos (mecA, van, betalactamasas de espectro ampliado [BLEA] y carbapenemasas) y los genes de virulencia estafiloc\u00f3cica (SE, pvl y tsst -1) se determinaron mediante PCR a tiempo real. Resultados. Se detect\u00f3 la presencia de cepas de Staphylococcus aureus, spp en un 48%, 54,7%, 56%, 21,3%, 18,7% y 4% de los billetes, respectivamente. Se observ\u00f3 la presencia de S. aureus resistente a meticilina, Enterococcus resistentes a vancomicina y gramnegativos productores de BLEA en un 46,8%, 1,3% y 28,7%, respectivamente. Los genes Pvl, tsst-1 y SE se encontraron en un 2,8/4,9%; 1,4/1,2% y 100/87,8% de las cepas de S. aureus/SCN, respectivamente. El gen sea fue el gen enterotoxig\u00e9nico m\u00e1s frecuente. Los genes blaTEM, 18,6%, respectivamente en cepas gramnegativas. Conclusi\u00f3n. Estos resultados son muy importantes para resaltar el estado higi\u00e9nico de los billetes. De este modo, los billetes pueden contribuir a la propagaci\u00f3n de pat\u00f3genos y de la resistencia a los antimicrobianos. Por lo tanto, es posible que debamos comenzar a utilizar productos alternativos a los billetes. Streptococcus pyogenes (SGA) es el agente bacteriano m\u00e1s com\u00fan de faringoamigdalitis agudas (FAA) en ni\u00f1os (30-40% entre los 3-13 a\u00f1os) y susceptible de tratamiento antibi\u00f3tico. El tratamiento precoz reduce la severidad y duraci\u00f3n de los s\u00edntomas, disminuye la transmisi\u00f3n y previene las complicaciones supurativas y no supurativas como la fiebre reum\u00e1tica y las infecciones invasivas [1]. El cultivo es el gold-standard para el diagn\u00f3stico de SGA pero la obtenci\u00f3n de un resultado requiere un m\u00ednimo de 18- 24 horas. Los test de detecci\u00f3n de ant\u00edgeno (TRDA) aportan rapidez al resultado y aunque no existe un criterio un\u00e1nime se han incluido en diversas gu\u00edas de pr\u00e1ctica cl\u00ednica por su utilidad para guiar las decisiones terap\u00e9uticas en las FAA [1-3]. Entre los TRDA destacan los inmunocromatogr\u00e1ficos que por sus caracter\u00edsticas pueden usarse como \"pruebas en el punto de atenci\u00f3n al paciente\" [4]. El objetivo del estudio fue evaluar en nuestro medio el test AlereTMTestPack+Plus with OBC Strep A (Alere-StrepA) para detecci\u00f3n de SGA en ni\u00f1os con sospecha de FAA. El cultivo fue el m\u00e9todo de referencia. Because of the limited number of subjects undetected. Since 2006, millions of human papillomavirus (HPV) vaccine doses have been distributed and a considerable amount of postlicensure safety data has been generated. The objective of this study was to review available HPV postlicensure safety studies and to and other rare diseases. Methods: this review meta-analysis, vaccine States as 1-dose schedule in 1996, changing to a of herpes zoster, peaking in 15-35 years after the start of varicella vaccination. Methods: This was a retrospective study of the MarketScan Commercial Medicare databases 1991-2016. Outcome measures were the incidences of herpes zoster per 100 000 person-years, by calendar year and age category, and the annual rates of change in herpes zoster by age category, in an interrupted time series increased throughout the period of 1991-2012 in all adult age categories, with a plateau in 2013-2016 that was most evident in the 65 age group. In 1991-1995, the herpes zoster incidences increased 18-34, 35-44, 45-54, the 1996-2006 and 2007-2016, to infant antibiotic its association with have We dose, timing, and type of infant antibiotic use the childhood the Tennessee were Infant antibiotic and asthma during infancy. You are the paediatric registrar on night shift in a busy district general hospital. Earlier in the day, a 2-year-old boy with symptoms and signs of lower respiratory tract infection (LRTI) was admitted to the ward. He is now febrile, and the nurse in charge contacts you to ask if she can give him a dose of ibuprofen to control his temperature. You recall a teaching session in the hospital about the association between non-steroidal anti-inflammatory drug (NSAID) use and invasive giving ibuprofen in the of LRTI is not without risk. Structured clinical question In children with symptoms compared with association with complicated respiratory disease (outcome)? En los \u00faltimos 25 a\u00f1os se ha producido un aumento global de casos de leishmaniasis. Se postula que el cambio clim\u00e1tico, el aumento global de la temperatura, las migraciones masivas del campo a la ciudad y los proyectos agroindustriales (creaci\u00f3n de pantanos, sistemas de riego, formaci\u00f3n de pozos...) potencian la aparici\u00f3n de reservorios de mosquitos flebotomos, que son los vectores de esta enfermedad. Cabe destacar que en la Comunidad Valenciana, zona end\u00e9mica, la tasa de incidencia ha sufrido un aumento considerable en los \u00faltimos a\u00f1os. Describimos a un paciente de dos a\u00f1os que presenta cuadro cl\u00ednico y anal\u00edtico compatible con leishmaniasis visceral (fiebre, esplenomegalia y pancitopenia) con el antecedente, varios meses antes, de leishmaniasis cut\u00e1nea. Existen pocos casos en la literatura m\u00e9dica que describan una afectaci\u00f3n cut\u00e1nea y visceral concomitante, hecho que otorga importancia a nuestro caso. La inmadurez de la respuesta inmune celular a esa edad podr\u00eda ser la causa de esta forma de presentaci\u00f3n at\u00edpica. El exantema periflexural asim\u00e9trico de la infancia es una entidad benigna y autolimitada que se manifiesta t\u00edpicamente en lactantes y preescolares con predominio del sexo femenino. La etiolog\u00eda es desconocida, aunque se ha relacionado con infecciones virales principalmente, y tambi\u00e9n bacterianas. El diagn\u00f3stico es cl\u00ednico y el tratamiento sintom\u00e1tico. A pesar de ser una enfermedad com\u00fan, es infradiagnosticada debido en parte al desconocimiento de esta. Nuestro objetivo es contribuir para mejorar el conocimiento de este trastorno. Se presenta el caso cl\u00ednico de una paciente diagnosticada de exantema periflexural asim\u00e9trico con el antecedente de pielonefritis aguda la semana anterior a la aparici\u00f3n de las lesiones cut\u00e1neas. El s\u00edndrome de shock t\u00f3xico estreptoc\u00f3cico (SSTS) es un cuadro grave e infrecuente en Pediatr\u00eda. Sin embargo, en las \u00faltimas d\u00e9cadas est\u00e1 aumentando la incidencia de infecciones invasivas por Streptococcus pyogenes o estreptococo del grupo A. Aparece m\u00e1s frecuentemente en ni\u00f1os preescolares, ya que el diagn\u00f3stico de enfermedad estreptoc\u00f3cica es m\u00e1s complicado a esta edad. Es fundamental el diagn\u00f3stico y tratamiento precoz debido a su potencial gravedad, precisando en algunas ocasiones medidas intensivas de soporte vital y prevenci\u00f3n del fallo multiorg\u00e1nico. Atopic dermatitis (AD) predisposes to viral skin infections, such eczema herpeticum (EH), and to such as those caused by Staphylococcus aureus (SA) A streptococcus (GAS). This study evaluated clinical features of EH and its frequency of codetection with SA or GAS in children hospitalized presumed AD skin infection. Methods: We retrospectively reviewed clinical data for children 18 years of age admitted to a large hospital system for AD with presumed skin infection from January 2004 to December 2018. Those with an alternate primary diagnosis or missing microbiologic data were excluded. Encounters with herpes simplex virus testing were identified as AD with EH (ADEH+) or without (ADEH). Encounters with bacterial skin culture growth were identified as SA or GAS. Results: Among 180 AD encounters with suspected skin infection, 133 (74%) were tested for herpes simplex virus. Clinical findings associated with ADEH+ status (n = 61) included fever on admission (59% vs. 32% in ADEH; P = 0.002), rash on the neck (30% vs. 13%; P = 0.015) and vesicular rash (70% vs. 49%; P = 0.011). Encounters in the ADEH+ group had a longer hospital length of stay compared with encounters in the ADEH group [median 4 days (interquartile range 3-5 days) vs. 3 days (interquartile range 2-3 days); P < 0.001]. GAS was identified in only 1 ADEH+ encounter (2%) versus 15 ADEH encounters (26%), P < 0.001. Conclusions: Providers should maintain a high index of suspicion EH in children admitted for presumed AD skin infection. GAS was more commonly associated with ADEH encounters. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of question as possible. This meant we shortened some steps of the normal Cochrane Review process. Nevertheless, we are confident that these changes do not our overall conclusions. We looked for studies that assessed the effect of any type of quarantine, anywhere, on the spread and severity of COVID-19. We also for alongside other measures, as isolation, social distancing, school closures and hand hygiene. COVID-19 is a new disease, so, to find as much evidence as possible, we also looked measured the number of COVID-19, SARS or MERS cases, how many people were infected, how quickly the virus spread, how many people died, and the costs of quarantine. Key results: We included 29 studies. Ten studies focused on COVID-19, 15 on SARS, two on SARS plus other viruses, and two on MERS. Most of the studies combined existing data to create a model (a simulation) for predicting how events might occur over time, for people in situations (called modelling studies). The COVID-19 studies simulated outbreaks in China, UK, South Korea, and on the cruise ship Diamond Princess. Four studies looked back on the effect of quarantine on 178,122 people involved in SARS outbreaks (called modelling studies all found that simulated quarantine measures reduce the number of people with the disease by 44% to 81%, and the number of deaths by 31% to 63%. Combining quarantine with other measures, such as closing schools or social distancing, is more effective at reducing the spread of COVID-19 than quarantine alone. The SARS and MERS studies agreed with the studies on COVID-19. Two SARS modelling studies assessed costs. They found that the costs were lower when quarantine measures started earlier. We cannot be completely certain about the evidence we found for several reasons. The COVID-19 studies based their models on limited data and made different assumptions about the virus (e.g. how quickly it would spread). The other studies investigated SARS and MERS so we could not assume the results would be the same for COVID-19. Conclusion: Despite limited evidence, all the studies found quarantine to be important in reducing the number people infected and the of deaths. Results showed that quarantine was most effective, and cost less, when it was started earlier. Combining quarantine with other prevention and control measures had a greater effect than quarantine alone. This review includes evidence published up to 12 March 2020. There is a lack of evidence-based guidance for management of cellulitis and use of outpatient parenteral antimicrobial therapy (OPAT) in children. The only published guidelines for skin infections are for adults.1 Lack of standardised guidelines for children can result in variation in paediatricians' practice, with implications on care and resources.2 Our aim was to understand paediatricians' opinions OPAT. This web-based anonymous survey was undertaken over 4 weeks at The Royal Children's Hospital in Melbourne. Acute care and none were mandatory. Resumen: estudia exhaustivamente la din\u00e1mica de transmisi\u00f3n en domicilio de S.aureus resitente a meticilina en ni\u00f1os con infecci\u00f3n de piel y partes blandas. El entorno dom\u00e9stico desempe\u00f1a un papel clave en la transmisi\u00f3n. Las futuras intervenciones deber\u00edan centrarse en los miembros del hogar y el ambiente domiciliario, enfoc\u00e1ndose en las estrategias de mejora en la higiene de las manos y los comportamientos higi\u00e9nicos en los convivientes. In the past 15 years, many high volume clinical laboratories implemented reverse sequence treponemal immunoassay as the initial screening step, instead of the traditional rapid plasma reagin. Reverse sequence screening is economical for high volume laboratories but has led to diagnostic difficulties when the testing algorithm yields discordant results, particularly for pregnant women. In this volume of The Journal, Williams et al evaluated 35 108 reverse sequence syphilis screening events among pregnant women in Ohio from 2011-2018. Overall, 127 women had discordant screening results, of which 85 (65%) were ultimately found to have a false positive treponemal immunoassay. These suggest results were often secondary to in pregnant women, as the stakes are high for early diagnosis and treatment to prevent congenital syphilis. From 2013-2017, of reported primary and secondary syphilis in women rose by 156%. In 2016, 628 cases of congenital syphilis were reported by CDC, with 41 cases of Congenital syphilis cases were concentrated in 9 regions across the US (Ohio was one of these areas), and the rise in syphilis in women has been linked and opioid epidemics. of may the women with discordant syphilis is the common tract illnesses in children. Rhinoviruses are classified into species A, B and C. We rhinovirus infections of in between September 2007 and December 2008. Results: Rhinovirus C is the most prevalent species in our study, and it was associated with severe wheezing and febrile illness. We also with wheezing. Conclusions: Our research supports the severity of the rhinovirus C-induced illness. Resumen: los tres modelos de predicci\u00f3n fueron consistentes y sugieren que la alta cobertura de vacunaci\u00f3n contra el VPH de las ni\u00f1as puede conducir a la eliminaci\u00f3n del c\u00e1ncer de cuello uterino en la mayor\u00eda de los pa\u00edses en v\u00edas de desarrollo para fines de siglo. El mantenimiento del cribado de c\u00e1ncer de cuello a amplios secotres de la poblaci\u00f3n femenina acelerar\u00e1 las reducciones y ser\u00e1 necesario para eliminar el c\u00e1ncer de cuello uterino en los pa\u00edses con mayor carga de la enfermedad. Conclusion: Our study demonstrated an absence of clear association between HPV vaccines and other rare diseases. The review also highlights the need for more systematic collaborations to monitor rare safety adverse events. La terapia con antibi\u00f3ticos a menudo se prescribe para la sospecha de neumon\u00eda adquirida en la comunidad (NAC) en ni\u00f1os a pesar de la falta de conocimiento del pat\u00f3geno causante. Nuestro objetivo en este estudio fue investigar la asociaci\u00f3n entre la prescripci\u00f3n de antibi\u00f3ticos y el fracaso del tratamiento en ni\u00f1os con sospecha de NAC que son dados de alta del servicio de urgencias (DE) del hospital. Conclusiones: Entre los ni\u00f1os con sospecha de NAC, los resultados no fueron estad\u00edsticamente diferentes entre los que recibieron y no recibieron una all culture-confirmed referred from children <16 years of age from July 2007 to June 2018 were assessed. Surveillance data were to of The most significant decline PCV serotypes in children <2 children <2 0.0463), trends observed for those 2-4 and 5-15 years of age. There were no clear vaccine replacement serotypes, instead a were of non-PCV13 serotypes further prevent IPD in children. Determinar la efectividad de la vacuna (VE) de PCV-13 y PCV-10 en la prevenci\u00f3n de la enfermedad neumoc\u00f3cica invasiva (IPD) y la otitis media aguda (OMA) en ni\u00f1os <5 a\u00f1os. Resultados: Se inform\u00f3 una eficacia significativa contra la ENI seg\u00fan el tipo de vacuna en ni\u00f1os 5 a\u00f1os para 1 dosis de PCV-13 en el esquema 3 + 1 (86% -96%) y 2 + 1 (67.2% -86%) y para PCV- 10 para los programas 3 + 1 (72.8% -100%) y 2 + 1 (92% -97%). En ni\u00f1os <12 meses de edad, la eficacia vacunal PCV-13 VE contra la serie post-primaria del serotipo 19A fue significativa para el esquema 3 + 1 pero no para el esquema 2 + 1. La protecci\u00f3n cruzada de PCV-10 contra 19A fue significativa en ni\u00f1os 5 a\u00f1os con 1 dosis (82.2% y 71%). Ninguno de los PCV result\u00f3 efectivo contra el serotipo 3. PCV-13 fue efectivo contra la OMA (86%; intervalo de confianza [IC] del 95%: 61 a 94). PCV-10 fue eficaz contra la OMA cl\u00ednicamente definida (26.9%; IC 95%: 5.9 a 43.3) y OMA bacteriol\u00f3gicamente confirmada (43.3%; IC 95%: 1.7 a 67.3). Conclusiones: Ambas vacunas PCV ofrecen protecci\u00f3n contra infecciones neumoc\u00f3cicas, con PCV-10 protegiendo contra 19A IPD, pero esta eficacia vacunal no se ha verificado en los grupos de edad m\u00e1s j\u00f3venes. The epidemiologic characteristics of type conjugate vaccine The immunization against Haemophilus influenzae type b differs in Europe. Methods: This is a retrospective observational study which evaluates all the data included in the molecular surveillance register for invasive infectious diseases at the Laboratory of Molecular Diagnosis at Meyer Children's University Hospital from December 2008 to December 2018 with a diagnosis of invasive HIBD in children <5 years of age. Results: We identified 4 cases of HIBD: all the cases presented signs or symptoms of invasive infection and the H. influenzae type b identified in cerebrospinal fluid, or blood or bronchoalveolar different (2p+1) 99.6%. This of 2p+1 HIBD in children <5 molecular test for HIBD diagnosis and surveillance. Resumen: la mortalidad por diarrea ha disminuido sustancialmente desde 1990, aunque hay variaciones seg\u00fan el pa\u00eds. Las mejoras en los indicadores sociodemogr\u00e1ficos podr\u00edan explicar algunas de estas tendencias, pero los cambios en la exposici\u00f3n a los factores de riesgo, particularmente mal saneamiento, el fallo de medro infantil y el bajo uso de la soluci\u00f3n de rehidrataci\u00f3n oral, parecen estar relacionados con las tasas relativas y absolutas de menor disminuci\u00f3n de la mortalidad por diarrea. Aunque las intervenciones m\u00e1s efectivas pueden variar seg\u00fan el pa\u00eds o la regi\u00f3n, identificar y ampliar las intervenciones destinadas a prevenir y proteger contra la diarrea que ya han mostrado reducir la mortalidad por diarrea, podr\u00edan evitar a\u00fan m\u00e1s miles de muertes debido a esta enfermedad. Resumen: nuestros resultados muestran que ha habido disminuciones sustanciales pero desiguales en la mortalidad por infecciones respiratorias bajas entre los pa\u00edses entre 1990 y 2017. Aunque las mejoras en los indicadores de desarrollo sociodemogr\u00e1fico podr\u00edan explicar algunas de estas tendencias, los cambios en la exposici\u00f3n a factores de riesgo modificables (por ejemplo vacunaciones) est\u00e1n relacionados con las tasas de disminuci\u00f3n en esta mortalidad. Ninguna intervenci\u00f3n individual acelerar\u00eda universalmente las reducciones en la p\u00e9rdida de salud asociada con estas infecciones en todos los entornos, pero enfatizar los factores de riesgo m\u00e1s dominantes, particularmente en pa\u00edses con alta letalidad, puede contribuir a la reducci\u00f3n de muertes prevenibles. Resumen: Los pacientes de atenci\u00f3n primaria con s\u00edndrome gripal (n=1629, la mitad confirmados con PCR como positivos a influenza) tratados con oseltamivir, se recuperaron en promedio un d\u00eda antes (HR: 1.02 d\u00edas; ICrB 95%: 0,74 a 1,31) que los manejados solo con atenci\u00f3n habitual. Los pacientes m\u00e1s mayores, con comorbilidades y una mayor duraci\u00f3n de estas se recuperaron 2-3 d\u00edas antes. En menores de 12 a\u00f1os el efecto fue menor (HR: 0,70 d\u00edas, ICrB 95%: 0,30 a 1,20). En el contexto generalizado de recursos limitados para financiar las intervenciones sanitarias disponibles para una poblaci\u00f3n, se requieren criterios expl\u00edcitos que permitan seleccionar el conjunto de prestaciones que aporten el mayor beneficio en salud posible con los recursos existentes. La evaluaci\u00f3n econ\u00f3mica de intervenciones sanitarias es una herramienta de an\u00e1lisis que compara los costes y los resultados en salud de programas sanitarios alternativos con el fin de informar sobre su eficiencia. El marco tradicional de la evaluaci\u00f3n econ\u00f3mica presenta algunas limitaciones para la evaluaci\u00f3n espec\u00edfica de intervenciones de salud p\u00fablica, como son los programas de vacunaci\u00f3n, especialmente los destinados a la poblaci\u00f3n pedi\u00e1trica. Entre ellos se destacan los desaf\u00edos que presenta evaluar intervenciones donde los efectos en salud ocurren en el largo plazo, sobre poblaciones diferentes a las que se aplica la intervenci\u00f3n, con posibles efectos adversos en poblaci\u00f3n sana, con efectos intangibles considerables, con implicaciones relevantes sobre la desigualdad, y que requieren de la medici\u00f3n de resultados en salud en ni\u00f1os y ni\u00f1as, as\u00ed como en sus entornos. Entre las principales v\u00edas de avance para que las evaluaciones econ\u00f3micas sean capaces de abordar las problem\u00e1ticas inherentes a los programas de vacunaci\u00f3n en poblaci\u00f3n pedi\u00e1trica destacamos la posibilidad de emplear medidas de resultados capaces de captar beneficios de bienestar social m\u00e1s all\u00e1 de las mejoras en salud individuales, as\u00ed como la aplicaci\u00f3n de los m\u00e9todos que caractericen los efectos din\u00e1micos y los altos niveles de incertidumbre cuando estos sean necesarios. El art\u00edculo \"Evaluaci\u00f3n econ\u00f3mica de la inclusi\u00f3n en el calendario vacunal de 4CMenB (Bexsero) en Espa\u00f1a\"1 concluye que, con la informaci\u00f3n disponible y el precio de la vacuna actual, un programa de vacunaci\u00f3n universal en lactantes con la vacuna 4CMenB no es una medida coste-efectiva para el Sistema Nacional de Salud (SNS). Estos resultados est\u00e1n en l\u00ednea con la amplia mayor\u00eda de evaluaciones internacionales realizadas en otros pa\u00edses. En la actualidad, la vacuna no se incluye en el calendario com\u00fan de vacunaci\u00f3n establecido por el Consejo Interterritorial del Sistema Nacional de Salud (CISNS) de Espa\u00f1a y su uso se limita a grupos de riesgo establecidos. Sin embargo, algunas comunidades aut\u00f3nomas (CC. AA.) han aprobado y administran de forma sistem\u00e1tica la vacuna en la poblaci\u00f3n infantil. He le\u00eddo con inter\u00e9s el art\u00edculo publicado recientemente en Gaceta Sanitaria \"Evaluaci\u00f3n econ\u00f3mica de la inclusi\u00f3n en el calendario vacunal de 4CMenB (Bexsero) en Espa\u00f1a\", firmado por los autores Rafael Ruiz-Montero et al.1, donde hacen un excelente an\u00e1lisis de coste-utilidad, siguiendo procedimientos cl\u00e1sicos y modelos estandarizados en el campo de la farmacoeconom\u00eda aplicada a vacunas2, pero al que, a mi juicio, cabe hacer algunos comentarios. OBJECTIVES: To determine if a multicomponent intervention was associated with METHODS: The study was conducted at Kaiser Permanente Colorado, a large health care organization with 127 000 members <18 years of age. After conducting a gap analysis, an intervention was developed to antibiotic prescribing for pediatric Intervention activities case-based educational session, pre- and postsession e-mailed knowledge assessments, and a new UTI-specific order set within the electronic health record. Most activities were implemented on April 26, 2017. The time series comparing antibiotic prescribing before versus after the implementation date. Infants <60 days old and children persisted end A multicomponent intervention with educational and process-improvement lack of knowledge of causative pathogen. Our objective in this study was to investigate the association between antibiotic prescription and treatment failure in children with suspected CAP who are discharged from the hospital emergency department (ED). METHODS: We performed a prospective cohort study of children (ages 3 months-18 years) who were discharged from the ED with suspected CAP. The antibiotic receipt treatment failure (ie, hospitalization after being discharged from the ED, return visit with antibiotic initiation or change, or antibiotic change within 7-15 days the ED attributable to treatment selection between children who did and did not receive an antibiotic prescription. RESULTS: Of 337 eligible matched on the basis of propensity score. There was no statistical difference in treatment failure between children who received antibiotics and those who did not (odds ratio 1.0; 95% confidence interval 0.45-2.2). There was no difference in proportion children with return visits (3.4% suspected CAP, the outcomes were not statistically different between those who did and did not receive an antibiotic prescription. BACKGROUND: The ability criteria to accurately identify infants at low risk for serious infections been recently reevaluated. METHODS: We assembled a multicenter cohort of infants to 60 days of age who had cerebrospinal fluid (CSF) and blood cultures obtained. We report the performance of the modified Boston criteria (peripheral white blood cell count [WBC] 20 000 cells per mm3, CSF WBC 10 cells per mm3, and identification of invasive bacterial infections (IBIs). We defined IBI as bacterial meningitis (growth of pathogenic bacteria from CSF culture) or bacteremia (growth from blood Boston Philadelphia criteria misclassified 17 of 53 (32.1%) and 13 of 56 (23.3%) infants with bacterial meningitis, respectively. CONCLUSIONS: criteria misclassified a substantial number of infants 29 to 60 days old with IBI, including those with bacterial meningitis. Background: Limited data are available on childhood Pediatric children diagnosed with encephalitis <18 years of age admitted to 1 of the 8 pediatric intensive care units (PICU) in the Netherlands between included 121 children with a median age of 4.6 years (IQR A herpes simplex virus infection (13.2%) was mainly seen in children <5 years 10.4 3.72-14.18). An age of 5 years at initial presentation was associated with a lower mortality (OR 0.2 [CI 0.08-0.78]). The detection of a bacterial (OR 9.4 [CI 2.18-40.46]) or viral (OR 3.7 [CI 1.16-11.73]) with a higher mortality. Conclusions: half of encephalitis, a causative pathogen could not need for enhancement of microbiologic diagnostics. The detection of a bacterial or viral pathogen associated with higher are (MEE) occurrence in this population. We assessed MEE and the degree of transient scheduled follow-up linear MEE, defined as type B tympanogram (normal ear volume little newborn period. Results: Forty-four symptomatic patients had 1 tympanogram ranged from 10 to 40 dB, as decrease, which can reduce the efficacy of a hearing aid in those with SNHL. It is warranted is a common finding in CCMV the age of presentation overlaps with autoimmune neutropenia (AIN). AIN represents one common forms of chronic CCMV and AIN was conducted: PubMed (MEDLINE), Ovid and Web of Science. We further describe 2 cases of concurrent CCMV and AIN. Both cases were confirmed with the indirect immunofluorescence test demonstrated neutropenia while undergoing treatment Valganciclovir, the other was never treated. With interruption of Valganciclovir in infant A, neutrophil counts (ANC) did not improve for. clinicians to consider years of age after HPeV infection and hospitalization Bayley the Child Behavior We Fifty a mean age of 41 months, were followed for 3 years after hospital admission with HPeV infection. There were 47 children whose original illness was fever without source or sepsis-like illness and 3 who had encephalitis. All children in the HPeV cohort showed age-specific development within the population normal the Bayley Scales of Infant and Development-III. There was no neurodevelopmental delay at 3 years of age, it was associated with increased behavioral problems in infancy. Resumen: 74 ni\u00f1os atendidos en el Children's Hospital de Colorado con enfermedad neurol\u00f3gica por enterovirus. EV-A71 fue identificado en 43 (58%) de estos ni\u00f1os. La mediana de edad de los ni\u00f1os con enfermedad neurol\u00f3gica EV-A71 fue de 22,7 meses (RIQ: 4,0-31,9), y la mayor\u00eda de estos ni\u00f1os eran varones (79%). 93% de ni\u00f1os con enfermedad neurol\u00f3gica por EV-A71 ten\u00edan hallazgos sugestivos de meningitis, 72% mostraron evidencia de encefalitis y 23% de ni\u00f1os cumplieron con la definici\u00f3n de caso de mielitis fl\u00e1cida aguda. Todos los ni\u00f1os con la enfermedad EV-A71 ten\u00edan fiebre y el 42% ten\u00edan lesiones en manos, pies o boca al inicio neurol\u00f3gico o antes. Los ni\u00f1os con enfermedad EV-A71 se diferenciaron mejor de aquellos con otros enterovirus (n = 31) por los hallazgos neurol\u00f3gicos de mioclonus, ataxia, debilidad e inestabilidad. De las muestras recolectadas de ni\u00f1os con EV-A71, este enterovirus se detect\u00f3 en el 94% de las muestras rectales, el 79% de las orofar\u00edngeas, el 56% de las nasofar\u00edngeas y el 20% de las muestras de l\u00edquido cefalorraqu\u00eddeo. El 93% de ni\u00f1os con enfermedad neurol\u00f3gica EV-A71 que pudieron ser seguidos mostraron una recuperaci\u00f3n completa en 1-2 meses. En comparaci\u00f3n con los ni\u00f1os con mielitis fl\u00e1cida aguda asociada con EV-D68, los ni\u00f1os con mielitis fl\u00e1cida aguda asociada con EV-A71 eran m\u00e1s j\u00f3venes, mostraban un inicio neurol\u00f3gico antes del inicio de los s\u00edntomas prodr\u00f3micos, ten\u00edan una debilidad m\u00e1s leve, mostraban una mejor\u00eda m\u00e1s r\u00e1pida y eran m\u00e1s propensos a la recuperaci\u00f3n completa. Resumen: analizan 556 casos de Zika confirmados por laboratorio y 548 casos no relacionados con zika. La definici\u00f3n de caso de la OMS hubiera detectado 176 casos confirmados de zika, y la definici\u00f3n de la OPS 109, la mayor\u00eda de los cuales presentaron un perfil cl\u00ednico similar al dengue. Los dos tercios restantes de los casos de zika, caracterizados por fiebre indiferenciada o erupci\u00f3n cut\u00e1nea afebril, se hubieran quedado sin diagn\u00f3stico. Entre los casos de zika, la erupci\u00f3n cut\u00e1nea (n = 440), especialmente la erupci\u00f3n eritematosa generalizada (n = 334), la fiebre (n = 333), la leucopenia (n = 217) y el dolor de cabeza (n = 203) fueron m\u00e1s comunes y alcanzaron su punto m\u00e1ximo a los 3 d\u00edas de inicio de enfermedad. La presentaci\u00f3n m\u00e1s com\u00fan de zika durante la primera semana de enfermedad fue solo erupci\u00f3n (n = 80). Adem\u00e1s, el zika se manifest\u00f3 de manera diferente en la edad pedi\u00e1trica: los ni\u00f1os m\u00e1s mayores con zika se presentaron con un perfil cl\u00ednico similar al dengue, mientras que los casos m\u00e1s j\u00f3venes de zika se presentaron con fiebre indiferenciada o erupci\u00f3n cut\u00e1nea afebril. La mayor\u00eda de los casos pedi\u00e1tricos de zika no se detectan seg\u00fan las definiciones de casos de la OMS y la OPS, lo que sugiere que las normas actuales para la determinaci\u00f3n de casos de zika deben de ser revisadas. Abstract: Coronaviruses (CoVs) are a CoVs that can East respiratory syndrome coronavirus (MERS-CoV) in 2012. The 2019 novel currently causing a severe outbreak of in China and multiple other countries, threatening to cause a global pandemic. disease in this age group compared with adults, and are associated with much lower case-fatality rates. Preliminary evidence suggests children are just as likely adults to become infected with SARS-CoV-2 but symptoms. However, the importance of children in transmitting the virus remains uncertain. Children more often have gastrointestinal symptoms compared with adults. Most children with SARSCoV present with fever, but this is not the case for the other novel CoVs. Many children affected by MERS-CoV are asymptomatic. The majority of children infected by novel CoVs have a documented household contact, often showing symptoms before In contrast, adults more findings, as well as for common circulating and novel CoVs infections in humans with a focus on infections in children. We first described the 2019 novel coronavirus infection in 10 children occurring in areas other than Wuhan. The coronavirus diseases in children are usually mild epidemiological exposure is key shedding feces at the convalescent stage. A small number of cases of coronavirus disease 2019 (Covid-19) have been described in children,1,2 and our understanding of the spectrum of is limited.3 We conducted a retrospective analysis involving in Wuhan, China. From January 7 to January 15, 2020, a total of 366 hospitalized children (16 years of age) were enrolled in a retrospective study of respiratory infections at three branches of... Since early January 2020, after the outbreak of 2019 novel coronavirus infection in Wuhan, China, 365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily is residents in on sources used in this study, 9 infants were infected with COVID-19 and were hospitalized in China between December 2019 and February 6, 2020. of infected infants identified was small. This may be due to a lower risk of exposure or incomplete be infected to a male infants requires further sample size, inclusion only of infants who inclusion of asymptomatic patients. Although a systematic and comprehensive the epidemic toys and tableware regularly To determine the epidemiology of 2019 novel coronavirus disease (COVID-19) in a remote region of China, far from Wuhan, we analyzed the epidemiology of COVID-19 in Gansu Province. From January 23 through February 3, 2020, a total of 35 (64.8%) of 54 reported cases were imported from COVID-19-epidemic areas. Characteristics that differed significantly during the first and waves were mean patient age, occupation, having epidemic transportation. Time from infection to illness onset for family clusters was Wuhan, or hospitalization. Spatial distribution pattern analysis indicated hot spots and spatial outliers in Gansu Province. As a result of adequate interventions, transmission of the COVID-19 virus in Gansu Province is decreasing. We report an asymptomatic child who was positive for a 2019 novel coronavirus by reverse transcription PCR in a stool specimen 17 days after the last virus exposure. The child was virus positive in stool specimens for at least an additional 9 days. Respiratory tract specimens were negative by reverse transcription PCR. To determine possible modes of virus transmission, we investigated a cluster of COVID-19 cases associated with a shopping mall in Wenzhou, China. Data indicated that indirect transmission of the causative virus occurred, perhaps resulting from virus contamination of common objects, virus aerosolization in a confined space, or spread from asymptomatic animal to with alarming and mortality. In December 2019, 2019 novel coronavirus (2019-nCoV), was recognized in Wuhan, China, and has caused serious illness and death. The ultimate scope and effect of this outbreak is unclear at present an increased risk of urinary tract infections (UTI). At present, the management of these patients is controversial and the utility of continuous antibiotic prophylaxis (CAP) remains uncertain as the literature presents contradicting evidence. The aim of this observational study was to assess UTI occurrence in children without antibiotic June 2012 and August 2016, we evaluated the incidence of UTI and the clinical and ultrasonography evolution in 407 children with subjects underwent two prenatal ultrasounds at 20 weeks and 30 weeks of gestation and within 1 month of birth. diagnosis of US at 6, 12 24 months of life. According to the UTD classification system groups: (low risk group), UTD-P2 (intermediate risk group), and UTD-P3 (high risk group). Voiding cystourethrogram was performed in all patients who presented a UTI and in those with patient underwent CAP. Results Postnatal US confirmed the patients presented a UTI (19 out 278). Eleven out of 19 had vesicoureteral reflux (VUR), and other with dilatation was low. selection of multirestistant germs in patients with exposed previously healthy boy, hailing from an Indian had a history of hematuria, proteinuria, and generalized swelling for 3 renal He presented with hypotensive shock following of hemoptysis of small amounts this episode. Evaluation for of progressive with oral albendazole 400 mg once a day and oral ivermectin (200 mcg/kg/day) initially for 4 days because clearing of the parasites in the peritoneal fluid within days of subcutaneous Ivermectin, the child succumbed to multiorgan failure. We describe the case of a 7-year-old girl with repeated vaginal Enterobius and neck, 2 hours after sun exposure (figures 1 and 2). He had severe ulceration and crusting affecting the helix of 14-day-old female infant presented to the hospital with cough for 4 days, black discoloration of her lips and tongue, lethargy, decreased feeding for 1 day and 1 episode of blood-tinged emesis. She was born full term via normal vaginal delivery with a birth weight of 2.5 kg. Antenatal period was uneventful, and there was no maternal history of antibiotic use during pregnancy or of prolonged vaginal leakage. She was exclusively breast-fed, and there was no history of local trauma. On examination, the baby was toxic appearing with a temperature of 38.9\u00b0C, heart of 94% in ambient air and capillary refill time of <3 seconds. The baby had respiratory distress with subcostal and crackles were heard. El artesunato iv se recomienda actualmente como f\u00e1rmaco de elecci\u00f3n en casos de malaria grave, con una disminuci\u00f3n de mortalidad del 23% en ninos comparado con quinina. SE ha descrito la posibilidad de anemia hemol\u00edtica asociada a su uso. Los tres pacientes hab\u00edan nacido en Espa\u00f1a, sin antecedentes personales de malaria previa. Dos hermanas de 6 y 4 anos fueron diagnosticadas en nuestro centro de malaria grave por P. falciparum. Estancia reciente en Senegal sin profilaxis. Recibieron artesunato iv (2,4 mg/kg/dosis, cada 12 horas las dos primeras dosis, y cada 24 horas con posterioridad), con un n\u00famero acumulado de 5 dosis la hermana mayor y 4 dosis en la menor, seguidos de piperaquina-artenimol durante 3 d\u00edas. Ambas quedaron afebriles y con desaparici\u00f3n de la parasitemia en las primeras 48 horas. En controles anal\u00edticos, se objetivaron par\u00e1metros compatibles con anemia hemol\u00edtica a los 10 d\u00edas del inicio del tto: descenso de hemoglobina hasta 7,4 mg/dl en la hermana mayor y 6,3 mg/dl (en control de 5 d\u00edas previos, hemoglobina 8,8 g/dL) en la menor, incremento de LDH hasta 751 U/L y 1831U/L respectivamente, niveles de haptoglobina indetectables y Coombs negativo en los 2. Ante la sospecha de anemia hemol\u00edtica secundaria a artemisininas, y una vez descartadas hemoglobinopat\u00edas, se inici\u00f3 prednisolona a 1 mg/kg/d\u00eda durante 3 d\u00edas con buena evoluci\u00f3n 10-year-old previously healthy female admitted to injury (AKI) (creatinine clearance < of 3.5% and (29,000/mm3). not hemodynamical support blood pressure 107/68 and heart (HR) 110 bpm). She was 48 and H1N1 Influenza A was detectedas the trigger agent. Treatment with oral Oseltamivir 30 mg od. (adjusted for AKI) was initiated. Twelve hours after the first dose we noticed a severe bradycardia on the cardiacmonitor, with a normal blood pressure ..... La ingesta de cuerpos extra\u00f1os es un accidente frecuente en ni\u00f1os, representando el 70% de todos los casos de perforaci\u00f3n, siendo el es\u00f3fago la localizaci\u00f3n m\u00e1s frecuente 1. Las complicaciones derivadas de la perforaci\u00f3n son raras. La perforaci\u00f3n con migraci\u00f3n del cuerpo extra\u00f1o asociada, es a\u00fan m\u00e1s rara, pudiendo ocasionar complicaciones cervicales2. Ni\u00f1a de 3 a\u00f1os que acude a urgencias por fiebre, sialorrea y lateralizaci\u00f3n del cuello. Antecedente de ingesta de pescado, seguido de dolor retroesternal y salivaci\u00f3n. De forma urgente se realiza fibrobroncoscopia y gastroscopia, objetivando edema epigl\u00f3tico, sin lograr identificar ning\u00fan cuerpo extra\u00f1o. Dada la persistencia de la cl\u00ednica se completa el estudio con ecograf\u00eda (fig. 1) y TC cervical (fig. 2) donde se observa flem\u00f3n retrotraqueal y retrofar\u00edngeo con formaci\u00f3n de absceso tiroideo derecho secundario a perforaci\u00f3n esof\u00e1gica por espina de pescado migrada. Se realiza cervicotom\u00eda exploradora y faringoscopia r\u00edgida donde se identifica la espina de pescado a nivel cervical y perforaci\u00f3n de la pared esof\u00e1gica posterior, a la altura del esf\u00ednter esof\u00e1gico superior. La no detecci\u00f3n del cuerpo extra\u00f1o en la endoscopia, no descarta su presencia, por lo que, ante una cl\u00ednica persistente es necesario llevar a cabo pruebas diagn\u00f3sticas de imagen, para valorar su posible migraci\u00f3n3. of postnatal screen, postnatal age other major outcomes of prematurity, including BPD and units managed by the Pediatrix Medical Group from January 1, 2002, through December 31, 2016. Infants hospitalized on postnatal day 21 diagnosis CMV and hearing screen results after a postmenstrual age of 34 weeks were included in the study population. Data were analyzed from December 11, 2017, to June 14, 2019. Main Outcomes and Measures Infants between and the risk of failed hearing screen, postnatal age at discharge, growth, BPD, and Results A total of 304 infants with postnatal CMV were identified, and 273 of these (89.8%; [56.8%]) were matched CMV (148 boys [54.2%]). screen 273 infants postnatal ratio [RR], P = CMV was also with an increased postnatal age of 11.89 days (95% CI, 6.72 to 17.06 days; P < .001) and lower weight-for-age z score (0.23; 95% CI, 0.39 to 0.07; P = .005). Analysis confirmed an increased risk of BPD (RR, 1.30; 95% CI, to 1.44; P < .001), previously reported on infants from this cohort from 1997 to 2012, but not an increased risk of NEC after postnatal day 21 (RR, 2.00; 95% CI, 0.18 to 22.06; P = .57). Relevance These postnatal associated with lasting the with prolonged Prospective whether human with a global seroprevalence of approximately In all human history, most CMV have probably been acquired from breastfeeding. Hayes 1972 demonstrated that CMV could be cultured in breast milk, and breastfeeding was proposed as a mechanism by which the virus could be transmitted to the neonate. Subsequent work of glucocorticoids may to date, the use of glucocorticoid therapy in SMPP is limited to small case series, and the glucocorticoid dosage for children with SMPP has not been Here, we used method to collect from randomized control of different doses of methylprednisolone in SMPP to assess the safety and efficacy of treatment with low- versus high-dose methylprednisolone in children with SMPP. Results: We included 13 Chinese randomized control trials that included 1049 children. The high- and low-dose groups were comprised of 524 and 525 children, respectively. The high-dose group was significantly more effective than the low-dose group clinical efficacy ratio = 1.30, 95% confidence interval (CI) in the conclude that high-dose is effective in por Pneumocystis jirovecii (PJP) es una enfermedad potencialmente letal en ni\u00f1os inmunocomprometidos. Nuestro objetivo es analizar las caracter\u00edsticas epidemiol\u00f3gicas y cl\u00ednicas de la PJP, describiendo el pron\u00f3stico y los factores de riesgo. M\u00e9todos Estudio retrospectivo (enero 1989-diciembre 2016) de pacientes pedi\u00e1tricos (18 a\u00f1os) con PJP. Definici\u00f3n de caso: paciente con neumonitis aguda y detecci\u00f3n de P. jirovecii en lavado broncolaveolar o aspirado traqueal usando tinci\u00f3n con plata-metenamina o inmunofluorescencia directa, o reacci\u00f3n en cadena de polimerasa en tiempo real. Resultados. Se identificaron veinticinco casos (0,9 casos/a\u00f1o); edad mediana: 2,2 a\u00f1os (rango intercuart\u00edlico: 0,5-12,3), 64% de sexo masculino, y 12% bajo profilaxis anti-PJP. La coinfecci\u00f3n por citomegalovirus se demostr\u00f3 en el 26%. Las enfermedades subyacentes m\u00e1s frecuentes fueron las inmunodeficiencias primarias (36%) y el 16% estaban infectados por el VIH. Dieciocho ingresaron en Cuidados Intensivos Pedi\u00e1tricos (UCIP) y la mortalidad global a los 30 d\u00edas fue del 20% (31,25% en VIH- vs 0% VIH+; OR: 0,33 95%CI 0,02-7,24 p=0,55). El pron\u00f3stico fue peor en ni\u00f1as y en aquellos que recibieron tratamiento adyuvante con corticoides. Se identificaron como factores de riesgo para ingreso en UCIP la ausencia de infecci\u00f3n por VIH, valores iniciales elevados de LDH, menor edad y un per\u00edodo m\u00e1s corto entre el diagn\u00f3stico de PJP y la enfermedad subyacente (p=0,05, p=0,026, p=0,04 y p=0,001, respectivamente). Conclusiones. Tras la aplicaci\u00f3n generalizada de la terapia antirretroviral, la PJP se diagnostica casi exclusivamente en ni\u00f1os no infectados por el VIH en los que, adem\u00e1s, se identific\u00f3 una mayor morbilidad. Background Urinary tract infection (UTI) is a Cost-effectiveness of Objective determine cost-effectiveness collection invasive months in the emergency department. Costs included equipment, staff time and hospital bed occupancy. If initial collection attempts were a hospital bed was the most significant determinant of cost. Conclusion Catheterisation an increased risk of urinary tract infections (UTI). At present, the management of these patients is controversial and the utility of continuous antibiotic prophylaxis (CAP) remains uncertain as the literature presents contradicting evidence. The aim of this observational study was to assess UTI occurrence in children without antibiotic June 2012 and August 2016, we evaluated the incidence of UTI and the clinical and ultrasonography evolution in 407 children with subjects underwent two prenatal ultrasounds at 20 weeks and 30 weeks of gestation and within 1 month of birth. diagnosis of US at 6, 12 24 months of life. According to the UTD classification system groups: (low risk group), UTD-P2 (intermediate risk group), and UTD-P3 (high risk group). Voiding cystourethrogram was performed in all patients who presented a UTI and in those with patient underwent CAP. Results Postnatal US confirmed the patients presented a UTI (19 out 278). Eleven out of 19 had vesicoureteral reflux (VUR), and other with dilatation was low. selection of multirestistant germs in patients with exposed (UTI) are the most common bacterial infections among infants and young children with fever without a source. Extended-spectrum -lactamases (ESBLs) have emerged as emerging cause of however, data about risk factors and clinical features of children with ESBL-UTI have the to December 31, 2016. Pediatric patients with UTI were compared with patients with UTI matched for age and year of diagnosis. Results: A total of 720 children were enrolled (240 cases and 480 controls). Patients with ESBL-PB UTI were more likely to have a history of prior intensive care unit (ICU) admission (22.5% vs. 0.001), within days before culture (7.5% vs. 4.2%, = 0.035), and (7.9% vs. 1.5%, P < compared with those with non-ESBL-PB UTI. Patients with ESBL-PB UTI were more likely to present with hypothermia (48.8% vs. 38.5%, P = 0.009); CI: 2.5-5.5)} and were more likely to be admitted to the ICU [odds ratio (OR) 1.8; 1.3-4.3) isolates tested risk for ESBL-PB UTI, but majority of ESBL research to determine strategies for rational antimicrobial use. Selecci\u00f3n del tratamiento antibi\u00f3tico emp\u00edrico en pielonefritis seg\u00fan el perfil del paciente. An Pediatr (Barc). 2020;92:181-2 En nuestra opini\u00f3n, existe una diferencia significativa en cuanto a microorganismos aislados y resistencias entre los lactantes con su primera ITU alta, y aquellos que la presentan teniendo antecedentes de uropat\u00eda conocida, ya est\u00e9n intervenidos o instrumentalizados en el entorno sanitario, con o sin profilaxis previa, siendo un porcentaje importante de los episodios, de repetici\u00f3n. Presentamos nuestra experiencia de microorganismos aislados en pielonefritis entre 2013-2017 .Se observa una diferencia claramente significativa en los aislamientos microbiol\u00f3gicos de ambos grupos . Un an\u00e1lisis bayesiano tipos (WISCA)2-4sobre la sensibilidad a los distintos antibi\u00f3ticos generalmente indicados emp\u00edricamente, as\u00ed como a combinaciones de biterapia, muestra como en el grupo de primera infecci\u00f3n urinaria febril sin antecedentes conocidos de uropat\u00eda se mantiene una aceptable sensibilidad a amoxicilina-clavul\u00e1nico (87%) en nuestro medio, lo que nos permite su uso emp\u00edrico con seguridad, tanto oral como intravenosa. En cambio, en el grupo con uropat\u00eda conocida, las resistencias en monoterapia de amoxicilina-clavul\u00e1nico, cefotaxima, ceftazidima y gentamicina superan el umbral de seguridad (38,5, 38,8, 25 y 18%, respectivamente) probablemente con relaci\u00f3n a que aproximadamente la mitad de los aislamientos se trataba de enterobacterias no coli, Pseudomonas aeruginosa y Enterococcus, a\u00f1adido a un porcentaje del 17% de productores de betalactamasas de espectro extendido. A la vista de los resultados, nosotros optamos por una terapia emp\u00edrica con amoxicilina-clavul\u00e1nico tanto oral sin ingreso hospitalario, como intravenosa con ingreso, en el primer grupo, con buenos resultados validados en el \u00faltimo a\u00f1o y que obviar\u00eda los problemas de desabastecimiento temporales de cefalosporinas (cefuroxima axetilo y cefixima). En cuanto al segundo grupo, la biterapia con ampicilina o amoxicilina-clavul\u00e1nico en combinaci\u00f3n con gentamicina o amikacina alcanza sensibilidades de hasta el 99% permitiendo el ahorro de otras opciones emp\u00edricas de mayor espectro e inducci\u00f3n de resistencias, como cefalosporinas de tercera generaci\u00f3n, quinolonas y carbapen\u00e9micos. Su empleo estar\u00eda, no obstante, condicionado a un filtrado glomerular normal, monitorizaci\u00f3n de niveles y sustituci\u00f3n por alternativa seg\u00fan antibiograma cuanto antes. Nuestra propuesta es que se distingan, al menos, estos 2 grupos diferenciados en los futuros estudios epidemiol\u00f3gicos de resistencias, tratamientos emp\u00edricos y recomendaciones de consenso. Ecograf\u00eda cl\u00ednica en la infecci\u00f3n del trato urinario. An Pediatr (Barc). 2020;92:182-3 Igual que se proponen una serie de signos y s\u00edntomas cl\u00ednicos compatibles con la infecci\u00f3n urinaria, creemos que deber\u00edan considerarse tambi\u00e9n los criterios ecogr\u00e1ficos caracter\u00edsticos de la misma. En el caso de infecci\u00f3n urinaria baja las caracter\u00edsticas ecogr\u00e1ficas de la vejiga pueden ser determinantes para su diagn\u00f3stico topogr\u00e1fico. La pared vesical engrosada en vejiga distendida (>3mm), su espesor disuniforme a modo de \u00abmamelones\u00bb y/o la presencia de contenido hiperecog\u00e9nico y m\u00f3vil, en un contexto cl\u00ednico compatible, son muy sugerentes de cistitis infecciosa. Si bien es cierto que ante una pielonefritis aguda no complicada podemos tener una ecograf\u00eda del aparato excretor normal, hay signos caracter\u00edsticos de un mayor grado de afectaci\u00f3n como son el aumento del tama\u00f1o renal (global o focal), alteraciones de ecogenicidad (aumentada o disminuida) con respecto al resto del par\u00e9nquima renal, p\u00e9rdida de diferenciaci\u00f3n c\u00f3rtico-medular y engrosamiento de las paredes de la pelvis renal o de los ur\u00e9teres. Es admitido que la ecograf\u00eda es la prueba diagn\u00f3stica de elecci\u00f3n para el estudio inicial del tracto urinario en pediatr\u00eda (tabla 1). Las recientes recomendaciones publicadas por Pi\u00f1eiro et al.1 consideran, si se realiza sondaje vesical, bacteriuria significativa>10.000UFC/ml. Sin embargo, en la Gu\u00eda de pr\u00e1ctica cl\u00ednica de infecci\u00f3n del tracto urinario de la Academia Americana de Pediatr\u00eda (AAP), publicada en 20112 y revisada en 2016, se define infecci\u00f3n del tracto urinario (ITU) en los pacientes de 2 a 24 meses como la presencia de piuria y>50.000UFC/ml de un \u00fanico pat\u00f3geno. Las gu\u00edas europeas publicadas recientemente. Wolf et al.4 y otros autores definen ITU como la presencia de piuria y>10.000UFC/ml o>50.000UFC/ml de un \u00fanico pat\u00f3geno de orina obtenida por sondaje vesical. La bibliograf\u00eda publicada hace pensar que el diagn\u00f3stico de ITU podr\u00eda definirse como la presencia de>50.000UFC/ml de un \u00fanico pat\u00f3geno, o 10.000-50.000UFC y piuria asociada. En cuanto al tratamiento ambulatorio recomiendan cefixima con En la bibliograf\u00eda m\u00e9dica reciente no existen estudios en los que se compare la pauta v\u00eda oral de cefixima de doble dosis el primer d\u00eda con la dosis est\u00e1ndar. Tanto en la Gu\u00eda de pr\u00e1ctica cl\u00ednica de infecci\u00f3n del tracto urinario de la AAP publicada en 20112, como en el protocolo de infecci\u00f3n urinaria de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda6, se indica la pauta de cefixima 8mg/kg/d\u00eda.El hecho de que no existan estudios comparativos de ambas posolog\u00edas v\u00eda oral, el que haya discrepancias en cuanto a la pauta m\u00e1s adecuada para el tratamiento de la ITU en diversas publicaciones y que el pautar doble dosis el primer d\u00eda sea una pauta diferente a la establecida en la ficha t\u00e9cnica, pudiendo inducir errores en la dosificaci\u00f3n del f\u00e1rmaco, hace pensar que la pauta m\u00e1s adecuada para el tratamiento ambulatorio sea cefixima 8mg/kg/d\u00eda. \u00abRecomendaciones sobre el diagn\u00f3stico y tratamiento de la infecci\u00f3n urinaria\u00bb, respuesta de los autores. An Pediatr (Barc). 2020;92:184-6 Con respecto a la r\u00e9plica de Lorente y V\u00e1zquez2, aunque la American Academy of Pediatrics mantiene el punto de corte en 50.000UFC/ml para considerar bacteriuria significativa en orinas recogidas mediante sondaje vesical, existen otros estudios3 que recomiendan bajar el l\u00edmite a 10.000UFC/ml. Igualmente, hay publicaciones4 que consideran que el diagn\u00f3stico de ITU. puede establecerse si hay fiebre, piuria y un recuento 10.000UFC/ml, sin afectar la especificidad y aumentando la sensibilidad. Recientemente, una amplia revisi\u00f3n5 concluye que establecer el diagn\u00f3stico con 10.000UFC/ml aumenta la sensibilidad sin disminuir la especificidad, por lo que ayudar\u00eda a evitar el infradiagn\u00f3stico. Sin embargo, un metaan\u00e1lisis6 publicado tambi\u00e9n en 2019 resume que el punto de corte m\u00e1s id\u00f3neo sea 100.000UFC/ml, con independencia del m\u00e9todo de recogida . Es decir, la evidencia es insuficiente en la actualidad. En el documento de recomendaciones1 se ha optado por la opci\u00f3n con mayor sensibilidad. En relaci\u00f3n con la dosificaci\u00f3n doble de cefixima el primer d\u00eda de tratamiento, la recomendaci\u00f3n se basa en el cl\u00e1sico estudio de Hoberman et al.7, si bien deber\u00eda ajustarse a los menores de 2 a\u00f1os tal y como se detalla en el art\u00edculo y en el Pediam\u00e9cum8. Con respecto a la r\u00e9plica de Oltra-Benavent et al.9, en el documento de recomendaciones se realizan propuestas basadas en los patrones de susceptibilidad descritos en la literatura revisada1. De forma paralela al desarrollo de dicho documento, el Grupo de Trabajo coordin\u00f3 un estudio nacional de susceptibilidad en 1.200 ITU pedi\u00e1tricas. El microrganismo predominante fue Escherichia coli (E. coli) (> 80%). Un 19% de los ni\u00f1os presentaron malformaci\u00f3n urinaria, un 6,7% recib\u00eda profilaxis antibi\u00f3tica y un 8,5% hab\u00eda recibido antibi\u00f3ticos el mes anterior. En la tabla 1 se muestra un extracto de la sensibilidad frente a diferentes antimicrobianos. Mediante an\u00e1lisis de regresi\u00f3n log\u00edstica, el \u00fanico factor de riesgo asociado con la presencia de bacterias productoras de betalactamasas de espectro extendido (BLEE) fue la profilaxis antimicrobiana11. Background after in the same population or in two or more different patient populations within one study at different time periods; and (3) with reported detection rate of review recommendations of the Collaboration overall prevalence of VUR was not significantly different between the early and the late VCUG groups (risk ratio 0.98, 95% CI 0.81 to 1.19). Prevalence of VUR stratified by grade was significantly different between the two groups. Conclusion Early VCUG within 8 days after onset of or data, clindamycin is widely prescribed in the neonatal intensive care unit. We evaluated the association between clindamycin exposure clindamycin before postnatal day 121 who were discharged from a Pediatrix Medical Group neonatal intensive care ratio = 1.95 [1.04-3.63]), but exposure was not associated with death, sepsis, seizures, intestinal perforation or intestinal strictures. Of 25 had MRSA bacteremia, 19 (76%) cleared the clindamycin exposure death or nonlaboratory adverse events. The use of pharmacokinetic models combined with electronic health record data offers valuable, approach analyzing when asthma presents to clinic. months ago, he had an asthma exacerbation while outside the UK and was prescribed azithromycin. His mother has continued giving it to urine or saliva samples by infection due to cytomegalovirus (cCMV), the \"who\" of screening is as yet unsettled. The \"why\" of screening would be to sequelae cCMV all infants who could hearing over time? With the additional lack of understanding of the \"what to do\" with a positive PCR result, their infants as cCMV-infected, 11 state legislatures (starting with Utah in 2013) have enacted laws to mandate targeted screening for surveyed 365 caregivers whose children were being seen in an otolaryngology clinic at a tertiary pediatric hospital about their knowledge of and attitudes toward cCMV and cCMV screening. Descriptive statistics to their Results cCMV screening of infants was important. Most caregivers did not know that cCMV screening was required by law in Utah if an infant is referred after newborn hearing screening. A majority wanted to know if their child had cCMV even if asymptomatic and were willing to pay $20 for cCMV screening. Caregivers of children who had been tested for cCMV were significantly more likely to be strongly in favor of cCMV screening than expected by chance. Caregivers in the highly knowledgeable cluster were more likely to be strongly in favor of cCMV screening. Conclusions of and community transmission in European Union and European Economic Area (EU/EEA) is becoming more likely. We provide for the polio epidemics of the 1950s through immunisation led to the development of a national immunisation strategy in the UK and the formation of the Joint Committee on Vaccination and Immunisation 1963, which oversees the immunisation programme and advises the UK Department of Health on new vaccine introductions. As a result of technological advances in vaccine development and scientific advances in immunology and microbiology over the 56 years since then, and the formation of a comprehensive public health surveillance system for vaccine-preventable disease, the National Health Service immunisation programme now covers 18 serious diseases of childhood, with an astonishing impact on child health. Here we consider the formation of the JCVI and the development of the national immunisation programme and review the introduction of vaccines over the past half century to defend public health. Objective To determine the timing of peak coronary artery dilation design This retrospective study analyzed 231 children hospitalized for Kawasaki disease in Hawai'i over a period of 7 years. Clinical and echocardiographic data were collected to calculate the timing peak z score, and dilation on at 11.5 days from the onset of fever (median 8, IQR 7-13 days). Among coronary arteries during the initial encounter 16 (10%) developed coronary artery dilation or aneurysm at the second 5 (3%) continued to have coronary artery during the diagnostic accuracy of clinical criteria at the time of arrival, compared with a septic shock definition, in detecting septic shock within the first 24 hours? The Archivist has seen the impact of Sepsis six and now, Sepsis three with concern about the over use of antibiotics and antimicrobial resistance. Rudd KE important of this devastating disease. The Global Burden of Disease (GBD) is a group of more than 3600 researchers examining health issues from around the world. GBD 2017 reports on 282 underlying causes of death in 195 countries. This group has estimated the global, regional, and national incidence ... Introducci\u00f3n. Las infecciones son una causa importante de morbimortalidad en los pacientes con c\u00e1ncer (mortalidad estimada en 3%). La neutropenia febril conlleva con frecuencia el ingreso hospitalario de los pacientes oncol\u00f3gicos, incrementando el riesgo de infecci\u00f3n nosocomial as\u00ed como los costes sanitarios por ingresos. M\u00e9todos. Estudio observacional ambispectivo (01/07/2015 - 31/12/2018) de los episodios de neutropenia febril posquimioterapia en poblaci\u00f3n pedi\u00e1trica. Se recogieron edad, sexo, percentil de peso (OMS), estancia hospitalaria (d\u00edas), temperatura (oC), aislamiento de germen, foco infeccioso, profilaxis o no antibi\u00f3tica y antif\u00fangica, cifras (mg/L) y procalcitonina (PCT) (ng/ml) al ingreso y d\u00edas con neutropenia<500/mm3. El an\u00e1lisis estad\u00edstico se realiz\u00f3 con el programa SPSSv.23. Resultados. De 69 pacientes, se registraron 101 episodios. La estancia media fue de 7,43 d\u00edas (mediana 6 d\u00edas). Se aisl\u00f3 germen en un 44,6% de los episodios, no identific\u00e1ndose foco infeccioso en un 36% de los mismos. Se hall\u00f3 correlaci\u00f3n inversa entre hemoglobina, plaquetas y linfocitos al ingreso con la estancia hospitalaria (-0,356 (p 0,001); -0,216 (p 0,042) y -0,216 (p 0,042) respectivamente). La estancia media fue mayor si al ingreso presentaron PCR>90mg/L (10,94 vs. 6,66 d\u00edas p 0,017), si PCT>1ng/ml d\u00edas p 0,0002), si 100 neutr\u00f3filos (8,27 vs. 5,04 d\u00edas p 0,039) y si hubo aislamiento microbiol\u00f3gico (9,54 vs. 5,78 d\u00edas p 0,006). Conclusi\u00f3n La relaci\u00f3n entre hemoglobina, plaquetas y linfocitos al ingreso con la estancia media es inversamente proporcional. Adem\u00e1s, aquellos pacientes con 100 neutr\u00f3filos al ingreso, PCR>90mg/L y PCT>1ng/ml presentaron mayor estancia media. Estos factores podr\u00edan ser importantes en el manejo de la neutropenia febril en el paciente con c\u00e1ncer infantil. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. Published online February 14, 2020. doi:10.1001/jama.2020.2131 Based on the sources of data used in this study, 9 infants were infected with COVID-19 and were hospitalized in China between December 2019 and February 6, 2020. of infected infants identified was small. This may be due to a lower risk of exposure or incomplete be infected to a male infants requires further sample size, inclusion only of infants who inclusion of asymptomatic patients. Although a systematic and comprehensive the epidemic and tableware regularly. PARA Common Cold. JAMA. 2020;323(8):707-708. animal to with alarming and mortality. In December 2019, 2019 novel coronavirus (2019-nCoV), was recognized in Wuhan, China, and has caused serious illness and death. The ultimate scope and effect of this outbreak is unclear at present the situation is rapidly Association of postnatal screen, postnatal age other major outcomes of prematurity, including BPD and units managed by the Pediatrix Medical Group from January 1, 2002, through December 31, 2016. Infants hospitalized on postnatal day 21 diagnosis CMV and hearing screen results after a postmenstrual age of 34 weeks were included in the study population. Data were analyzed from December 11, 2017, to June 14, 2019. Main Outcomes and Measures Infants between and the risk of failed hearing screen, postnatal age at discharge, growth, BPD, and Results A total of 304 infants with postnatal CMV were identified, and 273 of these (89.8%; [56.8%]) were matched CMV (148 boys [54.2%]). screen 273 infants postnatal ratio [RR], P = CMV was also with an increased postnatal age of 11.89 days (95% CI, 6.72 to 17.06 days; P < .001) and lower weight-for-age z score (0.23; 95% CI, 0.39 to 0.07; P = .005). Analysis confirmed an increased risk of BPD (RR, 1.30; 95% CI, to 1.44; P < .001), previously reported on infants from this cohort from 1997 to 2012, but not an increased risk of NEC after postnatal day 21 (RR, 2.00; 95% CI, 0.18 to 22.06; P = .57). Relevance These postnatal associated with lasting the with prolonged Prospective infection and whether antiviral treatment reduces bacteriuria without pyuria in asymptomatic children by a systematic review of the literature. We searched MEDLINE on bacteriuria in asymptomatic children up to 19 years of age had urine collected by abstracted Fourteen were included. The prevalence of asymptomatic bacteriuria was 0.37% (95% CI, 0.09-0.82) in boys and 0.47% (95% CI, 0.36-0.59) in girls. corresponding values <1 year of age and females >2 years of age. In males, the prevalence of asymptomatic bacteriuria after infancy of asymptomatic bacteriuria in untreated boys and girls, from the one study reporting this outcome, was 1.5 and 2 months, respectively. Some clinicians are that nonlocalizing as having a is the this will occur extremely rarely. These data suggest that the current definition of UTI should be revisited. El acn\u00e9 es una dermatosis cr\u00f3nica de presentaci\u00f3n cl\u00ednica variable y con frecuencia mixta, que requiere tratamiento farmacol\u00f3gico hasta en un 30% de los casos. - La selecci\u00f3n del tratamiento debe ser individualizada, en funci\u00f3n de la gravedad, la presentaci\u00f3n cl\u00ednica, las posibles secuelas psicol\u00f3gicas y la afectaci\u00f3n de la calidad de vida. - En general se recomienda un tratamiento escalonado y progresivo, siendo la primera opci\u00f3n -para los casos leves- el tratamiento t\u00f3pico (en monoterapia o asociaci\u00f3n), en segundo lugar, la asociaci\u00f3n de f\u00e1rmacos t\u00f3picos con antibi\u00f3ticos orales y finalmente los retinoides sist\u00e9micos (isotretino\u00edna oral) o los anticonceptivos orales (en mujeres). - Para reducir el riesgo de resistencias, se recomienda que los antibi\u00f3ticos no se utilicen nunca como tratamiento de primera l\u00ednea, de mantenimiento, ni en monoterapia, limitar su administraci\u00f3n ( 3-4 meses) y no asociar antibi\u00f3ticos t\u00f3picos y orales. - El tratamiento debe evaluarse a los 2-3 meses (1-2 meses los antibi\u00f3ticos) y si la respuesta es inadecuada, antes de pasar al siguiente escal\u00f3n, probar todas las opciones posibles y descartar otras posibles causas de ineficacia. - Los retinoides (t\u00f3picos y sist\u00e9micos) est\u00e1n contraindicados en embarazadas; y las mujeres tratadas con isotretino\u00edna oral con capacidad de gestaci\u00f3n, deben seguir el \"Plan de prevenci\u00f3n de embarazos\". - Los pacientes que precisen tratamiento con isotretino\u00edna oral requieren un seguimiento especial y deben derivarse a dermatolog\u00eda. Tambi\u00e9n deben derivarse: los pacientes con acn\u00e9 cicatrizante; efectos adversos graves; intolerancia a los tratamientos habituales; recidiva tras tratamiento sist\u00e9mico; o, alteraciones endocrinas. - Tras finalizar un tratamiento de choque, se recomienda tratamiento de mantenimiento t\u00f3pico para prevenir las reca\u00eddas en todos los pacientes, excepto en los tratados con isotretino\u00edna oral. - Independientemente del tratamiento farmacol\u00f3gico, todos los pacientes con acn\u00e9 deber\u00edan seguir las medidas complementarias, pero no parece necesario modificar la dieta. \u00b7 Acute Otitis Media. JAMA Pediatr. Published online January 27, for rAOM were grouped according to detection of bacterial otopathogen in their middle ear effusion (MEE) at the time of VTI, episodes were similar between groups. Of the 63 children had PCR +ve MEE, 58.7% required repeat VTI no otopathogen detected in their MEE (odds ratio detection of bacterial otopathogen, specifically nontypeable H. the middle ear a predictor of children otitis (OM) episodes in early childhood is unclear. We compared the risk of OM episodes among children age <2 years before and after (2006-2014) of recurrent OM (3 episodes in 6 months or 4 We episodes and 24 875 PET insertions among 368 063 children. OM and PET insertion the PCV7 risks were of first, subsequent, and recurrent OM. Conclusions. The transition from PCV7 to PCV13 was with a decline of OM among children aged <2 years due to a reduction in the risk of both the first and subsequent OM episodes. With more than 28 million doses administered since 2014, the CDC hasn't identified any new or unexpected safety concerns with the human papillomavirus vaccine, according to a pair of CDC studies published in Pediatrics. The first study mined data from 7244 reports of adverse events the verified deaths after use of the vaccine but found no evidence that the vaccine caused the deaths. The overall rate of adverse event reports was 259 per million doses of 9vHPV and 7 serious adverse event reports per million that their data were consistent with prelicensure safety data and with safety data from the previous quadrivalent HPV vaccine. The second of 9vHPV-associated adverse events from October 2015 to October 2017. During the 105 weeks of surveillance, 838 991 doses of the vaccine were given. Unexpected signals for a statistical relationship between vaccination and appendicitis among boys aged 9 to years after the third dose, pancreatitis among men aged 18 to 26 years, and allergic reactions in girls and women after the second dose identified. However, further analysis didn't confirm this large observational study, we contribute reassuring postlicensure data that will help of 9vHPV,\" the second study's authors wrote. The evidence the of tonsillectomy in children with PFAPA syndrome = reduction in and severity (length of episode) of any further However, the evidence is of moderate certainty (further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate) due to the relatively small sample sizes of the studies and some of the results. the weigh the risks consequences of alternative of using spontaneously and can be administered to try and reduce the severity of individual episodes. It is uncertain whether adenoidectomy combined with tonsillectomy adds additional The review authors searched for available trials and included seven trials. The trials were conducted in a total of 1140 children aged from 3 months to 5 years. Children who were given racecadotril were compared to a control group (children who, instead of racecadotril, received a placebo (a dummy drug that contains no racecadotril) or no drug). The review shows that when children with diarrhoea were given racecadotril, compared to placebo or no drug: may reduce the risk of rehydration failure (low-certainty we are uncertain make little of hospital stay for inpatients (low-certainty evidence); racecadotril may make little or side-effect events IPV-only schedules, IPV-OPV may have difference on SAEs (serious adverse events), probably has little or IPV doses as part of a IPV-OPV schedule does not appear to be between countries. Se conoce como episodio de hipoton\u00eda-hiporrespuesta a un evento adverso de baja frecuencia de la vacunaci\u00f3n infantil predominantemente del componente antitosferina. Es caracterizado por una p\u00e9rdida s\u00fabita del tono muscular asociada a hiporreactividad a est\u00edmulos y a cambios en la coloraci\u00f3n de la piel (palidez cut\u00e1nea o cianosis). Debido a que es una entidad poco conocida, secundaria a mecanismos fisiopatol\u00f3gicos desconocidos y con diagn\u00f3stico por exclusi\u00f3n, adquiere una mayor importancia el conocimiento por el profesional sanitario de este evento, para elaborar un adecuado diagn\u00f3stico diferencial de episodios colapsiformes, evitar pruebas o medidas innecesarias y prevenir el miedo poblacional a las vacunas. Se presenta el caso de un lactante de 2 meses que acude a su centro de salud para iniciar el calendario vacunal sistem\u00e1tico. Aproximadamente un minuto tras la administraci\u00f3n de las vacunas correspondientes a su edad (vacuna hexavalente [difteria, t\u00e9tanos vacuna antineumoc\u00f3cica conjugada de un episodio brusco de palidez cut\u00e1nea, hipoton\u00eda e hiporreactividad, manteniendo respiraci\u00f3n espont\u00e1nea y el presented with a newly developed, nontender subtle medio, de apariencia colapsiforme, con recuperaci\u00f3n espont\u00e1nea y progresiva en los siguientes dos minutos. A 6-year-old boy was treated with sultamicillin for 6 days for frontal sinusitis. Upon clinical improvement, he was discharged with oral antibiotics to be continued for another week. Within 24 hours, he frontal swelling. His general condition was not compromised, and there were no signs of local inflammation or a history of recent trauma. A cranial computed tomography scan and clindamycin for 14 days. The patient was discharged home in good condition without presented with a sudden onset, asymptomatic rash around the eyes for the past 3 days. She was receiving treatment for an upper respiratory tract appeared spontaneously and was not revealed bilaterally symmetrical, erythematous, lower eyelids (Figure). There were no similar lesions and was unremarkable. Facial purpura. La infecci\u00f3n por Pantoea agglomerans es muy rara de forma global y particularmente en Pediatr\u00eda. La mayor\u00eda de las infecciones que causa son nosocomiales en pacientes inmunodeprimidos. Se han descrito infecciones articulares tras punci\u00f3n con espinas vegetales dando lugar a artritis, sinovitis u oste\u00edtis; meningitis o septicemia neonatal tras la contaminaci\u00f3n de la nutrici\u00f3n parenteral o transfusiones de hemat\u00edes; infecciones de orina o respiratorias y peritonitis. En inmunocompetentes las infecciones son excepcionales, por lo que se aconseja realizar estudio de inmunidad, como en nuestro caso. El germen es muy resistente a antibi\u00f3ticos betalact\u00e1micos y para erradicarlo suele ser necesario tratar seg\u00fan antibiograma. El edema agudo hemorr\u00e1gico del lactante (EAHL) es una vasculitis de peque\u00f1o vaso que afecta caracter\u00edsticamente a los lactantes, con predominio en varones. Su etiolog\u00eda es desconocida pero con frecuencia se asocia a infecciones o f\u00e1rmacos. Las lesiones cut\u00e1neas que provoca son purp\u00faricas y asocian edema y febr\u00edcula. Su evoluci\u00f3n es favorable y sin secuelas, se resuelve en pocas semanas y el tratamiento es sintom\u00e1tico. El caso cl\u00ednico que presentamos trata de un lactante var\u00f3n de 15 meses atendido en nuestro centro de salud con episodio de otitis media aguda y posterior aparici\u00f3n de edema agudo hemorr\u00e1gico. La urticaria multiforme es un trastorno cut\u00e1neo, propio de lactantes y ni\u00f1os peque\u00f1os, caracterizado por lesiones habonosas de centro viol\u00e1ceo y morfolog\u00eda anular. Presenta similitud con el eritema multiforme, pero a diferencia de este, tiene un car\u00e1cter benigno y autolimitado. Su etiolog\u00eda es desconocida y el tratamiento, sintom\u00e1tico. Su conocimiento y diagn\u00f3stico diferencial es importante para evitar pruebas diagn\u00f3sticas innecesarias, realizar un manejo correcto y proporcionar informaci\u00f3n adecuada a los padres. Caso cl\u00ednico de lactante de 4 meses con urticaria multiforme. A 7-year-old boy from rural northern India presented with complaints of fever, headache, and vomiting for the last 4 months. His headache was moderate to severe in intensity and associated with vomiting. was no history were The remainder of the systemic examination disseminated made. We present a case herpes zoster ophthalmicus in an otherwise healthy 14-month-old and treatment of vaccine-strain herpes zoster. Sepsis continues to kill children around the world. The death of a child with sepsis in New York State resulted in a state-wide mandate for sepsis care in 2013 (JAMA 2018;320:358-67). This mandate was later found to be associated with lower risk of mortality from pediatric sepsis. Since then, other states have prevent deterioration to septic shock. In this volume of The Journal, Scott et al derived and validated the first prediction model for pediatric septic shock. They used variables that are easily available from the electronic health records and are known upon arrival to the emergency department, including the initial vital signs. The model, developed using a modern predictive algorithm, strongly to initial clinician suspicion of sepsis. The model can be incorporated in the electronic health records to automate the stratification of the risk of pediatric shock. Stratification of the risk of pediatric shock will allow for timely intervention before deterioration occurs. It is a step the prevention of death from pediatric sepsis. The prediction model by Scott et al is a positive step toward this direction. The need for immediate recognition and treatment of sepsis has been a major focus of quality improvement efforts in medicine over the past decade, exemplified to raise setting of studies focusing solely on infants less than 1 of both preterm and term gestational age infants. In this volume of The Journal, et al days, IQR 18-114 days) hospitalized in a neonatal intensive care unit, time to antibiotic administration was associated with increased rates of mortality at 14 and 30 inotrope-free days.2 In this single-center prospective 12-week window in 114 children <5 years of age. Previous TSTs and chemoprophylaxis had no previous TSTs a negative to a positive QFT-GIT result. To determine if time to antibiotic administration is associated with mortality and in-hospital outcomes was calculated from time of sepsis identification, defined as the order time of either blood culture or an antibiotic, to time of used linear models with generalized estimating time to and mortality, ventilator-free and inotrope-free was associated with significantly increased risk of mortality at 14 days (OR, 1.47; 95% CI, 1.15-1.87) and 30 days (OR, 1.47; 95% 1.11-1.94) as time to antibiotic administration was an independent risk factor for death and prolonged cardiovascular dysfunction. Further study is t\u00e9tanos es una enfermedad aguda grave cuyo tratamiento es dif\u00edcil y, por tanto, es fundamental su prevenci\u00f3n. La administraci\u00f3n de cinco dosis de vacuna antitet\u00e1nica es suficiente para conferir una protecci\u00f3n a largo plazo. En los \u00faltimos a\u00f1os se ha observado cierta disminuci\u00f3n en las coberturas, lo que supone la existencia de poblaci\u00f3n no suficientemente inmunizada. El objetivo de este estudio es analizar la cobertura vacunal de la dosis de recuerdo frente al t\u00e9tanos en adolescentes en la localidad de Santa Amalia, provincia de Badajoz (Espa\u00f1a), durante los \u00faltimos 20 a\u00f1os (1996-2016). Material y m\u00e9todos: estudio observacional transversal. Se revisaron las tarjetas de vacunaci\u00f3n y los registros de las dosis administradas en los documentos manuscritos y registro inform\u00e1tico en el entorno JARA Atenci\u00f3n Sanitaria (JARA-AS). Entre 1996 y 2001, la vacunaci\u00f3n se hac\u00eda en el centro escolar, con registro manual. Desde 2002, se administr\u00f3 la vacuna en el centro de salud, con registro manual (2002-2007) e inform\u00e1tico (2008-2016). Resultados: analizada la cobertura de forma agrupada, los peores resultados de vacunaci\u00f3n se apreciaron en centro de salud utilizando registro manual (35,6%), mientras que las mejores cifras de vacunaci\u00f3n se encontraron en centro de salud con registro inform\u00e1tico (100%), seguido por el grupo de centro escolar (83,0%). Conclusiones: este estudio pone de manifiesto una alta cobertura de vacunaci\u00f3n frente a t\u00e9tanos en la dosis de recuerdo en adolescentes de 14 a\u00f1os en Santa Amalia, similar a la cobertura nacional, a diferencia de la baja cobertura existente en el resto de resExtremadura. CONCLUSIONES: La vacunaci\u00f3n obligatoria y la magnitud de las multas se asociaron con una mayor cobertura de vacunaci\u00f3n. Adem\u00e1s, la vacunaci\u00f3n obligatoria se asoci\u00f3 con una menor incidencia de sarampi\u00f3n en los pa\u00edses con vacunaci\u00f3n obligatoria sin exenciones no m\u00e9dicas. Estos hallazgos pueden informar las pol\u00edticas legislativas destinadas a aumentar la cobertura de vacunaci\u00f3n. Urinary tract infection (UTI) is a common cause of fever in children. Despite the increasing numbers of extended-spectrum pneumoniae and Proteus spp. at Ramathibodi Hospital from 2011 to 2017. The patients were classified into IAT and appropriate empirical The common causative organism was E. coli (88.8% and 96.2% in the and IAT clinical failure, microbiologic failure, relapse or time to defervescence between the 2 groups. No patients stay was longer in the IAT than AT group [4.00 was found between pediatric patients receiving AT and IAT for the treatment of UTI. In the era of increasing antimicrobial resistance, third-generation cephalosporins may still be an empirical antimicrobial for children diagnosed with community-onset UTI. On December 31, 2019, China reported to the World Health Organization (WHO) cases of pneumonia in Wuhan, Hubei Province, China, caused by currently designated 2019-nCoV. Mounting cases to at least 4 continents. As of January 28, there are more than 4500 confirmed cases (98% in China) and more than 100 deaths.1 In this Viewpoint, we describe the current status of 2019-nCoV, assess the and offer proposals for strategies to bring the outbreak under control. For the third time in as many decades, a zoonotic coronavirus has crossed species to infect provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market. The rapid response of the Chinese public health, clinical, and scientific recognition reports indicated that human-to-human transmission was limited or nonexistent, but we now know that such transmission occurs, although to what extent remains 24, 2020, there were more than 800 reported cases, with a mortality rate of 3% (https://promedmail.org/. opens in new tab). In December 2019, a cluster of patients with pneumonia of unknown cause was linked to China. A and SARS-CoV, is the seventh member of the and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.). An outbreak of novel (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and symptoms at 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection. The Streptococcus anginosus group of at Texas Children's Hospital. We undertook a retrospective review to describe the and of infections. Methods: We database of the microbiology laboratory at Texas Children's Hospital from 2011 to 2018 for SAG-positive cultures. Cases included were those associated with (1) either otitis media or sinusitis with substantial morbidity. These infections are becoming increasingly common at our center although the precise reason for this temporal trend is unclear. While antibiotics are life-saving drugs, their use is not risk, including adverse and antibiotic resistance. this study to describe trends in outpatient oral antibiotic rates decreased 5%, from 877 prescriptions per 1000 persons in 2011 to 836 per 1000 persons in 2016. During this period, rates of prescriptions dispensed to children decreased 13%, while adult ratio of broad- to narrow-spectrum antibiotics decreased from 1.62 in 2011 to in driven by decreases in macrolides fever without a source (FWS) in children and detection of human enterovirus (HEV), human parechovirus (HPeV), adenovirus (AdV) and human herpesvirus type 6 (HHV-6) in the plasma; and to assess whether the detection of viruses in the plasma is associated with a reduced risk of serious bacterial infection (SBI) and antibiotic single-centre, diagnostic study tested the children <3 years old with FWS. Real-time (reverse-transcription) PCR for HEV, HPeV, AdV addition was also tested for presence of viruses in their blood. Results HEV, HPeV, AdV and HHV-6 were tested for in the plasma of 135 patients of median age 2.4 months old. At least one virus was detected in 47 of 135 (34.8%): HEV in 14.1%, HHV-6 in 11.1%, HPeV in 5.9% AdV in There was no difference in antibiotic use between patients with or without virus detected, despite a relative risk of 0.2 for in the plasma of children with FWS. Antibiotic use was similar between viraemic and Point-of-care viral PCR testing of reduce antibiotic use and possibly investigations and admission rates human papillomavirus (HPV) vaccination before age intervention to improve HPV vaccination the HPV vaccine from pertussis incidence mortality rates no data have come from September 2012 to March 2016 at 6 hospital sites and confirmed by polymerase chain reaction testing were included. randomly selected controls were matched to each case patient estimated as (1 - OR) \u00d7 100%. RESULTS: Seventy-one case patients and 300 controls were included in the analysis. Forty-nine percent of case patients and 78% of controls had mothers who were vaccinated during pregnancy. second or third trimester of pregnancy. CONCLUSIONES: La mayor\u00eda de los ni\u00f1os con infecciones urinarias resistentes a cefalosporinas de tercera generaci\u00f3n que comenzaron con antibi\u00f3ticos discordantes experimentaron una mejor\u00eda cl\u00ednica inicial y pocos requirieron una intensificaci\u00f3n de la atenci\u00f3n. Nuestros hallazgos sugieren que la terapia emp\u00edrica de espectro bajo es apropiada mientras se esperan los resultados finales del cultivo de orina. World Health Organization announced vaccine hesitancy among the top 10 threats to global health in 2019. While the number of persons looking for information on health topics on the internet is increasing, information regarding immunization on the internet is often inaccurate and misleading. We aimed to determine the kind of information parents seek on the internet for decision-making regarding immunizations for their children. Methods: We investigated threads of an internet vaccine forum, where parents can get personalized advice from a vaccine expert, with regard to the types of vaccines and content of the questions. One thousand six consultations questions) between September 2001 and these, 1386, including 4000 questions, were related to immunizations of the user's child. Date of consultation, user gender and country of residence, age of the child; kind of vaccine(s), and topic of The Archivist is currently working in an environment where there is a high prevalence of methicillin resistant Staphlococcus aureus (MRSA) skin and soft tissue infections. Management of this remains a major challenge to the paediatric and adult antibiotic stewardship world. When we identify this infection what should we do? If we are to target the approaches to prevent these infections, we need to understand household longitudinal, aureus transmission dynamics in households of children ... Researchers have reported that a new vaccine against the dengue virus protected children and adolescents in a phase 3 trial conducted in Asia and Latin America. The most recent trial results of the new vaccine candidate, TAK-003, in about 20 000 young study participants suggest that its overall efficacy against infection is about 80%. Twelve months after the second dose, the vaccine was 95.4% infection, the vaccine's efficacy was 74.9%. At the American Society of Tropical Medicine and Hygiene's recent annual meeting, researchers reported that 73.3% 18 months. Based on the results of detection has sensitivity but good specificity. Performance of this test translates, on average, to a 52% chance of mistakenly indicating absence of infection and a 2% chance of mistakenly pointing to the presence of this condition. Because of its deleterious consequences for reproductive a rapid test for antigen detection. Research in this topic should focus on different technologies. We found five studies but it was not possible to tell how many participants were included as two studies only reported how many ears were treated. Different types of antiseptics Topical antiseptic (boric acid) versus no treatment (with a background treatment of ear cleaning) One study (254 children) compared using boric acid in alcohol ear drops with no topical antiseptic treatment. All children had their ears cleaned daily using cotton wool sticks (dry mopping). The very low certainty of the evidence means that it is unclear whether or not treatment with an antiseptic leads to an increase in resolution of ear discharge at four weeks or at three to four months compared with the group who did not receive any topical antiseptic. The study reported that there was no difference between the two treatment groups in hearing or suspected ototoxicity. There was no information for any of the other outcomes. Comparison of topical antiseptic agents: boric acid powder with daily acetic acid ear drops. The very low certainty of the evidence means that it is unclear if boric acid leads to an increase in ear discharge compared to daily acetic acid drops at four weeks. It was uncertain if one group had more ear discomfort than the other group. There was no information for any of the other outcomes. Authors' conclusions: Due to paucity of the evidence and the very low certainty of that which is available the effectiveness and safety profile of antiseptics in the treatment of CSOM is uncertain. There is low- and very low-certainty evidence intramuscular increase (GT) for reducing the duration of gastroenteritis Register and grey literature, published Results Of 797 titles identified, we included three studies (276 children). We performed a random effects model meta-analysis for the duration). We did not 0.62: I2=26%; two studies), at day to 3.47: I2=73%; 2.66: two abdominal pain and nausea. Conclusion The effect of GT was no different to placebo for mean diarrhoea duration (low certainty on the evidence) and stool frequency at day 2 (high certainty) and for the presence of diarrhoea at day 3 (very low certainty) of vomiting (moderate certainty) and of adverse events (low certainty). En segundo lugar, como mencionan Mill\u00e1n-Longo et al.1, cada vez es m\u00e1s conocida la base gen\u00e9tica de muchas IDP, gracias a los avances en t\u00e9cnicas de secuenciaci\u00f3n masiva disponibles en muchos centros que permiten un diagn\u00f3stico preciso con un mayor conocimiento de la historia natural de la enfermedad, una oportunidad de manejo m\u00e1s espec\u00edfico, as\u00ed como consejo gen\u00e9tico. Hemos le\u00eddo con inter\u00e9s el art\u00edculo publicado por Pi\u00f1eiro et al. \u00ab\u00bfEs la transmisi\u00f3n vertical de Chlamydia trachomatis un problema poco reconocido en Espa\u00f1a?\u00bb1, publicado en el n\u00famero de junio. En el citado trabajo, los autores hacen referencia a la transmisi\u00f3n perinatal de la infecci\u00f3n por Chlamydia trachomatis, y estiman una transmisi\u00f3n al reci\u00e9n nacido del 10,7% partiendo de una muestra de 103 mujeres infectadas en el puerperio. Los reci\u00e9n nacidos fueron analizados entre 7 y 10 d\u00edas despu\u00e9s del parto mediante exudado far\u00edngeo y conjuntival, este \u00faltimo en la parte final del estudio y en los casos que presentaron conjuntivitis. A new app will allow health repository, called CURE ID, is a collaboration between the FDA and the National Center for Advancing Translational Sciences, which is part of the National Institutes of Health (NIH). In addition, the app will offer a treatment discussion forum for clinicians to discuss treatments with other health professionals around the world. The FDA and NIH will remove posts that users flag as 1500 initial cases from clinicians and the published literature as well as 18 000 clinical trials were added in a recent update. The app is available at https://cure.ncats.io or from the App Store or Google Play. Hepatitis A is endemic in many countries. Swiss prevalence worldwide, more children are seronegative at arrival, highlighting the need for immunization in medical centers and refugee camps and questioning immunity according to origin and age, immunization strategies. We retrospectively analyzed 329 children's serostatus (1-16 assay local prices. Groups were compared with 2 test and the was studied linear with mostly negative serologies (71% strategy reducing costs by 2% compared with serology-guided immunization and compared with systematic vaccination. Many migrant children >5 years old are seronegative and at risk of clinical infection. They need to be immunized. New guidelines according to age and origin should be defined to immunization costs. We recommend systematic vaccination for patients low endemicity areas of seropositivity). For the others, we propose serology-based vaccination. El CAV-AEP publica anualmente el calendario de vacunaciones que estima id\u00f3neo para los ni\u00f1os residentes en Espa\u00f1a, teniendo en cuenta la evidencia cient\u00edfica disponible. Se mantiene el esquema 2+1 (2, 4 y 11 meses) con vacunas hexavalentes (DTPa-VPI-Hib-HB) y con antineumoc\u00f3cica conjugada 13-valente. Se aconseja un refuerzo a los 6 a\u00f1os, preferentemente con DTPa (si est\u00e1 disponible), junto a una dosis de polio para aquellos que recibieron esquemas 2+1, as\u00ed como vacunaci\u00f3n con Tdpa en adolescentes y en cada embarazo, preferentemente entre las 27 y las 32 semanas. La vacuna del rotavirus deber\u00eda ser sistem\u00e1tica para todos los lactantes. Se sigue proponiendo la incorporaci\u00f3n en el calendario de la vacuna antimeningoc\u00f3cica B, con esquema 2+1 en lactantes. Adem\u00e1s de la inclusi\u00f3n de la vacuna antimeningoc\u00f3cica conjugada tetravalente (MenACWY) a los 12 a\u00f1os con rescate hasta los 18 a\u00f1os, inclusive, el CAV recomienda que esta vacuna sea introducida tambi\u00e9n a los 12 meses de edad, sustituyendo a MenC. Igualmente, se recomienda en los mayores de 6 semanas de edad con factores de riesgo o que viajen a pa\u00edses de elevada incidencia de estos serogrupos. Se emplear\u00e1n esquemas de 2dosis para triple v\u00edrica (12 meses y 3-4 a\u00f1os) y varicela (15 meses y 3-4 a\u00f1os). La segunda dosis se podr\u00eda aplicar como vacuna tetrav\u00edrica. Se recomienda la vacunaci\u00f3n sistem\u00e1tica universal frente al VPH, tanto a chicas como a chicos, preferentemente a los 12 a\u00f1os, debiendo realizar un mayor esfuerzo para mejorar las coberturas. La de 9 genotipos ampl\u00eda la cobertura para ambos sexos. Controversy has arisen during the past decade or so regarding the medical and public health management of acute group A streptococcal pharyngitis (GAS) in children and adolescents. In particular, as the incidence of acute rheumatic fever (ARF) in many developed countries has declined, the need for testing throat swabs for GAS as an essential part of the routine evaluation of acute pharyngitis in has been administration\" for streptococcal pharyngitis \"can hardly be justified.\"2 Berkley presented 5 arguments to support of ARF in developed countries preceded the widespread use of antibiotics and is likely related to changes in the prevalence of GAS M protein types historically associated with ARF; (2) the military-based treatment studies have never been replicated and did not demonstrate 100% efficacy in preventing ARF, GAS is still endemic in developed countries despite widespread use of antibiotics, and there has not been a resurgence of ARF in developed countries that advocate withholding antibiotics; (3) the outbreak of ARF in Utah in the 1980s occurred due to the presence of a GAS M type (M18) previously associated with ARF, and some patients with ARF did not have a history of sore throat; (4) ARF is so rare in the US that \"any possible benefit [of antibiotic treatment of GAS pharyngitis] burden on medical resources\"; and (5) is swabbing antibiotic administration lack of evidence that antibiotic is beneficial in ARF prevention, recommend relative of conflicting approaches, a rigorous evidence base despite widespread use. In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone and 1 urban district emergency department in Perth, Western Australia. Inclusions were age >6 months, maximum weight enrollment in the study within the previous 14 days, and a high clinical suspicion of an alternative diagnosis. A total of enrolled and randomly (0.15 mg/kg; n = 410), or prednisolone (1 Primary outcome and interval steroid seems have no clinically significant impact on efficacy, both acutely and during the week after treatment. Global public health authorities have celebrated the eradication of wild poliovirus type 3, the second wild poliovirus strain to have been eliminated. The last type 3 case was detected in Nigeria in 2012. Now only a single strain remains: wild poliovirus type 1. In 2015, wild poliovirus type 2 was the first strain victory worldwide polio is within reach. \"Global wild poliovirus type 3 eradication is a tremendous achievement and is an important milestone on the Ghebreyesus, PhD, World Organization (WHO) and chair of the Global Polio Eradication Initiative Polio Oversight Board, said in a statement. \"This shows us that the tactics are working, as individual family lines of the virus are being successfully knocked out. But the job is not finished until ALL strains of poliovirus are fully to circulate in Afghanistan and Pakistan, according to the WHO. No wild type viruses have been detected on the African continent since 2016, David Salisbury, CB, chair of the independent Global Commission for the Certification of Poliomyelitis Eradication, said at said that vaccines now in development might help reduce the risk of infections linked to vaccine-derived strains. Las recomendaciones NO HACER son todas aquellas que no han demostrado eficacia, tienen escasa o dudosa efectividad, o no son coste-efectivas. Esta iniciativa parte de la National Physicians Alliance de Estados Unidos con el proyecto \"Choosing Wisely\" (Elegir con Prudencia), elaborando en cada sociedad cient\u00edfica un listado de cinco recomendaciones dirigidas a promover la mejora en la calidad de la atenci\u00f3n sanitaria. De forma simult\u00e1nea, la National Institute for Health and Care Excellence (NICE) ha venido elaborando las recomendaciones \"Do not do\" para las pr\u00e1cticas cl\u00ednicas que no aportan beneficio o en las que la relaci\u00f3n entre riesgos y beneficios no es razonable o bien no existe suficiente evidencia para aconsejar su uso sistematico. La Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica (SEIP) propuso a cada uno de sus grupos de trabajo la elaboraci\u00f3n de 5 recomendaciones NO HACER, centradas en la optimizaci\u00f3n del uso de antimicrobianos, en abandonar pr\u00e1cticas establecidas pero no respaldadas por la evidencia cient\u00edfica, en la utilizaci\u00f3n racional de las pruebas diagn\u00f3sticas y, en definitiva, en mejorar la calidad de la asistencia sanitaria en la patolog\u00eda infecciosa de la infancia. Acute otitis media (AOM) is one of the most common diseases in children: at least 60% of children under the age of 3 years have experienced at least one AOM episode and approximately 24% display 3 or more episodes.1,2 Moreover, AOM is one of the most frequent reasons for antibiotic prescription in children, accounting for up to 25% of the total number. Therefore, the appropriateness of antibiotic In some countries in some instances, their has contributed to reduce the unnecessary prescription of antibiotics by up to 12% with a 58% increase in antibiotics correctly were published in 2010,4 in recent years there have been advances in terms of the diagnosis, therapy and prevention of this disease. In recent years, new progress has been made regarding the diagnosis, treatment and prevention guidelines published in 2010. Methods: Literature searches were conducted on MEDLINE by Pubmed, including studies in children, in English or Italian, published between January 1, 2010, and December 31, 2018. The quality of the included studies was certain and the use of a pneumatic otoscope is of fundamental importance. As an alternative to the pneumatic otoscope, pediatricians can a To objectively establish the severity of the episode for the formulation of a correct treatment program, an AOM medical programs. The use of pneumatic otoscopes must be promoted, as they are not used in routine practice in Italy. treatment prevention otitis media (AOM) have been gained in recent years. For this reason, the Italian Paediatric Society has updated its 2010 guidelines. Methods: A literature search was carried out on PubMed. Only pediatric studies published between January 1, 2010 and December 31, 2018 in English or Italian were included. Each included study was assessed according of experts. Results: complications and/or a history of recurrence and for children under the age of 6 months. For children 6 months to 2 years of age, prompt antibiotic treatment is recommended for all forms antibiotic treatment years with severe bilateral AOM. A watchful-waiting approach can be applied to children over 2 years with mild or severe unilateral AOM or mild bilateral AOM. High doses of amoxicillin, or amoxicillin-clavulanic acid for patients with a high account of the child's age, the severity of the episode and whether it is unilateral or bilateral. In patients under 2 years, prompt antibiotic treatment is always recommended. In recent years, new information has been acquired regarding the diagnosis, treatment and prevention Italian Pediatric Society guidelines published in 2010. Methods: The search was conducted on Pubmed, and only those studies regarding the pediatric age alone, in English or Italian, published between January 1, 2010 and December 31, 2018, were included. Each study included in the review was assessed using the of AOM was reiterated with regard to the prevention of both the first episode of AOM and recurrences. Grommets can be inserted in selected cases of recurrent other D episodes risk factors and and vaccination. The use of other products such as probiotics and vitamin D is not adequate evidence. Kawasaki disease (KD), a systemic vasculitis, and management to reduce the risk of coronary artery damage that may cause significant ischaemia In practice, this is often difficult due to a lack of a diagnostic test and relies on the recognition of a constellation of clinical features. Since the American Heart Association (AHA) guideline in 2004,1 there have been over 2000 scientific and clinical publications on KD. The recently KD.2 Here we highlight and summarise the key updates relevance to paediatricians and discuss other recent features (box 1). KD can now be diagnosed with 4 days of fever when at least four principal diagnostic criteria are present (particularly if one of these is and oedema of the hands and feet). KD should still be considered if the resolves without treatment. should also be in: Infants irritability. Infants with prolonged fever and aseptic with prolonged fever plus unexplained lymphadenitis, retrotonsillar collection or shock. La infecci\u00f3n por el virus de la hepatitis E (VHE) es una de las principales causas de hepatitis aguda tanto en pa\u00edses desarrollados como en v\u00edas de desarrollo, situ\u00e1ndose como una enfermedad infecciosa de alta prevalencia e incidencia en Europa. La infecci\u00f3n por el VHE tiene mayor impacto cl\u00ednico en poblaciones especialmente vulnerables, como pacientes inmunodeprimidos, mujeres embarazadas y pacientes con hepatopat\u00eda base. Por todo ello, desde el Grupo de Estudio de las Hepatitis V\u00edricas (GeHEP) de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC) se considera de gran relevancia la elaboraci\u00f3n de un Documento de Consenso que sirva de ayuda en la toma de decisiones sobre el diagn\u00f3stico, manejo cl\u00ednico-terap\u00e9utico y la prevenci\u00f3n de la infecci\u00f3n por el VHE. El flujo vaginal es uno de los motivos de consulta ginecol\u00f3gica m\u00e1s frecuentes en ni\u00f1as prepuberales, y a menudo se debe a la presencia de vulvovaginitis1,2. La mayor\u00eda de los casos son de etiolog\u00eda inespec\u00edfica y se resuelven con medidas higi\u00e9nicas1,2. No obstante, cuando los s\u00edntomas persisten o recurren han de considerarse otras posibles causas, tales como procesos infecciosos, anomal\u00edas cong\u00e9nitas, trauma, reacciones al\u00e9rgicas, entidades dermatol\u00f3gicas o la presencia de cuerpos extra\u00f1os1,2. Presentamos el caso de una ni\u00f1a de 5 a\u00f1os sana... Los senos d\u00e9rmicos cong\u00e9nitos corresponden a una peque\u00f1a proporci\u00f3n de defectos de l\u00ednea media con una indicencia de 1-2.500/3.000 reci\u00e9n nacidos vivos. Normalmente se acompa\u00f1an de estigmas cut\u00e1neos en l\u00ednea media, especialmente en regi\u00f3n lumbosacra, y pueden asociar espina b\u00edfida oculta, siendo las infecciones y el d\u00e9ficit neurol\u00f3gico frecuentes1. Las lesiones cut\u00e1neas paramediales son extremadamente raras con tan solo 7 casos publicados2,3. Ni\u00f1a de 8 a\u00f1os con absceso gl\u00fateo derecho recurrente con celulitis local y drenaje purulento resistente a tto local y antibioterapia iv . No alteraciones neurol\u00f3gicas. Estudio de EII negativo. Como antecedente personal destaca la presencia de un orificio en la misma localizaci\u00f3n desde \u00e9poca neonatal. Radiol\u00f3gicamente se muestra un trayecto fistuloso gl\u00fateo que termina en fondo de saco por encima de la fosa isquiorrectal, sin comunicaci\u00f3n con el recto ni intraespinal , una malformaci\u00f3n sacrocox\u00edgea compleja con adelgazamiento del elevador del ano derecho y del m\u00fasculo isquiocox\u00edgeo, y una estructura osificada an\u00f3mala localizada entre los m\u00fasculos gl\u00fateos y la fascia endop\u00e9lvica , con ausencia de alteraciones del sistema nervioso central y cono medular. Se realiz\u00f3 ex\u00e9resis completa del trayecto fistuloso cuya histolog\u00eda correspondi\u00f3 a seno d\u00e9rmico. Tras 2 a\u00f1os de seguimiento, la paciente se encuentra with viruses. However, we present a novel case of a teenager with pneumococcal pneumonia and bacteremia myocardial in young Due to Non-vaccine was isolated from blood of twin 1-year-old girls within a 3-day interval, supporting the high invasive pneumococcal Region, investigation and surveillance of this serotype are necessary. La infecci\u00f3n por Pantoea agglomerans es muy rara de forma global y particularmente en Pediatr\u00eda. La mayor\u00eda de las infecciones que causa son nosocomiales en pacientes inmunodeprimidos. Se han descrito infecciones articulares tras punci\u00f3n con espinas vegetales dando lugar a artritis, sinovitis u oste\u00edtis; meningitis o septicemia neonatal tras la contaminaci\u00f3n de la nutrici\u00f3n parenteral o transfusiones de hemat\u00edes; infecciones de orina o respiratorias y peritonitis. En inmunocompetentes las infecciones son excepcionales, por lo que se aconseja realizar estudio de inmunidad, como en nuestro caso. El germen es muy resistente a antibi\u00f3ticos betalact\u00e1micos y para erradicarlo suele ser necesario tratar seg\u00fan antibiograma. Ni\u00f1o de 2 a\u00f1os ingresado de urgencia con fiebre, adenopat\u00eda cervical y crisis generalizadas t\u00f3nico-cl\u00f3nicas. Examen neurol\u00f3gico y anal\u00edtica anodinos. Se dio de alta al paciente con diagn\u00f3stico de crisis febril simple secundaria a infecci\u00f3n respiratoria viral. Al d\u00eda siguiente, el paciente reingres\u00f3 con estado epil\u00e9ptico febril. Los hallazgos de la TC cerebral fueron normales y el an\u00e1lisis del l\u00edquido cefalorraqu\u00eddeo (LCR) mostr\u00f3 pleocitosis (74 c\u00e9lulas/mm3) y niveles normales de prote\u00ednas y glucosa. El paciente presentaba adenopat\u00eda cervical y hepatoesplenomegalia. Se hizo un diagn\u00f3stico presuntivo de encefalitis... La malaria es considerada la cuarta causa de mortalidad infantil despu\u00e9s de la neumon\u00eda, las complicaciones por parto prematuro y la asfixia perinatal. Material y m\u00e9todos Estudio retrospectivo y descriptivo de los casos de paludismo confirmados y tratados en la Unidad de Enfermedades Infecciosas Pedi\u00e1tricas (edad inferior a 15 a\u00f1os) del Hospital La Fe (Valencia) en el per\u00edodo comprendido entre 1993 y 2015. Resultados Durante el per\u00edodo 1993-2015 se diagnosticaron 54 casos de malaria infantil, el 51,8% en varones. El 46,2% eran menores de 5 a\u00f1os. La mayor\u00eda de los ni\u00f1os proced\u00edan de Guinea Ecuatorial (68,5%). Solo en el 5,6% de los pacientes se pudo constatar que recibieran profilaxis antimal\u00e1rica. Se evidenci\u00f3 que Plasmodium falciparum fue la especie causal del 81,4% de los episodios. Siete casos (13%) presentaron malaria complicada. El tratamiento m\u00e1s empleado fue la quinina, sola o en combinaci\u00f3n con otros f\u00e1rmacos: atovacuona-proguanil fue empleada a partir del a\u00f1o 2010 y estuvo indicada en el 20,3% de los pacientes. A partir del a\u00f1o 2013 se inici\u00f3 la utilizaci\u00f3n de: artesunato, piperaquina y dihidroartemisina. No hubo mortalidad ni efectos adversos relevantes, siendo la respuesta cl\u00ednica favorable en el 100% de los ni\u00f1os. Conclusiones La malaria sigue siendo una enfermedad vigente en nuestra poblaci\u00f3n, consecuencia de la inmigraci\u00f3n y del turismo a pa\u00edses end\u00e9micos. Debe ser considerada como diagn\u00f3stico probable ante un ni\u00f1o febril que procede o ha viajado a un \u00e1rea end\u00e9mica en el \u00faltimo a\u00f1o. Introducci\u00f3n: No existen datos actuales de prevalencia de (ITU) en ni\u00f1os menores de 2 a\u00f1os con fiebre elevada en nuestro medio. M\u00e9todo: Estudio prospectivo, multic\u00e9ntrico, observacional incluyendo ni\u00f1os con fiebre a los que se realiz\u00f3 an\u00e1lisis de orina para descartar ITU en un periodo de un a\u00f1o en siete servicios de urgencia pedi\u00e1tricos espa\u00f1oles. Se incluyeron ni\u00f1os menores de un a\u00f1o y ni\u00f1as menores de 2 a\u00f1os con fiebre sin focalidad > 39\u00b0C y sin antibioterapia previa. El diagn\u00f3stico de ITU se bas\u00f3 en la presencia de leucocituria y urocultivo positivo. Resultados: Un total de 1675 pacientes fueron incluidos. Doscientos sesenta ni\u00f1os (15,5%, 95% IC 13,8-17,3) fueron diagnosticados de ITU. La prevalencia puntual de ITU fue 32,9% (95% IC 26,6-39,9) en lactantes febriles menores de 6 meses y 19,3% (95% IC 16,1-22,9) en lactantes febriles menores de 12 meses. La prevalencia puntual de ITU fue 13% (95% IC 10,8-15,6) en ni\u00f1os menores de 2 a\u00f1os con fiebre de menos de 24 horas de evoluci\u00f3n versus 17,5% (95% IC 15,2-20,1) en aquellos con m\u00e1s horas de evoluci\u00f3n de fiebre (p = 0,014). Conclusiones: La prevalencia puntual de ITU en ni\u00f1os con fiebre sin focalidad > 39\u00b0C en nuestro medio es superior a la referida previamente, especialmente en lactantes varones <6 meses y lactantes mujeres <12 meses. Nuestros resultados sugieren que los pediatras deben buscar de forma estrecha ITU en ni\u00f1os menores de 2 a\u00f1os con fiebre sin causa >39\u00b0C Pertussis months, To reduce morbidity and which was issued in 2012 and recommends administration recommendations a underlying is a to 2 tertiary pediatric hospitals in there were 131 presentations 127 (10%) septic arthritis (4%). In 19 frequent serotypes were 19A (19%), 3 and non-vaccine serotypes 22F (8%), 35B (6%), 15A (4%) and 38 (4%). Overall, 11% of isolates were non-susceptible to ceftriaxone. Only 36 patients (32%) had an immunologic support vancomycin treatment for children with pneumococcal meningitis given 11% of our isolates were not susceptible ceftriaxone. is important underlying Risk Among Under 5 Years Old: A Study of Hospital Admissions and Short Message Service-reported at 2020. Background: The season which a child is born may affect the immune system development and thereby influence the risk of infections. In this study, we examined the associations between birth season and the risk of hospital admission or symptoms associated with a wide range of infections. Methods: This study is a prospective cohort study of 2434 children with an average follow-up of 3.5 years. Admission data were obtained from the Danish National Patient Registry. Via short message service (SMS) questionnaires, 1279 families reported symptoms of infections in the 2434 children, 639 (26.3%) were admitted to the hospital, and the children experienced on average 64.4 days with symptoms of infection within 1 year. There was no association between birth season and hospital admissions due P = 0.471]. However, children born in the fall had a higher IRR for admission due to all infectious causes when excluding admissions within the first year of life. Winter- and spring-born children had lower IRRs for admission due to gastrointestinal infections than summer-born children, but this association was alone present when admissions within the first year of life were included. The short message service-survey showed significantly fall-born children (IRR = 0.88; CI, with summer-born children. Conclusions: Birth season was associated with hospital admission due to all infectious causes within the first 5 years of age; however, fall-birth was associated with a higher IRR for admissions due to all infectious causes after the first year of life. The association between birth season and admissions due to gastrointestinal infections was only seen when including children admitted under the age of one. Being born in fall or winter was associated with a decreased IRR for number of days with any symptom in France in November were associated with changes in national outpatient national antibiotic modeled changes of broad-spectrum antibiotics following the guidelines in 2 age groups (0-5 and 6-14 years old). Results: We analyzed 123 antibiotic prescription rate decreased by 33.1% (from 1387 1000 pediatric inhabitants per year), consistently across age groups and major antibiotic agents except for amoxicillin (+14.4%). After the release of the guidelines, we observed a gradual increase in the proportion 6-14 years, respectively) concomitantly gradual decrease in old, 2011 in outpatient antibiotic with a replacement of broad-spectrum antibiotics by amoxicillin. Yellow fever is an endemic disease in tropical areas in America and Africa. We report a case where the wild-type yellow fever virus was detected in a breast milk sample of a 33-year-old woman, from a rural area in the municipality of S\u00e3o Paulo, thus highlighting a potential risk for transmission of yellow fever virus through breast-feeding. OBJECTIVE: To estimate the cost-effectiveness of febrile urinary tract infection (UTI), as recommended by the American of Pediatrics. STUDY DESIGN: We developed a decision analytic model that simulates a population of children after a first febrile UTI. The model the were inflated to 2018 dollars, incorporated a 3% discounting rate. We with routine RBUS after second UTI (ie, control arm). Our main outcomes were recurrent UTI rate and had an overall accuracy (true positives + true negatives) of 64.4%. The the intervention arm was 19.9% compared 21.0% in the control arm. Thus, 91 would need to be control group. CONCLUSIONS: Screening RBUS after a first, febrile UTI in children age 2-24 months does not meet cost-effectiveness guidelines. Our findings support until a second UTI. The problems of antimicrobial resistance (AMR) are global and enormous. Like other global, enormous problems it is often difficult to know where to start\u2014and it is easy to doubt that individual efforts will have meaningful impact. With all such problems, accurate data are important but are hard to come by. Li et al 1 from 39 hospitals in 12 countries provide revealing prescribing practices in neonatal units through a Neonatal AMR network (NeoAMR) of tertiary units in Asia, Africa and South America. The study proves that global-scale AMR surveillance networks can for clinicians and policy makers. In this study, AMR in neonatal infections (both early and late onset) was widespread. More was but were emerging as a problem in two countries (Nigeria and India). There are limitations in this early report from the NeoAMR in their method and in the data reported. The results do not tell us about population-based prevalence of AMR in newborn sepsis, nor health facilities prescribing drives AMR: it is a vicious cycle. The most revealing in the reported first-line antibiotic therapies the intervention on improving ongoing antimicrobial stewardship program. Study Design: A multidisciplinary team at Montreal Children's Hospital performed series of interventions designed to SAP in quasi-experimental was performed to assess SAP compliance before and following the interventions. Our study included patients under 18 years old undergoing surgery between April and September in 2013 (preintervention) and in 2016 (postintervention). A 10-week washout period was compliance without cases requiring SAP were included in our primary analysis. The composite partial and total against Meningococcal B UK vaccination Public Health England advised paracetamol to be given prophylactically with the is associated with an increase in adverse events (AEs) in the 48 hours after vaccination in preterm infants and (ii) Retrospective case-note review of preterm infants, within a UK level 3 neonatal unit, receiving first or second 4CMenB vaccination, within 3 periods; (i) 1 prophylactic paracetamol): June 2016-May 2018. Data were collected on a predefined list of postvaccination AEs within 48 hours of vaccination: (i) number to and uninfected children at 22 US and Puerto Rico. Birth cCMV prevalence was estimated in a subset of participants had blood pellets collected within three weeks of birth and underwent 1 of 6 assessments evaluating cognitive and language development including an audiologic examination between 1 and 5 years of age. Detection of CMV DNA by polymerase chain reaction testing 895 eligible HIV-exposed uninfected children delivered between 2007 and 2015. Most (90%) were on combination antiretroviral therapy, 88% had an HIV viral and 93% had CD4 cell down compared with at increased risk for cCMV La exacerbaci\u00f3n de la enfermedad pulmonar obstructiva cr\u00f3nica y la neumon\u00eda adquirida en la comunidad son las infecciones del tracto respiratorio inferior m\u00e1s frecuentes en la pr\u00e1ctica cl\u00ednica diaria. La selecci\u00f3n del antibi\u00f3tico es un componente crucial en su tratamiento y, en la mayor\u00eda de las ocasiones, se realiza de forma emp\u00edrica. Las sociedades cient\u00edficas elaboran recomendaciones terap\u00e9uticas basadas en la evidencia cient\u00edfica y/o recomendaciones de expertos que son de gran ayuda para los cl\u00ednicos. Los betalact\u00e1micos, las fluoroquinolonas y los macr\u00f3lidos son los f\u00e1rmacos m\u00e1s utilizados por v\u00eda oral. Desde un punto de vista pr\u00e1ctico, existen tres claves para la adecuada elecci\u00f3n del tratamiento antibi\u00f3tico oral, que son la efectividad, la seguridad y el impacto ecol\u00f3gico en la microbiota del paciente, incluyendo el desarrollo de resistencias, que van a ser valoradas en profundidad en esta revisi\u00f3n. El Virus Linfotr\u00f3pico Humano T tipo 1 (HTLV-1) afecta hasta a 10 millones de personas en todo el mundo. Est\u00e1 directamente asociado a una de las neoplasias malignas de c\u00e9lulas T m\u00e1s agresivas: Leucemia-Linfoma de c\u00e9lulas T del Adulto (LLTA) y a un trastorno neurol\u00f3gico progresivo: Paraparesia Esp\u00e1stica Tropical / Mielopat\u00eda Asociada a HTLV-1 (PET/MAH). Adem\u00e1s, los pacientes infectados tienden a tener formas m\u00e1s graves de enfermedades infecciosas como la Estrongiloidiasis y Tuberculosis. El HTLV se propaga a trav\u00e9s de las siguientes v\u00edas: parenteral, sexual y vertical. La transmisi\u00f3n viral efectiva se produce principalmente por el mecanismo de contacto directo de c\u00e9lula a c\u00e9lula, a diferencia de otros retrovirus como el VIH, que generalmente se propaga infectando a las c\u00e9lulas mediante part\u00edculas virales libres. El HTLV-1 tiene una distribuci\u00f3n peculiar, con grupos de alta endemicidad en \u00e1reas cercanas de muy baja prevalencia o ausencia del virus. Esto podr\u00eda explicarse por factores que incluyen un posible efecto fundador, el predominio de la transmisi\u00f3n vertical (leche materna) y los mecanismos de transmisi\u00f3n por contacto c\u00e9lula a c\u00e9lula. Hoy en d\u00eda se necesitan m\u00e1s datos epidemiol\u00f3gicos para desarrollar estrategias en \u00e1reas end\u00e9micas, destinadas a reducir la diseminaci\u00f3n viral. En esta revisi\u00f3n, se analiza la patog\u00e9nesis, la epidemiolog\u00eda, el diagn\u00f3stico, las enfermedades asociadas, las estrategias preventivas y los tratamientos del HTLV-1, con \u00e9nfasis en el riesgo emergente para Europa y particularmente Espa\u00f1a, centr\u00e1ndonos en los m\u00e9todos de prevenci\u00f3n para evitar la transmisi\u00f3n viral y las enfermedades asociadas. "}